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Abstract 
ABSTRACT 
This study was conducted in order to develop novel chitosan/poly(ethylene 
oxide)(PEO) blend films crosslinked by genipin as potential membranes for potential 
medical applications, such as controlled drug carriers and separation of proteins from 
eleutherococcus senticosus (ES). 
Genipin, a naturally occurring and non-toxic crosslinking reagent, was used to form 
chitosan and chitosan/PEO blend networks. Genipin is found in traditional Chinese 
medicine and extracted from Gardenia fruit. Importantly, it overcomes the problem of 
physiological toxicity inherent in the use of common synthetic chemicals as 
crosslinking agents. 
The miscibility and morphology of chitosan /PEO blends were examined by means of 
differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy 
(FT-IR) and small angle X-ray scattering (SAXS). The experimental results indicate 
that the chitosan/PEO blends are miscible over the whole composition range. A 
phenomenon was observed for chitosan/LPEO (lower molecular weight PEO) blends: 
when the composition of chitosan was less than 60% by weight, the melting points 
increased as the composition of chitosan was increased. It is believed that there are 
strong molecular interactions between chitosan molecules and the molecules in the 
crystalline phase of LPEO in the chitosanALPEO blends. 
FT-IR and UV spectra analysis of the crosslinking reaction of chitosan revealed that 
the hydroxyl groups (3400 cm-1) and the amide groups (1645 cm-) in chitosan 
participated actively in the reaction. SAXS results showed that a heterogeneous 
structure exists in the chitosan/HPEO (or /LPEO) blend networks. Crosslinking by 
genipin restricts crystallisation and leads to smaller crystals. 
The mechanical properties, the stability in water, the swelling behaviour and 
surface properties of the films were also investigated. Improvements in the 
mechanical properties and the stability were achieved when the blends were 
crosslinked by genipin. The swelling characteristics of the crosslinked chitosan 
and chitosan/PEO blend films exhibit sensitivity to the environmental pH and 
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temperature. The polar functionalities in PEO and genipin help to improve the 
wetting capability of the films. 
In order to get a better insight into the effect of solution pH on film formation of 
chitosan solution, which has an influence on mechanical properties of chitosan films, 
conformation of chitosan macromolecules in solutions were studied. The results of 
static laser light scattering showed that chitosan has an extended chain conformation 
in low pH solutions and a tendency to aggregate in high pH solutions. In the dilute 
chitosan solution, a coil to globule transition of the single chain occurred. In low pH 
solutions, a homogenous gel network was obtained due to intermolecular chain 
association during gelation, resulting in better mechanical properties of chitosan films. 
In order to understand the effect of crosslinking temperature on mechanical properties 
of chitosan films, the temperature dependence of crosslinking reaction were studied. 
The results from FT-IR and UV spectra analysis showed that at a lower crosslinking 
temperature, a homogeneous crosslinking reaction occurred and this resulted in better 
elongation at break of the chitosan films. At higher temperatures, heterogeneous 
crosslink density in the films formed. 
For the purpose of potential medical applications, the controlled release of vitamin 
B12 and ES was investigated. The drug release rate was controlled by the mesh size of 
the membrane, which can be adjusted by a number of factors, such as crosslink 
density, the presence of PEO in the membrane, external pH, and the degree of 
deacetylation of chitosan. The potential study of protein separation from ES using the 
chitosan membranes was performed. The crosslinked chitosan membrane has the 
ability to separate proteins from ES. 
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CHAPTER1 
Introduction and Aims 
1.1 Background on Biomaterials 
Polymeric biornaterial science is a modern and interdisciplinary field with great 
prospects [1]. It primarily involves the medical use of biocompatible polymers in 
applications such as sutures, heart valves, hip and knee joints, intraocular and contact 
lenses, dental implants, various drug delivery systems and tissue regeneration [2-5]. 
Since the 1980s, it has shown remarkable development [3-5]. In recent years, in 
particular, polymeric biomaterials have become more attractive and of increasing 
interest. These smart materials have resulted in the development of advanced 
technologies of controlled drug and targeting delivery and the new concept of tissue 
engineering [5]. 
For a material to be a biomaterial, the minimum requirements are biocompatibility, 
biodegradability and non-toxicity [6]. These properties are essential for biomaterials 
as they are always in direct contact with living cells that are very vulnerable to, and 
could be readily killed by, physical and chemical stimuli. Clearly, not only the 
polymer, but also its possible degradation products, any residual monomer and all 
additives should be free of harmful effects. These requirements have not always been 
met. 
Chitosan, a natural biornaterial, has recently attracted much attention from scientists 
in different parts of the world [4,5]. It has been re-evaluated and found to be a useful 
resource as a functional material that more than satisfies the above criteria [7,8,9]. 
The characteristics of chitosan make it suitable for use in various biomedical 
applications, such as artificial skin, tissue regeneration and drug delivery systems [I- 
3,10]. For such applications, especially in tissue regeneration, chitosan must be 
mechanically satisfactory as well as meeting the minimum requirements for a 
functional biomaterial. In terms of mechanical performance, for example in 
structured materials in hip reconstruction and replacement, the biomaterial's strength 
and other physical properties are critically important and the most difficult to satisfy. 
I 
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For these reasons, the application of chitosan as a biomedical material has been 
limited to a few specific areas [4,5]. 
To achieve optimum effectiveness in biomedical applications, it is often desirable to 
crosslink biological molecules. The presence of free amino groups in chitosan 
enables it to be crosslinked. Conventional [11,12,13] crosslinking methods have 
involved reaction with dialdehydes, such as glutaraldehyde, digycidyl ethers or 
epoxides, whose chemically synthesized nature and non-exemption from the cause of 
physiological toxicity [14] pose problems. Recently, it was found that genipin is a 
biological material and it is suitable as a naturally occurring crosslinking agent with 
crosslinkable functional groups, such as amino groups or the like [15]. Itincorporates 
easily into biornaterials and is free of harmful effects [15]. It is, therefore, a possible 
solution to the above problem. 
1.2 Alms of the Project 
This project intends to develop novel chitosan/PEO blend films, which are crosslinked 
by naturally occurring genipin, for medical applications. Its main aspects are as 
follows. 
Preparation of novel chitosan/PEO blend films crosslinked by genipin 
Chitosan (CS) and chitosan/poly(ethylene oxide) (PEO) blend films crosslinked by 
genipin will be prepared. Two different molecular weight samples of PEO, one 
20,000g/mol and the other 600g/mol, will be used. PEO is chosen as the second 
component because it is a flexible polymer and it would greatly change the 
mechanical properties of the blends. PEO is also a biologically inert material [16], 
and therefore, suitable for biomedical applications. Thus, the blends are designed to 
produce mechanically resilient, chemically inert and stable films. In order to obtain 
the most suitable chitosan/PEO blend films for controlled drug release systems, the 
chitosans with different degrees of deacetylation will be used to produce the novel 
films. 
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Studies on morphology and physical properties 
To obtain optimum novel films, the study of morphology and physical properties of 
the films will be carried out. These will include molecular interactions between 
chitosan and PEO, miscibility of chitosan/PEO blends, phase behaviour of crosslinked 
chitosan/PEO blends, mechanical and surface properties, and swelling behaviour and 
stability of these chitosan/PEO films. A number of techniques will be employed, such 
as Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry 
(DSC), small angle x-ray scattering (SAXS), tensile test and contact angle 
measurement. 
Studies on conformation of chitosan macromolecules in aqueous solution 
Chitosan is an acidic soluble polymer. Solution pH may influence its solution 
properties and this may also affect the mechanical properties of the chitosan film. In 
order to understand better these properties, the conformation of chitosan 
macromolecules in aqueous solutions will be investigated by means of static laser 
light scattering (SLLS). Muti-chain aggregation behaviour and single chain coil-to- 
globule transition (collapse) of chitosan macromolecules in the solution will be 
investigated. 
Studies on temperature-dependence of the crosslinking reaction 
In order to understand the effect of crosslinking on the mechanical properties, the 
temperature-dependence of the crosslinking reaction of chitosan with genipin will be 
studied by means of Fourier transform infrared spectroscopy (FT-IR) and 
ultraviolct/visible spectrometry (UV). From this study, the details of the crosslinking 
process will be observed and the effect of crosslinking temperature on mechanical 
properties of chitosan films will be understood. 
Medical applications: controlled drug release and protein separation 
For medical applications we propose to develop such biofilms as potential functional 
membranes for controlled drug delivery systems. Vitamin B12 and eleutherococcus 
senticosus (ES), which is an herbal Chinese medicine, will be chosen as the two drug 
models for the controlled-release studies. The drug release behaviours from a carrier 
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under both conditions of fixed and moving boundaries will be performed and their 
release mechanism will be investigated. 
We also propose to develop these biofilms as potential membranes for separating 
protein from ES. ES is a powerful tonic herbal medicine that has been widely used in 
a number of countries in the world to treat heart disease, diabetes and blood 
circulatory problems [17]. However, because of its high protein content, ES can only 
be taken in tablet form, and therefore, its use is limited. We aim to use these 
membranes to widen its use by separating off the un-wanted protein. 
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CHAPTER 2 
Literature Review 
2.1 Polymeric Biomaterials 
A biornaterial is defined as a material that is capable of establishing an interaction 
with the surrounding biological environment without stimulating an adverse response 
by the host [ 18,19]. 
There are three sources of polymeric biornaterials [20-23]. 
1. Natural polymers, mainly polysaccharides and some proteins, such as cellulose, 
starch, chitin/chitosan, hyaluronan, gelatin and collagen etc. These polymers are 
biocompatible and primarily attacked and degraded by enzymes. 
2. Synthetic polymers, particularly aliphatic polyesters such as poly(glycolic acid) 
(PGA), polylactic acid (PLA) and poly(c-caprolactone) etc. The main mechanism 
of degradation is the hydrolysis of the backbone chains. 
3. Modifications of natural or synthetic polymers such as graft and block 
copolymers, polymer blends and networks etc. 
For polymeric biornaterials to be in contact with blood, tissue and organs in the 
human body without any toxic effects or provoking a reaction from the body's 
immune system, they must have excellent biocompatibility [1-5,24]. Interactions 
occur between a biomaterial and the living tissue when the foreign material comes in 
contact with the living body. As a result, the biomaterial may undergo detectable 
alteration in surface and bulk structure, giving rise to hydrolysis, deterioration, and 
fatigue [1,20-23]. The living body, on the other hand, responds to the foreign material 
by invoking an immune reaction. Hence, a material is said to be biocompatible, or 
more specifically, interfacially biocompatible when such adverse biological responses 
do not occur, or occur at much reduced rates [1,5]. Biocompatible polymers must 
often also be biodegradable, and non-harmful products should be generated as a result 
of their biodegradation. In the human body, biornaterials can erode and degrade step 
by step due to the ubiquitous distribution of water or enzymes, and the degradation 
products do not introduce any disturbance in the body. Eventually, by diffusion, 
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oxidation and metabolic processes, the final products are naturally occurring, such as 
water and carbon dioxide, which are excreted by the kidneys and lungs. 
Functional groups of a polymeric material are usually responsible for its 
biocompatibility and/or biodegradability and may impart to it either therapeutic or 
toxic characteristics. For example, carboxylic groups induce the therapeutic activity 
of many drugs [4]. Cell and protein binding reactions and growth may be strongly 
affected by functional groups of an implanted polymer. Encapsulation of an implant 
is triggered by adsorption of various proteins on its surface and adhesion of cells from 
the adjacent tissue. The nature of such a biofilm may be strongly influenced by the 
surface properties of the polymeric material. Cell and protein binding reactions and 
growth of the attached cells can be effectively manipulated by appropriate 
functionalization of the surface of such implants [1,2,4]. 
As indicated above, an implanted polymeric material may be considered to be 
'biocompatible', if its insertion into the body does not provoke an adverse reaction. A 
thrombus is quickly formed when most polymers come into contact with blood cells. 
Materials with non-thrombogenic blood-compatible surface must, therefore, be used 
in contact with the blood stream. Truly biocompatible polymers used for medical 
purposes should be able to recognize and cooperate in harmony with bio-assemblies 
and living cells without any non-specific interactions [1-5,20-24]. To achieve these 
goals, appropriate functional groups should be incorporated into surfaces, which 
would resist non-specific adsorption of proteins [25]. 
Biodegradable polymers (also called bioerodible or bioresorbable polymers) may be 
of synthetic or natural origin. Non-toxic alcohols, acids and other low molecular 
products, easily eliminated by the body, are formed as a result of hydrolysis in vivo 
for such biocompatible polymers. High molecular weight polymers with 
hydrolytically unstable crosslinks may be bioerodible as a result of the breakdown of 
their crosslinked chains. Finally, water-insoluble polymers may be converted into 
water-soluble ones as a result of ionisation, proteination, or hydrolysis of side chains. 
Such conversions do not significantly affect molecular weight, but may be responsible 
for bioerosion in typical applications. Progress in the field of tissue engineering 
depends on the development of novel biocompatible, fully bioresorbable polymers 
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and the introduction of processing techniques, which will enable reproducible three- 
dimensional architectures on the macro- and nanometre scales [1,3,5]. 
Chitosan has more than satisfied the above criteria [7,8]. Chitosan has not only been 
extensively used in biotechnology, health care, food and beverages, chitosan has also 
been found to be a promising base material for numerous blending, grafting and 
coating bio-applications [20-23] to improve and achieve the desired properties. 
Because chitosan has favourable biological properties, such as biodegradability and 
biocompatibility, it has attracted a lot of attention in the life science and it emerges as 
an important biomedical material of the future [3]. 
2.2 Chitosan as a Biomaterial 
2.2.1 Introduction of chitosan 
2.2.1.1 Definition and chemical structure of chitosan 
Chitosan is a naturally occurring polysaccharide. It is also the principal component of 
chitin, which is one of the most naturally abundant biopolymers, being second only to 
cellulose and is found in the cell walls of fungi such as mushrooms, yeasts, and the 
hard outer shells of insects and crustaceans, like crabs, shrimp and krill [26-29]. 
Chitosan is produced by alkaline deacetylation of chitin. The structures of chitin and 
chitosan are depicted in Figure 2.2.1. The backbone consists of P-1,4-linked 
glucosamine with a high degree of N-acetylation, a structure very like that of 
cellulose, except that the acetyl amino group replaces the hydroxyl group on the C-2 
position. Thus, chitosan is poly(N-acetyl-2-amino-2-deoxy-D-glucopyranose). The 
N-acetyl-2-amino-2-deoxy-D-glucopyranose (or Glu-NI-12) units are linked by (1--)' 4) 
P-glycosidic bonds [30,3 1]. 
The difference between chitin and chitosan is essentially related to the possibility of 
solubilizing the polymer in dilute acidic media. Thus, when the structure can be 
dissolved in this kind of solvent, it corresponds to chitosan, in the reverse case, to 
chitin. Therefore, the degree of acetylation (DA), which is related to the balance 
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between acetylated and deacetylated residues, is essential to define these two terms. 
When chitin is deacetylated in heterogeneous conditions, the solubility in water is 
only achieved for DA generally below 30% [32]. Nevertheless, on reacetylating 
chitosan in homogeneous conditions, it is possible to observe a solubilization up to a 
DA close to 60% [32,33]. As a consequence, the frontier between chitin and chitosan 
can be located at a DA of 60%. As we shall see, DA is also an interesting adaptable 
parameter whose simple modification allows us to provide this series of copolymers 
with a very great variety of properties. In numerous circumstances, this opportunity 
gives the advantage of avoiding some difficult and expensive chemical modification. 
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Figure 2.2.1 Chemical structures for cellulose, chitin and chitosan. 
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2.2.1.2 Production of chitosan 
Chitin is produced essentially from the cuticles of crustaceans, especially from crab 
and shrimp shells. Another interesting source is presented by the endoskeletons of 
cephalopods. Chitin is closely associated with proteins, inorganic materials, which is 
mainly CaC03, and pigments and lipids. Various procedures have been adopted to 
remove these impurities [301. 
Chitosan is synthesized from chitin by removing and refining the acetyl groups 
through a process called deacetylation [30]. The method is relatively simple and 
consists of two successive extractions. The first is dernineralisation related to the 
presence of a more or less significant amount of calcium carbonate in the shell. This 
step is performed by means of mineral acids including HCI, HN03, CH3COOH and 
HCOOH [30]. It must be performed with care, particularly for medical applications 
for which the mineral part must be eliminated, but also because polysaccharides are 
well known to be easily hydrolysed in acidic media. Dernineralization with acid may 
be carried out at temperatures from 0 to I OOOC. Table 2.2.1 shows the variation in the 
HCI concentrations and lengths of time of the treatments used. The second step is 
deproteinization, which consists of placing the material in alkaline media of sufficient 
concentration associated with moderate heating [29]. Also, the complete 
deproteinization is very important in the case of medical uses. A wide range of agents 
for the deproteinization includes NaOH, Na2CO3, KOH, K2CO3 etc. NaOH is the 
preferred agent. Table 2.2.2 shows the treatments for a wide variation in temperature 
and duration. 
Chitosan is obtained from the N-deacetylation of chitin and all the methods are 
derived from the description given in two patents [34,35]. The extent of deacetylation 
is governed by the alkali concentration, the temperature and the time of reaction. The 
higher the concentration of alkali the lower the temperature and/or the shorter the time 
required. The treatment with 50 wt% NaOH at 100'C for I hour gave a product 
having 82% degree of deacetylation [30]. Extending the reaction time to 48 hours 
enabled almost 100% deacetylation to be achieved [30]. For the exoskeleton of 
crustaceans containing colouring matter, principally, carotenoids, this matter can be 
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destroyed by bleaching by using KMn04, NaOCI, S02, and NaHS03 [30]. The 
process for the production of chitosan can be described by Figure 2.2.2. 
Table 2.2.1 Conditions for dernineralisation of chitin-containing waste materials [30] 
Material source 
HCI 
Concentration 
(M) 
Temperature 
0Q 
Time 
(hour) 
Shrimp 0.275 20 16 
Shrimp 0.5 Not stated Not Stated 
Crab 0.65 20 24 
Crab 1.0 20 12 
Crab 1.0 20 1 
Crab 2.0 20 48 
Prawn 1.57 20-220C 1-3 
Table 2.2.2 Conditions for deproteinisation of chitin-containing waste materials [30] 
Material source 
NaOH 
Concentration 
(M) 
Temperature 
0c) 
Time 
(hour) 
Shrimp 0.25 65 16 
Prawn 0.125 100 0.5 
Prawn 1.25 100 24 
Crab 0.5 65 2 
Crab 1.0 80 3 
Crab 1.25 100 0.5 
Crab 2.5 20 72 
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Figure 2.2.2 Chitosan production flow chart 
For mild conditions, these methods allow us to reach in one step DA close to 10- 15%. 
If repeated once, the deacetylation can be within 90-95%. Although each step 
operated in relatively drastic conditions contributes to an important deacetylation, the 
chain length becomes relatively low at the end of the treatment [30]. In order to avoid 
this problem, the use of sodium thiophenolate has been proposed, allowing both the 
catalysis of the reaction and the protection of the polymer chains from degradation. 
This method allows us also to considerably decrease the amount of sodium hydroxyde 
used [36]. 
Deacetylation of. chitin yields chitosan, which is relatively reactive and can be 
produced in numerous forms, such as powder, paste, film, fibre, and others [37,38]. 
The degree of deacetylation (DD) usually ranges from 70% to 95% depending on the 
methods used [39]. The DD determines the content of free amino groups in chitosan 
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and is, therefore, one of the important chemical characteristics. The extent of 
deacetylation also depends on the applications. For instance, pharmaceutical grade 
chitosan would require 90 to 95% deacetylation, while the food grade requires 
between 75 and 80% [40]. The biomedical grade/purified chitosan is prepared by 
repeating the deacetylation process. 
2.2.2 Physicalchemical properties of chitosan 
Solubility of chitosan 
Solutions of chitosan corresponds to the most important physical state for this 
polymer, either from a fundamental point of view or for the very great number of 
applications obtained from this physical form. The solution behaviour of chitosan is 
informative of the properties of this polymer. Indeed, it reflects the role of the 
structural parameters and the molecular weight distribution, based on the interactions 
with the solvent and on the molecular and supramolecular organisation [30]. The 
various interactions in which this polymer can be involved can be understood from 
solution behaviours. 
As seen from the chemical structure schematised in Figure 2.2.1, chitosan is highly 
functionalized. When the glucosamine residues are in the free amine form, these 
structures are strongly involved in the formation of three-dimensional networks by 
hydrogen bonding [30] and hydrophobic and van de Waals interactions [30]. So, the 
solubility of chitosan depends on parameters such as the degree of deacetylation, the 
molecular weight and various environmental parameters[30]. 
At neutral or basic pH, chitosan contains free amino groups and is insoluble in water, 
while at acid pH, chitosan is soluble in water due to protonation of the amino 
functions. The solubility depends on the degree of deacetylation and pH [31,36]. 
Chitosans with a low degree of deacetylation (-<40%) are soluble up to a pH of 9, 
whereas highly deacetylated chitosans (ý: 85%) are soluble only up to a pH of 6.5. The 
addition of salts to the solution interferes with the solubility of chitosans. The higher 
the ionic strength, the lower the solubility as charge neutralisation occurs by 
increasing concentration of the counterion. Increasing degree of deacetylation 
increases the viscosity [30]. This can be explained by the fact that high and low 
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deacetylated chitosans have different conformations. Chitosan has an extended 
conformation with a more flexible chain when it is highly deacetylated because of the 
charge repulsion in the molecule. However, the chitosan molecule has a rod-like 
shape or a coiled shape at a low degree of deacetylation due to the low charge density 
in polymer chain [41,42]. The viscosity of chitosan solution is also affected by factors 
such as concentration and temperature. As the concentration increases and 
temperature decreases, the viscosity increases [43]. 
For thermodynamic reasons, the solubility of a neutral polymer is known to decrease 
with increase in molecular weight [44]. In the case of chitosan, two factors play an 
additional role, the possibility of inter-chain associations by hydrogen bonding and 
the polyelectrolyte character. 
The solubility of chitosan can also be constrained by use of acids, which can interact 
with chitosan in a particular way. The most typical behaviour is that of sulphate ions, 
which interact with chitosan [30,43]. 
Chitosan has specific solution properties. The following lists the key solution 
behaviour of the two amine forms of chitosan [30,43]. 
Free amine (-NH2): 
-*. - Soluble in acid solutions 
4- Insoluble at pHs >6.5 
4- Insoluble in H2SO4 
-*. - Insoluble in most organic solvents 
Cationic arnine (-NH3+): 
4. - Soluble at pHs<6.5 
-*. - Fonns viscous solutions 
Solution shear thinning 
Forms gels with polyanions 
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The origin and the quality of the materials and processes can also play an important 
role in the solubility of chitosan. Although the chemical structure of chitosan is 
independent of the source, the DA value and molecular weight are related to the 
source and the quality of the treatment. 
Chitosan gel 
Chitosan can exist in a gel state. This gel is always formed in the presence of water. 
The formation of a physical gel needs to be at a concentration sufficiently high to 
favour the chain entanglement necessary for the formation of a continuous gel. This 
critical concentration is well-known as C* and is easily deduced from the inverse of 
intrinsic viscosity [43]. The formation of a gel can only be achieved when chitosan is 
initially in the form of a salt of a weak acid such as acetic acid. By contract, if 
chitosan is in the form of a hydrochloride, gel formation is not observed. The gel 
formation is related to the balance between attractive and repulsive interactions along 
the polymer chains and the ability to favour the formation ofj unction points by means 
of ordered domains. This balance can be influenced in different ways. It is obviously 
dependent on the molecular mobility of polymer chains in the media and on the 
degree of deacetylation [30,43]. In some circumstances, the gels are thermoreversible 
30,43]. They can also be fully regenerated in the form of pure chitosan gels after a 
complete exchange of the components of the initial media of their formation [30,43]. 
The mechanical properties of chitosan gels are very interesting because of their 
numerous possible applications. As for all gels, they obviously depend on the density 
of reticulation, the polymer concentration in the gel, and the molecular weight. The 
limitation comes from the fact that the best gels are necessarily obtained from the 
highest molecular weights, the highest DA, and the highest polymer concentrations. 
The consequence is that it is difficult to prepare chitosan gels containing more than 2 
% polymer because of high viscosities and the kinetics of gelation [43]. These gels 
are completely exchangeable in pure water with no major alteration of their properties 
and have significant potential of medical applications [43]. These gels are formed 
mainly due to the conjugation of hydrogen bounding and hydrophobic interactions. 
From a physical point of view, in addition to their good mechanical properties, in 
relation to a high polymer concentration, they necessarily have a high porosity. The 
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consequence is that these gels can be used to interact with a great variety of molecules 
[43]. 
Crystallinity and morphology 
Chitosan is a semi-crystalline polymer and as such, most of its properties in the solid 
state depend essentially on the percentage of the crystalline part and sometimes on the 
crystalline form [30,43]. The degree of crystallinity is a function of the degree of 
deacetylation. The crystallinity, as measured by X-ray diffraction at the different 
degrees of deacetylation, is shown in Figure 2.2.3 [45]. During the deacetylation up 
to a degree of deacetylation of 71%, the crystallinity decreased slightly and then more 
rapidly, so that by 89% deacetylation the crystallinity peaks had almost disappeared 
and the sample was completely amorphous. 
DD: degree of deacetylation 
DD - 32% 
DD - 45% 
DD - 55% 
PD-71% 
DD-89% 
DD-95% 
V 104 156 20* 24' 
Figure 2.2.3 X-ray diagrams of chitosan with different degrees of 
deacetylation [44]. 
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By 95% deacetylation, the material was again crystalline, but the peak position had 
moved as seen in Figure 2.2.3.0 and 95% deacetylated chitosan give maximum 
crystallinity, while intermediate degrees of deacetylation give the lowest crystallinity 
[46]. The crystalline structure of chitosan means that it is stable and insoluble in 
aqueous solutions above pH 7, but fully soluble in dilute acids such as acetic and 
formic acids [30,43]. 
A number of changes in the infrared spectrum of chitin during deacetylation have 
been attributed to changes in the degree of crystallinity [47]. In the 2600-3800 cm"l 
region, as the extent of deacetylation increases from 91% to 99%, three distinct, sharp 
peaks appear at 3455,3365 and 3313 cm-1 as shown in Figure 2.2.4. These bands 
were described [47] as 'crystallisation-sensitive' bands. 
CL) 
Li 
9 
3400 3000 2600 
Wavenuanber (cm-1) 
LA 
Figure 2.2.4 IR spectra of chitosan with different degrees of deacetylation 
[39]: (a) 88%, (b) 91%, (c) 96%, (d) 99%. 
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The solid state of chitosan can vary from a morphologyical point of view. Its 
properties in this state depend on the origin of the material and on the method of 
processing [30,43]. Moreover, they depend on whether chitosan is used as received 
from the manufacturer or whether it has been regenerated after solubilization. In 
former case, the material has the memory of the crystalline organisation and in the 
later case the solubilization destroys this organisation. 
Hydrogen Bonding and Electrostatic Interactions 
Alcohol, amine, amide, and ether functions present in the structure of chitosan can be 
involved in the formation of hydrogen bonds either with various substrates or by 
means of inter- and/or intra-molecular bonding [30,43]. The most important substrate 
in the formation of this kind of interaction is water. It participates in the formation of 
the hydrogen bonds responsible for the solubility of chitosan in water. Nevertheless, 
the competition between inter- and intra-molecular bonding is always present. This 
competition is regulated by the balance between attractive and repulsive interactions. 
Here, the degree of ionisation and the degree of deacetylation can play important 
roles. In the solid state, the hydrogen bonding is responsible for the ordered structures 
in the crystalline domains and for the inter-chain interactions which reinforce the 
stability of these domains. 
The polyelectrolyte character of chitosan was clearly illustrated by Kurita et aL [47]. 
At acid pH, chitosan is a linear polyelectrolyte and has a high charge density. The 
chitosan molecules show strong positive charges that attract negatively-charged 
molecules and ionically bind them [30,49-511. They also form gels with polycations 
at low pH and have antacid anti-ulcer activities [29,49-5 1 ]. The charge density allows 
chitosan to form insoluble ionic complexes or complex coacervates with a wide 
variety of water-soluble anionic polymers. The adsorption capacity for metal ions 
depends on the amine group concentration of the chitosan. It is not the total 
concentration, but the concentration of accessible amine groups that is importantý 
since these are the ones available for complex formation. Because the chitosan charge 
density is pH dependent, transfer of these ionic complexes to physiological pH can 
result in the dissociation of a portion of the immobilised polyanion. This property can 
be used as a technique for drug delivery [4,5]. 
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The chemical structure of chitosan is able to give rise to all the known interactions of 
chemistry. The nature of these interactions depends particularly on two parameters, 
the degree of deacetylation and the degree of ionisation of the ionised functions. 
It can be seen from Figure 2.21 that chitosan has a reactive amino group at C2 and a 
hydroxyl group at the C6 positions, which can be modified chemically for various 
applications [52]. The important chemical reactions of chitosan were reviewed by 
Muzzaraelli in the late 1970s [53]. The more recent developments in the chemical 
modifications of chitosan, along with the resulting properties, were reviewed by 
Kurita [3 1 ]. 
Hydrophobic and van der Waals interactions 
Hydrophobic and van der Waals interactions are often used to interpret results 
especially in the case of amphiphilic polymers such as biopolymers. If we consider 
the structure of chitosan, the -CH, -CH2, --CH3 and -NH2. groups are hydrophobic. 
Ile conformation of chitosan in solution is relatively stressed and stiffness increases 
with DA. As a consequence, the deprotonation of amino groups and the increase of 
DA, temperature and dielectric constant influence not only the hydrogen bonding, but 
also this kind of interaction. When the temperature of chitosan increases, the 
solubility of chitosan decreases as a result of the disruption of hydrogen bonding with 
water and the increase in the hydrophobic and van der Waals interactions [30,43]. 
2.2.3 Biological properties 
Biodegradability 
Chitosan is completely absent in mammals. The first interesting biological property 
of chitosan is its ability to be biodegradable and bioresorbable. Chitosan-degrading 
enzymes were first identified by Monahghan et aL [54]. Studies with Penicillium 
islandicum indicates that the enzyme shows high specificity towards hydrolysis of the 
glycosidic link between C(l) of an N-acetyl-D-glucosamine residue and C(4) of a D- 
glucoisamine residue. The degradation process depends on the form of chitosan. 
Microcrystalline chitosan is more susceptible to enzymatic decomposition in 
comparison to standard chitosan [30]. The degradation process carried out in the 
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enzymatic media was also estimated according to the amount and type of liberated 
oligoaminosaccharides [30]. 
In vivo, chitosan is degraded by enzymatic hydrolysis. The primary agent is 
lysozyme, which appears to target acetylated residues [55]. However, there is some 
evidence that some proteolytic enzymes show low levels of activity with chitosan. 
The degradation products are chitosan oligosaccharides of variable length. The 
degradation kinetics appears [56] to be inversely related to the degree of crystallinity, 
which was controlled mainly by the degree of deacetylation. Highly deacetylated 
forms (e. g>85%) exhibit the lowest degradation rates and may last several months in 
vivo, whereas samples with lower levels of deacetylation degrade more rapidly [56]. 
Biocompatibility 
Chitosan lacks irritant or allergic effects and is biocompatible with both healthy and 
infected human skin [57]. The biocompatibility of chitosan has been studied. The 
first important results were obtained from experiments on dogs [58]. It was shown 
that in the case of a graft of aorta covered with chitosan, there was a good integration 
of the synthetic material owing to a local haemostasis on the surface of the material 
created by the chitosan coating. The direct injections of chitosan in blood have also 
been studied. In an experiment on rabbits, intravenous injection of chitosan oligomers 
was made at a dosage 4.5mg/kg body weight. No abnormal physiological symptoms 
were noticed after treatment for II days [59]. Some studies were performed in vitro 
on the role of the addition of chitosan solutions to cell suspensions. In the case of 
fibroblasts, it was observed that the presence of chitosan at low concentration 
inhibited the proliferation of the cells, but did not act as a cell killer [60]. 
2.3 Modification of Chitosan 
23.1 Poly(ethylene oxide) 
Since the 1960s, a range of synthetic biodegradable polymers has been developed, 
including poly(L-lactic acid) (PLA), polyglycolide (PGA) and poly(lactide-co- 
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glycolide) (PLG). Of recent interest is poly(ethylene oxide) (PEO). As shown 
below, PEO is a polyether type of the water-soluble synthetic polymer. 
-[CH2CH201n- 
When the molecular weight is less than 10,000 Daltons, the polymer is called 
poly(ethylene glycol) (PEG). Polymers with a higher molecular weight are known as 
poly(ethylene oxide) [161. Compared other polyethers, such as poly(propylene 
oxide), PEO is highly water soluble [60]. Kjellander and Florin [62] explained the 
higher water solubility of PEO in terms of a good structural fit between water 
molecules and the polymer, resulting in hydrogen bonding between the ether oxygen 
of PEO and water molecules. 
With PEO, aqueous solubility decreases with increasing temperature. The decreased 
solubility at elevated temperatures is due to a decrease in hydrogen bonding and 
corresponding increase in hydrophobic interactions between polymer chains [63]. 
Bjorling et aL [64] reported that PEO adapts to a gauche conformation in polar 
solvents such as water and a trans-conformation in non-polar medium. The gauche 
conformation would be more suitable for hydrogen bonding. 
At the solid-liquid interface, PEO anchored through terminal ends will interact with 
water molecules and extend into the bulk aqueous medium [65]. Surface-bound PEO 
molecules are very effective in preventing adsorption of other macromolecules by the 
steric repulsion mechanism [66]. 
PEO-rich surfaces have been prepared by physical adsorption of PEO [67]. Only high 
molecular weight PEO (M,, > 100,000) can be effectively adsorbed on hydrophobic 
surfaces [67]. PEO is relatively inert toward biological species, whether it exists in 
free homogeneous solution, is absorbed onto a substrate, is grafted onto polymer 
surfaces or formed into networks [68-70]. 
PEO is widely used to stablize aqueous colloids and dispersions, commonly by means 
of physical adsorption followed by steric repulsion of the modified particles [70,71]. 
Ile low molecular weight PEG is normally chosen as a pre-polymer in the synthesis 
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of polyurethanes, epoxies, and other polymers. PEG is widely used in the chemical, 
biochemical and biotechnological industries to make a variety of non-ionic surfactants 
[71]. 
PEO is both hydrophilic and hydrophobic, due to its solubility in both aqueous and 
non-polar solvents. In solutions, it tends to be highly dynamic, and yet it can readily 
pack and form crystalline solids. Despite its dynamics and mobility, it can complex 
and aggregate and develop specific helical and near-helical conformations [16]. More 
importantly, it can interact and complex with a variety of ionic and hydrogen bonding 
structures. PEO, as a molecule alone and as part of other molecules, is generally non- 
toxic and considered safe for a wide variety of food, cosmetic and biomedical 
applications [1-3]. It is a water soluble and biocompatible polymer, which are 
notable advantages of this material. 
PEO has often been used as a biomaterial due to its well-documented biocompatibility 
[72]. It is also noted for its low protein binding affinity [71]. This is especially 
critical in medical applications where protein adsorption on surfaces tends to alter its 
properties. This was evident in the study carried out by Alcantar et al. where 
poly(ethylene glycol) (PEG)-covered surfaces showed efficacy in protein rejection 
when brought in contact with albumin in solution [73]. Nelson et al. [74] tested the 
affinity of albumin on PEO-treated surfaces and concluded that improved 
biocompatibility was achieved when the high albumin affinity drug, warfarin, was 
tethered to the surfaces by PEO. 
Being a neutral and highly hydrophilic polymer, PEO tends to minimize electrostatic 
and hydrophobic interactions, respectively [75,76]. The high mobile and dynamic 
PEO chains create a strong repulsive interaction between proteins. 
2.3.2 Chitosan and Poly(cthylenc oxide) (PEO) Blends 
Chitosan is an amino polysaccharide and is thus anticipated to have high potential as a 
specialty polymeric material. However, these potential benefits are scarcely utilized 
because of the problems associated with solubility, multifunctional ity and reactivity. 
To develop advanced functions leading to utilization, much attention has been paid to 
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the modification of chitosan. Several chitosan modifications have been carried out up 
to now based generally on two types of processes: physicalchernical and chemical 
[77-82]. 
A chemical modification of chitosan based on a substitution of its amino - and/ or 
hydroxyl- groups has changed the behaviour of this polymer [77-82]. A 
physicalchernical modification of chitosan, concerned with suitable changes of 
molecular as well as super-molecular structure of the polymer, enables the creation of 
valuable forms of this natural high molecular weight compound with new, original 
properties and behaviour [77-82]. 
There have been some reports dealing with polyblends of chitosan with other natural 
or synthetic polymers [83-85]. For example, chitosan/poly(vinyl alcohol) blend film 
was found to have good dyeability, a chitosan/poly(vinyl alcohol) blend membrane 
was used in the pervaporation of ethanol and water [82,83], and chitosan/nylon-4 
blends were found to have good mechanical properties and retain the excellent 
chelating ability of chitosan [85]. 
Recently, chitosan and poly(ethylene oxide) (PEO) blends have been reported for the 
preparation of membranes for haemodialysis [86] and semi-IPNs for pl-l-sensitive 
drug delivery [87]. 
Investigations by several researchers demonstrated favourable intermolecular 
interactions between chitosan and PEO [88,89]. Jiang and Han [88] studied the inter- 
and intra-molecular interactions between chitosan and PEG by means of a viscosity 
method. Experimental results were fitted into a revised calculation of the 
thermodynmic interaction to obtain the thermodynamic parameter, X, where a 
negative value of X indicates an attractive intermolecular interaction between chitosan 
and PEG. 
Mucha et al. [89] further attested the miscibility of chitosan/PEO blends in the 
amorphous phase by the negative value of the Flory-Huggins interaction parameter. 
Their infra-red (IR) results proved that the intermolecular interaction between 
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chitosan and PEO molecules was by hydrogen bonding between the hydroxyl groups 
of chitosan and the ether oxygens of PEO, and that the amide groups do not 
participate in the moIecular interaction between chitosan and PEO. 
Wang et al. [90] further studied the miscibility of blends of PEO with two chitosans, 
which have tfie mole fraction of N-acetyl-D-glucosamine (FA) values of 0.25 and 
0.02, respectively. The results indicated that both commercial chitosan (0.25) and 
chitosan (0.02) are partially miscible with PEO due to the specific interactions 
between chitosan and PEO molecules. These interactions arise from the formation of 
intermolecular hydrogen bonds between chitosan and PEO. The specific interactions 
in chitosan (0.25)/ PEO blends are greater than in chitosan (0.02)/PEO blends, and 
maximum interaction was observed at 50% PEO content for the former and at 25% 
PEO content for the latter. This is because the PEO component is better dispersed in 
the continuous chitosan (0.25) phase than in the chitosan (0.02) phase due to the more 
amorphous structure of chitosan (0.25) compared with chitosan (0.02) [90]. 
The mechanical properties of chitosan/PEO blend films were examined by Alexeev et 
al. [9 1] and it was observed that the chitosan/PEO blends containing 16.7weight % of 
PEO had a6 times improvement in the relative elongation at break and the tensile 
strength doubled. It was shown that at 16.7 weight % of PEO, the film structure is 
likely to be less heterogeneous, therefore, giving rise to the improved mechanical 
characteristics. 
Recently, Khoo et al. [92] have investigated chitosan blends with hydrophilic 
polymers including poly(vinyl alcohol) (PVA), poly(ethylene oxide) (PEO) and 
poly(vinyl pyrrolidone) (PVP) as candidates for oral gingival delivery systems. The 
results from DSC, DMTA, FT-IR spectroscopy and tensile testing indicated that the 
chitosan/PEO and chitosan/PVP blends showed evidence of miscibility in all blend 
ratios studied, while the chitosan/PVA blend only showed evidence of interaction for 
the (50: 50) and (80: 20) blends, but not for the (20: 80) blend. The study also indicated 
that chitosan blends were superior in other properties compared to chitosan alone. 
These included improved comfort and reduced irritation, ease of processing, improved 
flexibility, and enhanced dissolution. Blends of chitosan with different hydrophilic 
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polymers are thus promising candidates for formulation in oral mucosal delivery 
systems. 
The porous structure chitosan/PEG blend membrane has been prepared by a selective 
dissolution method for the purpose of biomedical applications such controlled drug 
delivery [93]. The results indicated that the pore structure induced by this method is 
controlled by the compatibility of chitosan and PEG and by the multiphase structure. 
2.4. Applications of Chitosan 
Chitosan, being a deacetylated chitin, is a natural, biodegradable, water-insoluble 
biopolymer. Due to its better solubility in organic acids, chitosan is much more useful 
than chitin. Specific properties of chitosan specially connected with its 
biodegradability and bioactivity result in this polymer being a perfect raw material for 
several different applications such as in medicine, pharmacy, agriculture, food 
processing and cosmetics. The most observed and spectacular development of 
chitosan utilization in the above-mentioned areas started in the last few years [94,95], 
especially in the medical world. Table 2.4.1 highlights some of its applications. 
2.4.1. General applications 
Waste Water Treatments 
The presence of a high amino content in chitosan makes it a powerful chelating agent 
[96] compared with other materials like activated sewage sludge, poly(p-amino- 
styrene) or bark. Harmful metal ions such copper, mercury, lead and uranium are 
readily removed from waste water. Hirano at al. [97] found that 40-74% of the 
available uranium could be recovered from river and lakewater and 3% from 
seawater. The extremely low recovery rate from seawater might have been caused by 
the presence of large quantities of other metal ions. Recent studies reported that the 
chelating ability of chitosan could be improved by homogenous hydrolysis [98-100] 
and complexation with polymers such as glucan [ 10 1 ]. 
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Table 2.4.1 Applications of Chitosan 
Reference. q 
Controlled release of drugs 
Artificial blood vessels 
Artificial skin/skin bums 1,3,4,18, 
Wound healing ointments and 118,132,111, 
Medical dressings 112,113, 
Contact lens/eye bandages 114,115,116, 
Blood chlolesterol control 133,134,135,18 
Transportation of cells 8 
Dentistry 
Surgical sutures 
Antichlolesterol and fat-binding 
Preservatives 
Food Food stabilizer 1,3,4, 
Flavor and tastes 
Nutritional additives 
Removal of metal ions 
Sewage effuents 97,98,99,100 
Waste and water treatment Drinking water 
Pools and spas 
Seed coating 
Agriculture Hydroponic/fertilizer 
Controlled agrochemical release 
103,104,105 
Nernatocides and insecticides 
Hair treatment 
Moisturizers 
Cosmetics and toiletries 
Face, hand and body creams 
Make up powder 
Nail polish 
106,107,108, 
109 
Toothpaste 
Foam enhancing 
Surface treatment 
Pulp and paper Photographic paper 1,3,29,178 
Carbonless copy paper 
Immobilization of enzymes/cells 
Product separation and 
recovery (bioapplications) 
Membrane separations 
Permeability control 
1,4,5 
Reverse osmosis 
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No single decolourisation method is likely to be the optimum for all waste water 
streams [102]. Chitosan has an extremely high affinity for many classes of dyes, 
including disperse, direct, reactive, acid, vat, sulphur and naphthol dyes [30]. 
Chitosan is versatile in sorbing metals and surfactants, as well as derivatization to 
attract basic dyes and other moieties (e. g., proteins from food processing plants). 
Waste water pH may be an important factor in the sorption of certain dyes onto 
chitosan because, at low pH, the free amino groups of chitosan are protonated, 
causing them to attract anionic dyes. 
Agriculture 
Chitosan has been used successfully to reduce environmental damage caused by 
agrochernicals, such as fertilizers, herbicides, and pesticides. Reports showed that 
coating fertilizer pellets with films of N-acetyl or N-propionyl chitosan warrant a 
controlled-release effect, where the herbicide was trapped in the chitosan gels and was 
released over an extended period of time. The release time was greatly increased as 
compared to the uncoated control beads [103]. 
Chitosan is also useful in improving soil properties and preparing hydroponic 
fertilizer. It was found that the N-methylenechitsan gel bed greatly reduced the rate of 
water evaporation. Not only that, when N-methylenechitosan was mixed with sand 
and clay, young seedlings in this mixture survived longer when watering stopped, 
than seeds in a sand bed [ 104]. 
An increase in crop yield was noted when chitosan was applied in a seed coating 
application. Beneficial effects such as inhibition of fungal pathogens in the vicinity of 
the seeds and enhancement of plant-resistant responses against disease were observed 
[105]. Being naturally occurring and biodegradable, pollution problems are greatly 
reduced and chitosan would easily find its way in potential agriculture applications. 
Cosmetics 
Another application of chitosan can be found in the cosmetic industries [106]. For 
example, chitosan has the ability to remove left-over starch contained in shampoos. 
Its use also has the effect of conferring shine and strength to hair due to interactions 
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between the polysaccharide and hair proteins. Other uses in cosmetics include 
moisturizers, hair and skin fixatives, hair conditioners, nail polishes, cleaners and bath 
lotions [107-109]. 
Food and nutrition 
Animal nutritional studies have shown that the utilisation of whey may be improved 
if the diet contains small amounts of chitosan. This improvement is attributed to the 
change in the intestinal microflora brought about by the chitosan supplement [I 10]. 
Opthalmology 
Chitosan possesses all the necessary characteristics for making contact lenses, 
including optical clarity, mechanical stability, gas permeability, wettability, sufflicient 
optical correction and immunological compatibility [111]. Among these properties, 
gas permeability is the most important since oxygen must be transported from the tear 
fluid to the eye surface, whereas carbon dioxide needs to diffuse back from the eye 
surface to the fluid. These properties, coupled with the anti-microbial and wound 
healing benefits make chitosan suitable for the development of ocular bandage lenses 
[I 11]. 
Artificial skin 
Chitosan has been employed for making artificial skin [ 116]. Several investigations 
were carried out and reported [117-119]. A design for long-term chronic use was 
proposed by Yannas et al., whose focus was on a non-antigenic membrane, which 
serves as a biodegradable template for synthesis of neodermal tissue [120]. Chitin 
and chitosan can be made into fibres and have been found to be useful as absorbable 
sutures and in accelerating the healing of wounds by up to 75% [121-123]. Chitin 
sutures resist attack in bile, urine and pancreatic juice, which are problem areas with 
other absorbable sutures [123]. 
A chitosan-gelatin complex has been developed for surgical dressing by Sparkes and 
Murray [124], where the stiffness of the resulting dressing can be reduced by 
incorporating a certain amount of plasticiser such as glycerol and sorbitol into the 
mixture. It was claimed that, contrary to conventional biological dressings, this 
experimental dressing displayed excellent adhesion to sub-cutaneous fat. Another 
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development stemmed from polyelectrolyte complexes of chitosan with sulfonated 
chitosan, where Kim and Min [125] proposed that the oligomers of degraded chitosan 
by tissue enzymes accelerated wound healing. This material was found to be effective 
in regenerating the skin tissue in the area of the wound. Kifune et al. [ 126] developed 
a new wound dressing, Beschitin W, which contains a non-woven fabric and has been 
proven to be beneficial in clinical practice. 
Mi et al. [127] designed a novel asymmetric chitosan membrane whereby a 
macroporous sponge-like sub-layer supported the skin surface top-layer. This 
membrane showed controlled evaporation water loss and excellent oxygen 
permeability. It also promoted drainage of wound extrudate with minimum 
exogenous microorganism penetration due to the dense skin layer and the inherent 
anti-microbial property of chitosan. The asymmetric membrane acted as a 
haernostatic agent and histological examination confinned an increased 
epithelialization rate and a well-organized deposition of collagen in the dermis. 
Biagini et al. [128] developed a N-carboxybutyl chitosan dressing for plastic surgery 
donor sites. This dressing could promote ordered tissue regeneration compared to 
control donor sites. Better histoarchitectural order, better vascularization and the 
absence of inflammatory cells were observed at the dermal level, while fewer aspects 
of proliferation of the malpighian layer were reported at the epidermal level. 
A non-adherent wound dressing with sustained anti-microbial capability has been 
formulated and investigated by Loke et al. [129]. This double layer dressing 
comprises a carboxymethyl-chitin hydrogel upper layer capable of imbibing 4 times 
its own weight of water and is semi-porous to water vapour. The lower layer is a 
chitosan acetate foam incorporated with the anti-microbial agent chlorhexidine 
gluconate. In vitro drug release study showed that at the optimal loading 
concentration of 1% (w/v) chlorhexidine gluconate, the chitosan acetate foam was 
able to release up to 92% of its total chlorhexidine gluconate content at 37'C. It was 
reported that when placed on open wounds, this dressing serves the dual function of 
controlling fluid and heat loss from the wound and acting as a prophylaxis against 
wound sepsis [129]. 
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Although great strides have been taken to improve the quality of care of bum victims 
and patients with diabetic ulcers, the current materials are not able to induce healing 
in close to 100% of the cases. Even in successful applications, the cosmetic results 
are not always favourable. Significant efforts in the development of a new class of 
materials for skin regeneration are needed [3]. 
2.4.2 Drug-delivery systems 
Drugs are very important for health care and life. In recent years, the studies on anti- 
cancer drugs, anti-AIDS drugs [4,40], gene therapies and anti-sense drugs has been 
very active and brought great happiness to mankind. However, most drugs, including 
those mentioned above, are far from ideal for simple administration, e. g. by 
swallowing or injection. [4,5,40,130]. They may have very poor solubility or rapid 
metabolism and instability or unfavourable biodistribution or very high toxicities 
[1311. 
Controlled drug delivery technology represents one of the most rapidly advancing 
areas of science. Such delivery systems offer numerous advantages compared to 
conventional dosage forms including improved efficacy, reduced toxicity and 
improved patient compliance. 
The science and technology in this field have advanced significantly since 1980s. 
Some drug delivery systems have been invented and developed, mainly including 
diffusion or biodegradation control systems, water penetration control systems, self- 
regulated controlled systems and external regulated control systems etc. [132-135]. 
All controlled release systems aim to improve the effectiveness of drug therapy. The 
different forms that improvement can take can be summarised by two types of control 
over drug release, temporal and distribution control. 
In temporal control, drug delivery systems aims to deliver the drug over extended 
duration or at a specific time during treatment. Controlled release over an extended 
duration is highly beneficial for drugs that are rapidly metabolised and eliminated 
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from the body after administration and it ensures that the maximum possible benefit is 
derived from the drug. In distribution control, drug delivery systems aim to target the 
release of the drug to the precise site of activity within the body. A diverse range of 
mechanisms has been developed to achieve both temporal and distribution controlled 
release of drugs using polymers. This diversity is a necessary consequence of 
different drugs imposing various restrictions on the type of delivery system employed. 
The drug is released by diffusion or biodegradation and enters the body 
systematically. Controlled-release dosage forms enhance the safety, efficacy and 
reliability of drug therapy [40]. They regulate the drug release rate and reduce the 
frequency of drug administration to encourage patients to comply with dosage 
instructions [5,40,136]. This is a very important aspect of health care. As a material 
for drug carrier use, polymers, especially chitosan, are playing an increasingly 
important role for the above c9ntrol system formulations due to their enormously 
useful properties, such as degradability, non-toxicity and biocompatibility [7,81. The 
degraded products of chitosan do not introduce any disturbance in the body. Hence, it 
can be a suitable matrix, available in different forms, for sustained release of various 
drug formulations. Various drugs may be incorporated into a chitosan matrix in a 
variety of forms for controlled-release therapies [ 13 6-143]. 
Chitosan direct compression tablets triggered the sustained release of prednisolone 
[144,145], a water-insoluble drug. The release rate was controlled by changing the 
relative amounts and degree of deacetylation of chitosan and sodium 
carboxymethycellulose. Interaction of the drug diclofenac with the chitosan amino 
groups is a possible reason for the sustained release [ 146]. 
Recently, chitosan has gained importance as a disintegration agent due to its strong 
ability to absorb water. It has been observed that chitosan contained in tablets at 
levels below 70% acts as a disintegration agent [147,148]. Neau et aL [149] studied 
the sustained-release characteristics of ethylcellulose tablets containing theopyylline 
as the model drug. Several equations were tested to characterize release mechanisms 
with respect to the release data. The investigations revealed that, at high drug 
loading, the drug was released by a diffusion mechanism with a rate that increased 
with increasing aqueous solubility. At low drug loadings, polymer relaxation also 
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became a component of the release mechanism. However, its contribution to drug 
release was less pronounced as drug solubility decreased, becoming negligible in the 
case of theophyline [147,148]. 
Micro-spheres are one of the most useful and most widely studied drug delivery 
systems for the release of therapeutic agents. Chitosan micro-sphere degradation can 
be controlled by various cross-linking agents for specific applications. The release of 
mitoxantrone from glutaraldehyde cross-linked chitosan micro-spheres has been 
studied [150]. The histological analysis showed that the micro-spheres were tolerated 
by the living tissue [151]. The controlled release of bovine albumin and interleukin-2 
from alginate-chitosan micro-spheres has also been investigated. The sustained 
release of proteins from micro-spheres was for a greater duration than that from other 
micro-sphere formulations [ 152]. 
Thacharodi and Rao [153-155] reported permeation-control led trans-dermal drug 
delivery systems using chitosan membranes. The drug release was significantly 
reduced when crosslinked chitosan membranes were used to regulate drug release in 
the devices. It was observed that the drug release rate depends on the crosslink 
density within the membranes. Highly cross-linked chitosan membranes released 
only approximately 35% of the drug compared with 70% from weakly cross-linked 
membranes [153-1551. 
Interfacial formation of a chitosan polyelectrolyte complex film on the surface of 
thcophylline granules containing sodium tripolyphosphate has been investigated by 
Kawashima et al. [156]. This film coating on the granules significantly reduced 
release rate, which followed zero-order kinetics. Its thickness and hardness also 
affected the drug release rate [156]. 
Since chitosan is non-toxic and can be administered orally, it has mainly been studied 
as an oral delivery system in the form of tablets or micro-spheres. Its mucoadhesive 
and permeation enhancement properties have been used for trans-dermal and 
sustained gastrointestinal drug delivery. Its biodegradability and tissue compatibility 
make it a suitable component for implantable delivery devices. Despite the 
outstanding scientific progress being made in terms of the application of chitosan in 
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drug delivery systems, chitosan-based drug delivery products have not yet been 
launched on the market. With a wide range of potential applications in medicine and 
phannaceutics, there is tremendous scope for future research on chitosan and its 
derivatives [40]. 
2.4.3 Separation membranes 
Recent developments in the design of artificial kidney systems have made possible 
repetitive haemodialysis and the treatment of patients with kidney insufficiently. 
Haemodialysis is a method by which specific substances such as urea, uric acid, 
creatinin, among others, are separated from the blood in the course of so-called 
dialysis. During dialysis, the blood is led from blood vessel through an artificial 
kidney in which it flows along a semi-permeable membrane. An appropriately- 
composed rinsing liquid is located on the other side of the membrane into which the 
toxic substances travel through the semi-permeable membrane. The cleaned blood is 
then led back to the body. If such a treatment is not administered the blood becomes 
so strongly enriched with these hannful substances that sooner or later death occurs 
[4]. 
At present, commercially available dialysers are equipped with membranes made 
either of natural or synthetic hydrophilic and hydrophobic polymers. Previously, 
most membranes employed for haemodialysis were of a cellulosic basis, namely 
membranes of regenerated cellulose. Although advances have been made in the 
design of haemodialYsis instruments, the problem of blood-membrane interactions 
remains a major obstacle in haemodialysis treatment [157]. Surface-induced 
thrombosis and serum complement activation are the most serious clinical 
consequences of blood-membrane interactions. Thrombus formation on biornaterial 
surfaces is initiated by plasma protein adsorption, followed by the adhesion and 
activation of platelets [158]. On haernodialysis membranes, heparin is infused 
frequently to minimize surface-induced thrombosis. Anti-coagulation with heparin is 
associated with several side-effects, including the high risk of haemorrhage [159]. 
Complement activation by the alternative pathway results in a transient disease in 
leucocyte count observed within 30 minutes of hemodialysis treatment [160]. There 
has been on effort to improve the blood compatibility of hemodilysis membranes 
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[161-163]. In addition to surface modification of existing membranes, it is necessary 
to identify other materials with improved permeability as well as blood compatibility 
properties 
Chitosan, which has excellent film-forming properties and good mechanical strength 
suitable for haemodialysis [164], has the potential to be used as an artificial kidney 
membrane [36], When in contact with blood, chitosan, unfortunately, promotes 
plasma protein adsorption, platelet adhesion and thrombosis [165,166]. In order to 
improve the blood compatibility of chitosan membranes, without compromising the 
permeability properties, extensive research efforts [167-175] are being directed 
towards developing new or modified materials 
Several studies of chitosan/poly(vinyl alcohol) (PVA) blend membranes have been 
reported [167-172]. According to Miya et al. [167], chitosan formed clear 
homogenous blends with PVA, and the tensile strength of the blend was greater than 
the component value. These membranes showed good permeability. 
I Kim el aL [171] studied a chitosan/PVA blend membranes cross-linked with varying 
amounts of glutaraldehyde. The permeability was found to be pH dependent. The 
effect of cross-linking and blending of chitosan with PVA on the permeability of 
vitamin B-12 were also studied. The partition coefficients were nearly constant [172]. 
Albumin-blended chitosan membranes had superior permeability properties for 
smaller molecules compared to the standard cellulose membranes, and these 
membranes showed maximum reduction in platelet adhesion in comparison to other 
membranes as reported by some workers [173]. Chitosan membranes modified with 
thiol groups were investigated for the permeability of KCI and sucrose by glycol 
[174]. The study showed that permeation control can be achieved by varying the 
amount of crosslinking agent. Hirano et al. [175] prepared a series of membranes 
from chitosan and its derivatives and membranes showed improved dialysis 
properties. 
Recently, chitosan/PEO blend membranes for haemodialysis were investigated by 
Amiji [86]. The results indicate improvements in the permeability and blood 
compatibility. The equilibrium hydration increased from 44% for chitosan to 62.5% 
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for chitosan/PEO blend membranes when the molecular weight of PEO was 10,000 or 
higher. Electron spectroscopy for chemical analysis (ESCA) suggested an increase in 
PEO on the membrane surface with increasing molecular weight in the blend. The 
permeability coefficient of urea and other solutes through chitosan/PEO blend 
membranes were much higher compared to those in chitosan membranes or in 
commercially available Cuprophan ID membranes. The high permeability was either 
due to the porosity or an increased hydrophilicity of the membranes. Platelet 
adhesion and activation were significantly reduced on chitosan/PEO blend 
membranes. However, chitosan/PEO blend membranes did not prevent serum 
complement activation. The degree of complement was similar to that of Cuprophario 
membranes. The permeability is limit to size of molecule [86]. It, therefore, appears 
that there is a need to develop better haemodialysis membranes to improve flow data 
such as permeability, greater selectivity and higher dialysis rate, and further improve 
platelet adhesion and activation to meet the highly demands of haemodialysis 
membrane applications [136]. 
2.5 Genipin as a Naturally Crosslinker for Chitosan 
2.5.1 Introduction 
The crosslinking of chitosan extends its medical applications into area such as, 
implants, wound dressings, blood substitutes and drug carriers by improving 
otherwise poor mechanical properties. For example, biological tissues have been used 
in manufacturing heart valve prostheses, small-diameter vascular grafts and biological 
patches [176-178. ]. These biological tissues have to be fixed with a crosslinking agent 
and subsequently sterilized before they can be implanted in humans [179]. The 
fixation of biological tissue is to reduce antigenicity and immunogenicity and prevent 
enzymatic degradation [4]. Up to now, various crosslinking agents have been used in 
fixing biological tissues. These crosslinking agents are mostly synthetic chemicals 
such as formaldehyde [4], glutaraldehyde [4], dialdehyde and epoxy compounds 
[180]. However, these chemicals are all highly (or relatively highly) cytotoxic, which 
may impair the biocompatibility of biological tissues [4,7,8]. Glutaraldehyde is 
known [181] to have allergenic properties, giving rise to occupational dermatitis. 
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Like other synthetic chemical reagents, it is highly cytotoxic 1181.1821, and Ior 
gluteraldehyde, cytotoxicity occurred at concentrations greater than 10-25ppm. In 
tissue cultures. c otoxicity needs to be as low as 3ppm [15]. There is, therefore, I Yt 
increasing demand for a crossfinking agent that is able to form suitable biocompatible 
products without adding any cytotoxicity problems. Genipin is a naturally occurring 
crosslinking agent, which seems to display promising characteristics. 
2.5.2 Preparation and properties of genipin 
Genipin can be obtained from an iridoid glycoside and geniposide, which are the 
primary active components, abundantly present in gardenia fruit (Gardenia 
jasmindides Ellis) as seen in Figure 2.5.1. 
aor vw 
Figure 2.5.1 A photograph ofthe fruit ofGardenia jasmi nd ides Ellis 
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The iridoid glycoside gardenia and geniposide are mainly gardenoside, chlorogenic 
acid and ursolic acid. The methods of isolating iridoid glycoside and geniposide from 
Gardenia jasmindides Ellis have been described by Endo and Taguchi [ 183]. In a 
water-ethanol commercial extract of the fruits, iridoid glycoside and geniposide made 
up 70% of the extract [ 184] 
Genipin can be prepared from the latter by oxidation followed by reduction and 
hydrolysis, or by enzymatic hydrolysis [184]. Alternatively, racemic genipin may be 
prepared synthetically [185]. A variety of pharmacological activities of genipin has 
been reported; choleric action, inhibition of gastric acid secretion, and so on [ 186]. 
The chemical structure of genipin is shown in Figure 2.5.2. 
n OCH3 
Figure 2.5.2 Chemical structure of genipin. 
Reaction of genipin with glycine, alanine, histidine, lysine and glutamate in aqueous 
buffer solution converted the colourless starting materials to blue pigments. The dark 
blue pigments were obtained by its spontaneous reaction with amino acids or protein 
[28]. These dark blue pigments have been used in the fabrication of food dyes. Effect 
of pH on the formation of blue pigments was studied using a UV-vis 
spectrophotometer [187]. The optimum pH for the formation of the blue pigment was 
7.0. The rate of the formation of blue pigment was a constant from genipin with 
amino acids at various temperatures. The resulting blue pigments are more stable in 
alkaline (pH 9.0) than in natural (pH 7.0) and acidic solutions (pH 5.0) [188]. 
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Sung and co-workers [188-191] have undertaken studies to investigate the 
cytotoxicity, stability, feasibility and biocompatibility of genipin for biological tissue 
fixation. The results of a series of studies carried out on porcine pericardia crosslinked 
with genipin indicate that this agent can form stable crosslinked products [189]. In 
the feasibility study, it was found that genipin-fixed tissue has a resistance to 
enzymatic degradation comparable to the glutaraldehyde-fixed tissue. The 
biocompatibility of the genipin-fixed tissue was studied in a growing rat model 
subcutaneously [190]. It was found that the inflammatory reaction of the genipin- 
fixed tissue was significantly less than its glutaraldehyde- and epoxy-fixed 
counterparts. Genipin-fixed tissue has minimal calcium content, since calcification 
may lead to stiffening around an implant and eventual degradation and re-sorption 
into the surrounding tissue [ 190,19 1 ]. In addition, genipin-fixed tissue also displayed 
compatible strength and resistance against in vivo degradation to its glutaraldehyde- 
fixed counterpart [188,192]. Also, it was found that tissue fixation in glutaraldehyde, 
epoxy compound, and genipin produced distinct crosslinking structures [193]. The 
differences in crosslinking structure affected the crosslinking characteristics and 
mechanical properties of the fixed tissues. It was observed that the genipin-fixed 
tissue had the greatest ultimate tensile strength and toughness among all the fixed 
tissues [193]. Furthermore, it was found that gelatine-derived bioadhesives display 
higher biocompatibility and less cytotoxicity when crosslinked with genipin than with 
other agents, such as formaldehyde, glutaraldehyde and epoxy compounds. For 
example, genipin was 10,000 times less cytotoxic than glutaraldehyde and shows a 
higher stability for 6-month storage periods [194,195]. The aforementioned results 
demonstrated that genipin is a promising crosslinking agent for biological tissue 
fixation. 
Genipin is, therefore, much less toxic than glutaraldehyde and many others commonly 
used synthetic cross-linking agents. As described in a World Patent [15], it was found 
that genipin is a biological material as a naturally occurring cross-linking agent with 
cross-linkable functional group, such as amino group or the like. Genipin was shown 
to be an effective crosslinking agent for treatment of biological materials intended for 
in vivo biomedical applications, such as prostheses and other implants, wound 
dressings and substitutes [15]. These attractive properties of genipin and the presence 
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of free amino groups in chitosan, which enable it to be crosslinked, prompt us to 
develop novel chitosan-based polymeric networks for medical uses. 
2.6 Conclusions 
In this chapter, an overview of the properties of chitosan has been given. It confirms 
quite well the interest in the use of such a polyscaccharide for numerous applications 
in the life sciences. The physical and chemical properties of chitosan, such as inter- 
and intra-molecular hydrogen bonding and cationic charge in acidic medium, make it 
useful in the development of conventional and novel pharmaceutical products. In 
particular, a number of investigations have shown that chitosan networks can act as a 
carrier for specific drug delivery systems. However, the present limitations upon 
using chitosan concern the cytotoxicity of the currently available crosslinking agents. 
Genipin is a novel naturally occurring agent and it can be used solve present 
problems. 
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CHAPTER 3 
Experimental 
In order to show the validity of this research, the details of the materials, the methods 
of sample preparation and the characterisation techniques used are described in this 
chapter. 
3.1 Materials and Characterisation 
3.1.1 Materials 
Chitin was purchased from Fluka, UK. Its chemical structure was shown in Figure 
2.2.1. Chitosan (CS) was produced from the chitin by deacetylation. The molecular 
weight of chitosan was measured by means of gel permeation chromatography (GPC). 
The degree of deacetylation of the chitosan was determined by Fourier transform 
infrared (FT-IR) specroscopy. Chitosan with three different degrees of deacetylation 
was employed in this study. The characteristics of the molecular weight and the 
degree of deacetylation of these chitosans are listed in Table 3.1.1 
Poly(ethylene oxide) with a molecular weight, M,,, of 20,000g/mole (HPEO) was 
obtained from BDH Laboratory Supplies. Poly(ethylene glycol) powder with 
viscosity average molecular weight of 600g/mole (LPEO) was obtained from the 
Aldrich Chemicals, UK. 
Genipin was obtained from Challenge Bioproducts Co., Taiwan. The structure of 
genipin was shown in Section 2.5 (Figure 2.5.1) and Figure 3.1.1 is its FT-IR 
spectrum. 
Vitamin B12 (cyanocobalamin, approximately 98%) was bought from Fluka Chemical 
Co, UK. Hen egg white lysozyme (3xcrystallized and lyophillized) was obtained 
from Sigma. Eleuthcrococcus sentisocus (ES) was kindly provided by the Institute of 
Chinese Medicine, China. 
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Figure 3.1.1 FT-IR spectrum of genipin 
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Figure 3.1.2 FT-IR spectrum of ES 
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Acetic acid and phosphate saline (PBS) were obtained from Aldrich Chemicals, UK. 
All chemicals were used without further purification, except for eleutherococcus 
sentisocus. The water used was deionis4 
The purification of ES was carried out in the following manner. 5g of dried ES 
powders were dissolved in water, or water/ethanol mixture. The solution was stirred 
for 24h at room temperature and then filtered through filter paper. The filtrate was 
dried at about 35'C. The samples obtained then were kept in a cool chamber at below 
-35'C. Figure 3.1.2 is the FT-IR spectrum of ES. 
3.1.2 Preparation of chitosan samples with different degrees of deacetylation 
(DD) 
Chitosan is the deacetylated product of chitin, which was obtained by an alkali 
treatment. Dried chitin was put into 47% (wt) NaOH solution in a flask. The 
deacetylation, reactions proceeded at 62'C for 2 hours under a nitrogen atmosphere. 
Then the products were washed in water at about 80'C to neutrality. To obtain 
chitosan with a high degree of deacetylation the alkali treatment was repeated. 
Effective deacetylation was attained according to Mima's method [196]. Because of 
the inhomogeneity of the reaction, further deacetylation was prevented when the 
degree of deacetylation exceeded 90%. In order to obtain a higher degree of 
deacetylation of chitosan, i. e. up to 95%, threadlike chitosan with a degree of 
deacetylation of 87% was prepared by pouring the aqueous solution 
containing 1.51/o-2*/` chitosan and 2% acetic acid in a small stream into a large amount 
of IN NaOH solution. The threadlike chitosan was subjected to alkali treatment, but 
continuous alkali treatment was completed at 90'C instead of 60'C. By a series of 
alkali treatments, the chitosan product was easily obtained with an acetylation degree 
of up to 95%. The whole process of the alkali/washing treatment is schematically 
shown below. 
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Figure 3.1.3 The schematic process of the alkali/washing treatment 
Table 3.1.1 Characteristics of chitosan samples after deacetylation 
Chitosan 
Number 
of 
Steps 
Temp 
CC) 
Reaction' 
time(h) 
DD 
M 
M,, M. /M. 
Chitosan-I 2 62 4 72 3.0 X104 3.3 
Chitosan-2 4 62 8 85 3.3 x 104 5.5 
Chitosan-3 5 62; 90 10 95 4.4 x 104 4.1 
Figure 3.1.4 gives the infrared spectra of chitin and chitosan samples with different 
degrees of deacetylation. 
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Figure 3.1.4 FT-IR spectra of chitosan for different degrees of deacetylation: 
(A) in the 2000-800 cm-1 region, (B) in the 4000-2600 cm-lcm region. 
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As seen from Figure 3.1.4 part (A), the spectrum of chitin has a clear amide I band at 
1 1655 cm- , which decreased as the degree of deacetylation increased. The spectrum 
of chitosan with a degree of deacetylation of 85% has only a slight upward swelling at 
this frequency. In the spectrum of chitosan with a degree of deacetylation of 95%, 
almost no trace of the amide band could be detected, which is evidence of high 
deacetylation. 
In the 1655 cm" to 1560 cm" region, there were considerable changes as the extent of 
N-acetylation changed. These changes are attributed to the amino content in chitosan, 
as reported [197]. This characteristic can be used in the analysis of the degree of 
deacetylation of chitosan. 
Figure 3.1.4 (B) shows the FT-IR spectra in the 26004000 cm-1 region. A broad 
3468 cm-1 band with small shoulders at 3276cm-1 and 31 00cm" was observed when 
the degree of deacetylation was 72%, then gradually disappeared with increasing of 
deacetylation. These changes mean that the degree of crystalinity decreases with 
increasing the degree of deacetylation of chitosan [47]. 
3.1.3 Determination of the degree of deacetylation of chitosan by FT-IR 
The degree of deacetylation and the free amine group content are, of course, inversely 
related and the former may be obtained directly by determining the amide group 
concentration, or indirectly by determining the amine group concentration. There are 
a number of analytical tools [30,198-201] to determine the degree of deacetylation 
including IR spectroscopy, pyrolysis-gas chromatography, gel permeation 
chromatography, UV spectroscopy, 'H NMR spectroscopy, various titration schemes, 
and acid hydrolysis. 
Infrared spectroscopy (IR) has been used frequently to determine the degree of 
deacetylation of chitosan. It is one of the most widely used techniques for chitosan 
analysis. The methods described in the literature [ 198-20 1] to determine the degree of 
deacetylation from IR spectra, which employed different probe (PB) and reference 
(RB) bands (the intensities of respective bands change, but not with the degree of 
deacetYlation and baselines (BL)). 
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Figure 3.1.6 Standard calibration line obtained by IR spectroscopy using 
A1550/A2878 [201]. 
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The degree of deacetylation is calculated from the ratio of the absorbance (A) of the 
two bands, APB/ARB, either directly, using a formula [199,200], or using calibration 
lines [198-201]. 
The preparation of samples of chitosan for FT-IR measurements and the equipment 
used in the analysis are described in Section 3.3.3 and the spectrum is shown in 
Figure 3.1.5. 
Figure 3.1.6 is the standard calibration line obtained by IR spectroscopy [201] using 
A1550/A2878. The degree of deacetylation of chitosan samples used in this research was 
found to be 72%, 85% and 95%, respectively. 
3.1.4 Determination of molecular weight of chitosan by gel permeation 
chromatography (GPQ 
The molecular weight of chitosan was determined by means of GPC. Sample 
solutions were prepared by adding lOmL of 0.5M sodium nitrate as solvent to 10 mg 
of sample and using 0.01M sodium dihydrogen phosphate to adjust to pH 2.0. Then 
the mixture was left for four hours to dissolve. The solution was then warmed at 70'C 
for ten minutes. After cooling, the solutions were filtered through a 0.45ýLrn PVDF 
membrane prior to the chromatography. A column of Plgel 2x mixed-OH of 30cm 
length was used. A flow-rate of I. Oml/min and temperature of 30'C were used. 
The GPC system used was calibrated with poly(ethylene oxide)/poly(ethylene glycol) 
calibrants. The data were acquired and processed using a Viscotek Triesc 3.0 
software. The output for this polymer is shown in Figure 3.1.7 for the 95% DD 
sample.. 
GPC yields values of number and weight average molecular weight relative to the 
calibration standards used. The results for the three chitosans are listed in Table 3.1.1. 
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Figure 3.1.7 GPC chromatogram of chitosan (DD: 95%) 
3.2 Sample Preparations 
3.2.1 Chitosan/PEO blends 
Chitosan was dissolved in I. Owt% aqueous acetic acid. The concentration and pH of 
the prepared chitosan was 1.5wt% and 5.0, respectively. Chitosan was dissolved at 
room temperature overnight. Then the chitosan solution was filtered through filter 
paper to remove any un-dissolved gel. The clear lightly yellow chitosan solution was 
then mixed with 5% aqueous solution of HPEO or LPEO at 90: 10,80: 20,70: 30 etc at 
room temperature. The chitosan and PEO mixed solutions at different weight 
percentage ratios were stirred overnight at room temperature. The degassed and well- 
mixed solutions were then cast onto a glass plate, evaporated in an oven at 400C to 
remove the solvent and dried to constant weight. The thickness of dried films ranged 
from 0.3mm - 0.6mm. 
For further mechanical property studies, the films were also prepared at the solution 
pHs of 2.5,3.0, and 4.0, respectively. 
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3.2.2 Crosslinked chitosan/PEO blend films 
0.5wt of genipin (genipin/chitosan = 0.5%) was dissolved in 2ml water and then 
added to the chitosan solution or the chitosan/HPEO (or /LPEO) mixed solution. The 
solution was stirred for 30 minutes at room temperature. After two hours, the solution 
started to turn light blue and became increasingly viscous (see Figure 3.2.1). The 
solution was then cast onto glass plates and dried to constant weight at 400C. The 
crosslinked chitosan and chitosan/HPEO (or LPEO) blends become dark blue after I 
day (see Figure 3.2.2). The thickness of the dried films was measured to be 0.3 
-0.6mm. 
rosslinked 
Mtosan gel 
cMtosan 
solution 
Figure 3.2.1 A photograph of a chitosan solution and a crosslinked chitosan 
gel 
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Figure 3.2.2 A photograph of crosslinked chitosan films 
For further mechanical property studies, the films were also produced at 250C and 
60'C, respectively. For other studies such as those of swelling behaviour, controlled 
drug release and protein separation, films with different genipin contents were 
produced. 
Table 3.2.1 Symbols for the CS/PEO blend series 
System CS Content (wt %) PEO Content (wt %) 
cs 100 0 
CS/PEO 10 90 10 
CS/PEO 20 80 20 
CS/PEO 30 70 30 
CS/PEO 40 60 40 
CS/PEO 50 50 50 
CS/PEO 60 40 60 
CS/PEO 70 30 70 
CS/PEO 80 20 80 
CS/PE090 10 90 
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Table 3.2.2 Symbols for the CS/PEO network series 
System Genipin content CS Content (wt %) PEO Content (wt %) 
CSR/PEO 10 0.5% 90 10 
CSR/PEO 20 0.5% 80 20 
CSR/PEO 30 0.5% 70 30 
CSRJPEO 40 0.5% 60 40 
CSR/PEO 50 0.5% 50 50 
CSR/PEO 60 0.5% 40 60 
CSR/PEO 70 0.5% 30 70 
CSR/PEO 80 0.5% 20 80 
CSR/PEO 90 0.5% 10 90 
CSR 0.5% 100 0 
The abbreviation symbols used in the study for the CS/PEO blends and networks are 
shown in Tables 3.2.1 and 3.2.2. 
3.2.3 Determination of crosslinking density in chitosan films 
The crosslink density is defined as 
PC [3.2-1] 
The crosslink density of chitosan was determined by swelling measurements. The 
Flory-Rehner equation was used to calculate M,, the number average molecular 
weight between crosslinks [202]. The equation is: 
- 
[In(I 
- u, ) + u, + zu'] = pVOM -1 u 1/3 [3.22] rcr 
where X is the chitosan-water interaction parameter (0.5917) [202], p is the density of 
chitosan (1.25g/cm 3), VO is the molar volume of water (I 8CM3/Mol), and ur is the 
volume fraction of chitosan in the swollen state. ur was obtained through the swelling 
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experiment and on the basis of Wd xl. 003/[ Wd x 1.003 + (W. - Wd )x1.25], where 
W, and Wd are weights of the specimen in the dry and swollen states, respectively. 
The crosslink density and related parameters are listed in Table 3.2.3. The 
abbreviation symbols used in the study of the crosslinked chitosan samples with 
different crosslink densities are shown in Table 3.2.4. 
The crosslink densities of chitosan films, which were formed under different 
conditions, such as different solution pHs and crosslinking temperatures, were 
calculated and shown in Table 3.2.5. The experimental data suggest that with the 
same amount of genipin, the crosslinking density was not affected by either the pH of 
the chitosan solutions or the crosslinking temperature. 
Table 3.2.3 Crosslink density and related parameters 
Genipin content 
(wt. %) 
Wd 
(g) 
I 
W. 
(g) 
H Ur 
Crosslink 
density 
(%) 
01 0.0477 0.170 0.720 0.238 0.26 
0.3 0.0503 0.1519 0.669 0.284 2.23 
0.5 0.0715 0.1954 0.634 0.316 4.65 
0.8 0.1017 0.2493 0.592 0.356 9.22 
1 0.0895 0.2034 0.560 0.386 14.35 
H. the volume fraction of water in the films 
Table 3.2.4 Abbreviation symbols used in the study of crosslinked chitosan samples 
System Genipin content (%) Crosslink density 
O. ICSR 0.1 0.26 
0.3CSR 0.3 2.23 
0.5CSR 0.5 4.65 
0.8CSR 0.8 9.22 
ICSR 1 14.35 
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Table 3.2.5 Crosslink density for different crosslinking conditions 
Genipin 
content 
pH 
of chitosan 
solution 
Film-formation 
Temperature 
cc) 
Water 
content 
H 
Crosslink 
density 
(%) 
2.5 0.633 4.65 
3.0 0.615 4.41 
0.5% 4.0 40 0.634 4.64 
5.0 0.620 4.49 
4.0 25 0.633 4.65 
60 0.616 4.47 
3.2.4 Preparation of samples for studying the crosslinking process for FT-IR 
spectra measurement 
Genipin was added into 0.5% chitosan solutions and dissolved under stirring at 
reaction temperature. At different reaction times, the crosslinked chitosan hydrogel 
was then dialyscd against double-distilled water. After dialysis, a blue colour elastic 
gel was obtained. This crosslinked chitosan hydrogel was ground to powder and 
mixed with KBr, and then finally pressed into a disk. 
3.2.5 Preparation of samples for studying the crosslinking process for UV spectra 
analysis 
Genipin was dissolved in deionized water to prepare 50ppm of genipin solution. An 
aqueous chitosan solution was diluted and then added into the genipin solution at 
equimorlar ratio, and homogeneously mixed. The samples were analysed by UV 
spectrophotometers and monitored at time intervals to examine the variation of UV 
absorption between 190nm to 340nm. 
3.2.6 Preparation of samples for static laser light scattering measurements 
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Chitosan solutions with different pHs were prepared with concentrations of IxIO -6 
and 10-4 g/ml. All the solutions used for laser light scattering were clarified using a 
0.5 /zn Millipore filter to remove dust particles. 
3.2.7 Preparation of drug carriers for drug release study 
In order to study loaded drug release from a carrier, sorption and desorption 
experiments were employed. 
The membranes, which had previously been kept in equilibrium with water, were 
immersed in the drug solution for 2 weeks until they attained equilibrium. The volume 
of samples was measured using a picometer with resolution of lOgm. The 
concentration of ES solution was determined by a UV spectrometer at 200nm. The 
concentration of ES absorbed by the membrane, C, was calculated by measuring the 
concentration of ES in the aqueous solution prior to (Co) and after (C. ) the sorption 
experiments, using the expression 
c= 
(CO - cjv [3.2-31 
VP 
Vand Vp are the volumes of the aqueous solution and membrane sample, respectively. 
3.3 Instrumentation and Methods 
3.3.1 Small angle X-ray scattering (SAXS) 
The SAXS technique has been extensively used for the investigation of the 
morphology of polymer blends [204]. In this section, the principles of SAXS [204, 
205] are reviewed and important points regarding the practical measurements are 
made. 
Using Figure 3.3.1 parts (a) and (b), the principles of SAXS can be explained as 
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follows. If the sample has electron density inhomogeneities with colloidal size (I- 
100nm) and the incident beam, KO, is applied to the sample, the corresponding 
scattered beam, K, can be observed as shown in Figure 3.3.1(a). In this case, the Z' 
scattering angle to the incident bearn is given as 20. There are other cases where the 
angle is defined as 0. However, in this study, the scattering angle is expressed as 20. 
Scatteredbeam 
The scattering intensity, I(q), is expressed as a function of the scattering angle 20. 
The variable q can be expressed in terms of magnitude, 
qj = 
47c 
sin 0 
or in vector terms, 
4= 21r 10 [3.3.1-21 A 
(i 
-ý) 
where i' and 1; ' are the unit vectors of the scattering vector and the incident beam 0 tý I 
respectively. 
Ko 
Incident b cam 
Sa mp le 
20 
K 
(A) 
Figure 3.3.1 Scattering geometry ot'sniall anole X-ray scattering C, 
(B) 
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The general scattering fon-nula is given by the following equation. 
I(q) = FF fff fff dVI dV2 p 
(rl ý (r2 )exp (- 
iq 
(r, 
- r2 [3.3.1-3] 
VIV2 
where dV, and dV2 represent a volume element at position r, and r2, respectively. p, 
and p2 are defined as the number of electrons per unit volume at position r, and r2, 
respectively. (rj-r2) means the relative distance for every pair of points. To calculate 
Equation 3.3.1-3, an auto-correlation function, F(r), is defined by 
F(r)= fffdVp(rl)p(r2) [3.3.14] 
v 
where r--(ri-r2). 
Tbus, the density of these points, which have the relative distance r, can be given by 
F(r). Furthermore, the second integration can be carried out using the auto-correlation 
function. 
I(q)= fffdVF(r)exp(-iqr) [3.3.1-51 
v 
This is a Fourier transformation. Therefore, the intensity distribution in q is 
determined by the structure of the object, as expressed by F(r). 
Two restrictions in small angle scattering can be introduced to simplify the above 
equation. 
(a) The system is statistically isotropic. It makes no difference if this is a property of 
the system as a result of a time-average due to the random motions of the 
particles. 
(b) There exists no long range order. This means that there is no correlation between 
two points widely separated. 
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From the above restriction (a), the complex exponential in Equation 3.3.1-5 can be 
replaced by the fundamental formula of Debye [205]. 
(exp(- iqr)) = 
sin qr [3.3.1-61 
qr 
I(q)= 4nr2drF(r)sinqr [3.3.1-71 f 
qr 
According to restriction (b), at large distances the electron densities become 
independent, and can be replaced with a mean value <p>. The auto-correlation 
function must also tend towards a constant value . For the mean value <p>, the 
following correlation function can be applied. 
(P)2 
= Vr(r) [3.3.1-81 
The correlation function allows one to transform the scattering data back into a real 
space distribution. The scattered intensity is then given by the following equation. 
w 
I(q) =V 
f4; zr'dry(r) sin (qr)l(qr) [3.3.1-91 
0 
This is the most general formula for the diffraction of systems obeying the above 
restrictions (a) and (b). yfr) is found by the inverse transform correlation function. 
. 
fq'dqI(q)sin(qr)l(qr) [3.3.1-101 Vy Y(r) = 1,0 Ir 0 
For practical measurements, the data treatment is very important. In the case of 
SAXS, the following data treatments should be considered. 
(a) Raw data correlation 
(b) Background subtraction 
(c) Desmearing 
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First of all, the treatment of the raw SAXS data usually starts with a correction for the 
empty cell scattering, which is subtracted from the sample intensity. The second 
treatment is for the thermal motions of molecules in the sample. Because there exist 
density variations caused by not only the presence of different phases, but also by 
thermal motions of molecules in the sample, the resulting density variation gives rise 
to a background intensity. When a constant background level over a sufficiently large 
20 region is known, this level can simply be subtracted from the total observed 
intensity. The third treatment is for the smearing effect caused by slit collimation 
[206]. Applying this treatment can yield the pinhole pattern from the smeared pattern 
by taking into account the weighting function, which normally multiplies the intensity 
observed by using the slit geometry. 
Spatially averaged morphological characteristics of the chitosan films were 
investigated by SAXS. These investigations were performed using a Kratky Compact 
Small Angle system at Changchun Institute of Applied Chemistry using a stationary- 
anode copper-target X-ray tube (% = 0.154 nm) at room temperature. The fine-focus 
X-ray generator was operated at 45kV and 40mA. The measured intensity was 
desmeared and corrected for background scattering and photoelectric absorption [205] 
for all the samples. 
3.3.2 Static Laser Light Scattering (SLLS) 
SLLS is a classic and absolute analytical method, which measures the time-avcrage 
fluctuations of the scattered light produced by molecules or macromolecules [206]. 
The intensity of the scattered light is analysed by photon correlation spectroscopy. 
The scattered intensity can be related to the structure of a polymer and it has been 
widely used to characterise synthetic and natural macromolecules [206]. 
When a monochromatic, coherent beam of light is incident on a dilute solution of 
macromolecules or a suspension of colloid particles and where the solvent refractive 
index is different from that of the solute (macromolecules or colloidal particles), the 
incident light is scattered by each illuminated macromolecule or colloidal particle in 
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all directions. The scattered light waves from different n1acrornoICCLIles or particles 
can be described in terms of two fundamental qUantities: the rnornenturn transfer (hK) 
and the energy transfer (hVo)) obeying the following conservation equations 
hK = h(k, - k, ) [3.3.2-11 
hV(, ) = h((o, - mj [3.3.2-2] 
h =2Tclh with h being Planck's constant, k, k, and (i), (i), are, respectively, incident 
and scattered vectors and angular frequencies. A typical light scattering geornetry is 
shown in Figure 3.3.2. 
Sa mp le 
Vertical polarisation /, ".. 0 
1, (k, w. ) 
11 (kj. mi) It 'I. Wi) 
Figure 3.3.2 Scattering geometry of light scattering Z-1 
1,,, 1, and I, are, respectively, the incident, the scattered, and the transmitted 
intensities; 0 is the scattering angle; and KI - 27c/kI, K, - 27t/k, with ?, i -- (k, )/n) -- X, 
ý, O being the wavelength, and n the refractive index of the scattering medium. 
K[=(47r/, ?ý sin (0/2)] is the magnitude of the mornenturn transfer vector. Fo r 
visualisation of the geornetry in Equation 3.3.2-1, we set the incident bearn 
polarisation to be perpendicular to the plane ofthe paper and the scattering plane is 
defined by I, and I, 
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The scattered light from a well-defined incident beam has a distribution of wave 
vectors and at each wave vector, ks, there can be a distribution of frequencies 
depending on the dynamics in the scattering medium. As the energy transfers in 
terms of frequency change (Aco) depend on the scattering dynamics, the scattered 
intensity fluctuates as a function of time. 
The transfer of momentum (hK) corresponds to probing the structures of the system 
with a spatial resolution R- IC'. Measurements of the time-averaged scattered 
intensity <I(K)> can be related to the structural studies. 
The time dependence of the correlation (or probability) function becomes important in 
a problem involving random signals and noise. The measured bulk property of x at 
equilibrium is a time-average value 
X(- 
1+2T 
r, t X(r, t)it 
2T 
fl [3.3.2-31 
where to is the time at which the measurement is initiated and 2T is the time period 
over which it is averaged. If x is stationary, 
lim X( t), it T->. 2T T [3.3.24] 
where <x> is the time average of x and is independent of to. The integration can be 
from -Tto Torto 2T. We define the time correlation function ofx(t) as 
R., (r)=(x(t)x(t+r))= Jim 
I 
x(tý(t + r)dt [3.3.2-5] 
T-+002T T 
where r is the delay time. x(t)x(t-FT) =- x(tl)x(tj) with r= trti. 
The integral indicates a time average over all starting times t inside the periodgram of 
length 2T. Furthen-nore, we have taken the random process to be stationary, so that 
the joint probability distribution of x, and X2 depends only on the time difference and 
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not the particular value of t, and tj. The limit exists provided that the average 
power" in x(t), R., (O) (=- -: ýx2 (t)>, is finite. 
Wt + -r)x(t)) = (x(r)x(o)) [3.3.2-61 
For time-invariant random processes, the correlation function is independent of t. 
Then 
(X(t + r)x(t)) -> 
(jx(tý') [3.3.2-71 
T --+ 00 (X(t + T)X(t)) --> (x(r))(X(Q = (X) [3.3.2-81 
The auto-correlation function of a non-periodic property x decays from its initial value 
<X (t) 2> as T--+O and becomes <X (t) 2> as T--*oo. Figure 3.3.2 shows a schematic 
plot of the correlation function <, x(O)x(T)>. 
The correlation function and power spectral density, S,,, was connected through 
Fourier transforms. The X2T can be decomposed rigorously into its Fourier 
components. 
., 
x(o))exp(- icot)da) [3.3.2-9] X2T 
Wf 
and 
A I 
ot)dt [3.3.2-101 X2T 
(0)) 
= 
2r 
L 
X2T (t) exp(ic 
For complex x we have 
Is 
A 
(x(t + r)x* (t)) f dco 27c exp(- icor) [3.3.2-11] lim 
2T 
T -+ co 
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which gives 
(x(t 
+, r)x-(t» = 1- S"(w)exp(- iwa)dco [3.3.2-12] 
to 
1X12 >1 
Xj+1 
XAI 
I 
I 
Xn+l X+ 
At 
NN 
to + nAt to + 2T 
Figure 3.3.3 Schematic plot of the correlation function < x(O) x(T)>[206]. 
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The correlation function is an inverse Fourier transform of the power spectral density 
S., (co) and the power spectra density is the time Fourier transform of the correlation 
ftinction. 
S (co)= ' 1-. 
ýx(t+rý-(t)ýexp(icoa)dr [3.3.2-13] 
2x 
A commercial laser light scattering spectrometer (ALV/SP-150) equipped with ALV- 
5000 digital time correlator was used with a solid-state laser (ADLAS DRY42511, 
output power -4OOmW at X= 532.8nm) as the light source. The incident light beam 
was vertically polarised with respect to the scattering plane, and the intensity was 
regulated with a beam attenuator (Newport M-92513) so as to avoid localised heating 
in the light scattering cuvette. Light scattering results from polysaccharide solutions 
have often been complicated by the presence of the aggregates [206]. 
Ultracentrifugation and filtration of the solutions have a significant effect on the 
results. Usually solutions in concentration range of 104 to 10 -6 g/ml are used, but the 
lower the concentration the more reliable are the results obtained. 
3.3.3 Fourier Transform Infrared Spectroscopy (FT-IR) 
Fr-IR spectroscopy is a well established analytical technique employed particularly in 
the identification and study of organic molecules and is concerned with the detection 
of transitions between vibrational energy levels in molecules, resulting from 
stretching and bending vibrations of interatomic bonds [207]. The frequencies of 
such vibrations are characteristic of specific functional groups and are affected by the 
molecular environment, chain conformation (in polymers), morphology and 
intermolecular interactions. 
At room temperature, most molecules exist in their ground vibrational energy state. 
When molecular vibrations cause a change in the bond dipole-moment, resulting from 
a change in the electron distribution in the bond, it is possible to simulate transitions 
between energy levels by interaction with electro-magnetic radiation of the 
appropriate frequency. Molecular vibrations are enhanced when the electric sector of 
the incident radiation is in phase with the vibration dipole. When this happens, 
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energy is transferred from the incident radiation to the molecule and it is this 
absorption of energy which is the basis of FT-IR spectroscopy. In practice, spectral 
transitions are detected by scanning through the frequency range (typically 4000400 
cm-1), whilst monitoring the intensity of the transmitted light. 
An FT-IR spectrum represents a fingerprint of a sample with absorption peaks, which 
correspond to the frequencies of vibrations between the bonds of the atoms making up 
the material. FT-IR spectroscopy is widely used in both qualitative and quantitative 
analysis of polymers and additives [207]. It has also been applied to studies of the 
polymerisation process, end group analysis and investigations of mechanical 
deformation of material [208]. These techniques also allow information on chain 
conformations, stereochernical structure etc. of polymers to be obtained [208]. 
FT-IR can also be used to study physical interactions between the components of a 
mixture. Interactions between the molecules of two components in a polymer blend 
are often an important factor, which promotes miscibility, and such interactions can 
often be observed as a shift in the wavenumber of the bands relating to the groups 
involved. 
Figure 3.3.4 shows the layout of a typical FT-IR spectrometer. There are three basic 
components: a source, a Michelson interferometer (consisting of a beam splitter, a 
fixed mirror and a moving mirror) and a detector. Collimated radiation from the 
broad-band source is directed into the interferometer and impinges on the beam 
splitter. Approximately 50% of the light is transmitted through the beam splitter and 
is directed onto the fixed mirror. The remainder of the light reflects off the beam 
splitter and is directed onto the moving mirror. The beams reflect off the surfaces of 
the two mirrors and recombine at the beam splitter. Here, constructive and 
destructive interference occur, and depending on the relative position of the moving 
and fixed mirrors, absorption takes place. Finally, the light beam continues onto the 
detector. In simple terms, what is happening is that the interferometer encodes the 
initial frequencies (by optically taking the Fourier transformation of the incoming 
signal) into a special form that the detector can observe in time. The inverse Fourier 
transformation is a mathematical means of resorting the individual frequencies for the 
final presentation of the infrared spectrum. 
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Figure 3.3.4 Schematic diagram of af FT-IR spectrometer 
In our experiments, transmission spectra of the films were recorded using a Mattson 
3000 FI'IR spectrometer for 64 scans at a resolution of 4cm-1. The specimen films 
were prepared as described in Section 3.2.1, except that the concentration of solution 
was 0.5wt. % instead of 1.5wt. %. The dried films were treated by immersing films in 
methanol for 24 hours to remove acetic acid and were then dried for 24 hours at 35'C. 
The samples for the study of the crosslinking process by FT-IR spectroscopy were 
prepared in the manner described in Section 3.2.4. 
3.3.4 Differential Scanning Calorimetry 
Structural changes are usually associated with changes in heat absorption or emission 
and are measured by means of calorimetry. Differential scanning calorimetry (DSQ 
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can measure the changes at constant heating or cooling rates. DSC is an invaluable 
tool in the characterisation of polymer materials [209-211], yielding information on 
such processes as the glass transition, reaction kinetics, melting behaviour, structure 
relaxation, degree of crystallinity and other aspects of polymer morphology. A DSC 
instrument is a simple device for measuring the heat flow into and out of a sample, 
usually while it is subjected to an isothermal or linearly rising temperature 
programme. Tbc difference in heat loss or gain between the sample and reference 
cells is measured in a differential scanning calorimeter. In this case, the heat input 
needed to maintain both cells at the same temperature is measured. The principle of 
this technique is schematically illustrated in Figure 3.3.5. 
S"Ie 
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Figure 3.3.5 A schematic diagram of DSC 
The cells are mounted in a metal block, which can be cooled for more efficient heat 
stability. The thermocouples measure the temperatures as well as differences in 
temperature. The difference is quickly compensated by the heat controller, and the 
amount of compensation is measured. DSC curves reflect the temperatures and heat 
flows associated with transitions in materials as a function of time and temperature. 
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From these measurements, the rate of heat absorbed by, or evolved from, the sample 
can be computed. The more detailed description of the utility and design parameters 
of differential scanning calorimetry can be found [211,212] elsewhere. 
DSC has been used widely to characterise [209-211] the thermal properties of 
polymeric materials. DSC is a particularly useful tool in studying polymer-polymer 
miscibility and phase-separated polymer blends [210]. 
In this study, the thermal analysis was carried out using a TA Instruments differential 
scanning calorimeter, DSC, 2920. For each experiment, the sample had the same 
thermal history. LPEO, CS/LPEO blends, CS/LPEO blend networks, HPEO, 
CS/HPEO blends and CS/HPEO blend networks were heated to 80'C and kept at 
80'C for 10min. After this, the samples were cooled to -IO'C for CS/HPEO blends 
and their networks, to -35'C for CS/LPEO and their networks, respectively, at cooling 
rate of 10*C/min. Then, they were reheated at a heating rate of IOT/min. 
3.3.5 Ultraviolet/visible spectrometry (UV) 
UV spectrophotometry is based on the fact that electrons in certain types of chemical 
bonds are excited from the ground state when exposed to radiation in the wavelength 
range of 200 - 800 nanometres (UV: 200-380nm; Vis: 380-800nm). The sample will 
absorb energy at wavelengths whose energies correspond to that required for the 
electronic transition. The spectrum corresponds to electronic excitation and the 
energy levels depend on the chemical bonds within the specimen. a-electrons, 
involved in covalent bonds, absorb high energy photons in the UV region, whereas, 7r- 
electrons absorb photons at larger wavelengths, often in the visible region [213]. 
Absorption is determined by measuring the difference in the signal with and without 
the presence of the absorbing species. As a result, a typical electronic absorption 
spectrum is obtained [213]. 
UV-visible spectrophotometry consists in implementing Beer-Lambert's law. For a 
given sample, the light absorbed is a function of the concentration of its components: 
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A= kcl 
where A is the absorbance; k is the extinction coefficient and I is the path length. The 
measurement of light absorption at one, or several, wavelengths, thus allows 
quantification of the samples [213]. 
UV-visible spectrophotometry provides information on the multiple bonds and the 
aromatic conjugation with in molecules. The interaction between polymer molecules 
and the UV component in sunlight can lead to dissociation of cr-bonds and is principal 
cause of photodegradation of polymers [213]. Aromatic structures have delocalised 
electrons and exhibit strong UV absorption at very short wavelengths. The absorption 
in the far ultraviolet region, where wavelengths are shorter than 200nm, which 
involve the a bonds and 7c electrons in a nonconjugated system, cannot be detected. 
Only polymers having a fairly high percentage of conjugated systems will show 
characteristic absorptions [213]. Hence, ultraviolet absorption spectra have 
limitations with respect to the analysis and identification of polymers. However, it 
can be extremely useful for the determination of impurity traces of highly conjugated 
or aromatic materials in polymers [213]. 
The commonly used UV-visible spectrometers measure absorption of light in the 
visible and near ultraviolet region, i. e. 190-750nm. The basic instrumentation 
consists of one or several light sources such as a tungsten filament lamp for >375nm 
and a deuterium discharge lamp for <375nm. A monochromator selects the desired 
wavelength; a compartment is accessible by the sample; a detector is used to feed the 
ratio of reference beam to sample beam intensities (lo/1) to a pen recorder and a data 
processing system. Figure 3.3.6 illustrates the component parts. 
Of the few sampling techniques for UV spectrometry, the solutions technique is the 
most commonly used and was adopted in this research. By this technique, the amount 
of material that can be detected in solution is very small. The choice of solvent is 
important as the possibility of reaction or solute-solvent associations will affect the 
spectra. 
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In this study, an Uvicarn SP1800 spectrophotometer was used to record the UV 
spectra between 190nm and 400nm. The equipment settings are: absorbance meter 
range 0-2; slit width 0.34nm; scan speed 120nm/min. Deionised water was used as the 
reference. 
Source ZA, 
Entrance slit 
Monochromator Dispersive element 
Exit slit 
Sample Cell 
Detector 
Readout Amplifier 
system 
Display 
Figure 3.3.6 Schematic diagram of the component parts of a UV 
spectrophotometer 
3.3.6 Tensile tests 
The prime consideration in determining the general utility of a polymer is its 
mechanical behaviour: the deformation and flow characteristics under stress [214, 
215]. 
68 
Chapter 3: aperimental 
Testing usually consists of securing a standard test sample between two sets of grips. 
One set of grips is fixed and the other is attached to a moving crosshead and load-cell 
arrangement. The sample used is usually of a dumb-bell shape (see Figure 3.3.7) so 
that breaking occurs in the central area away from the grip regions. Crosshead speed 
depends on the nature of the polymer material [214,215]. It should be noted that test 
speed influences tensile behaviour dramatically. 
Figure 3.3.7 Dimensions of the dumbbell specimens that were used in this 
research 
The tensile testing results are usually shown as a plot of the stress versus the 
elongation (strain) as shown in Figure 3.3.8. The following tensile parameters were 
calculated [214]. 
(1) Tensile strength (a) - the maximum tensile stress which the test piece is capable of 
supporting. 
a= 
F (MPa) 
A 
[3.3.6-1] 
where F is the force, in N, and A is the initial cross-sectional area of the sample, in 
M2 
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(2) Elongation at break (c) -the extent of elongation when the sample ruptures. 
LL0 
X100 [3.3.6-2] Lo 
where L is length between reference marks at break, in mm and Lo is initial gauge 
length in mm. 
(3) Elastic modulus (modulus of elasticity or Young's modulus) - the ratio of applied 
stress to the strain it produces in the region where strain is proportional to the stress. 
Primarily a measurement of resistance to deformation, or the stiffness, of a material. 
Modulus = 
Ac (MPa) [3.3.6-3] 
Ac 
where Au is the difference in stress between two points on the straight line. AC is the 
difference in strain between the same two points. 
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Figure 3.3.8 A typical tensile stress-strain curve for a polymer. (A) for a 
brittle polymer, (B) for a toughness polymer, (C) for an elastic polymer 
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The tensile strengths of the films were measured using a Lloyd Instruments LIOOO 
tensometer and using a 50ON load cell operated according to the D638 ASTM 
standard. The extension rate was l0mm/min. In order to examine the physical 
properties of the films as a function of moisture content, they were placed in relative 
humidity chambers over distilled water; and the moisture content was determined by 
drying to constant weight. Each test was repeated at least 5 times and the average 
taken. 
3.3.7 Solubility and stability in neutral water 
The crosslinked/un-crosslinked CS and CS/HPEO (LPEO) blend films were 
immersed in 100ml methanol for 24 hours to remove the acetic acid in the films, then 
they were taken out and dried for 24 hours at 35'C. The dried films were weighed 
accurately with an electronic balance. The dried films were then immersed in distilled 
water (pH 7) for 8 hours, and the remaining films were then taken out and dried for 48 
hours in vacuum at 35'C. A second weighing was conducted to determine the amount 
of PEO extracted from blends. All the films used were from the samples used in the 
tensile strength measurements above. Stability, therefore, can be expressed by the 
following equation. 
S ý-- W2/Wl x 100 [3.3.7-11 
where S is the percentage weight of the extracted films after immersion in neutral 
water. W, and W2 are the weight of dried films before and after immersion in water, 
respectively. Each experiment was repeated three times and the average value taken. 
3.3.8 Swelling experiments 
The swelling behaviour of the crossl inked/un-crossl inked CS and their blend films 
with LPEO were determined by swelling the films in media of different pHs at room 
temperature and 38'C, respectively. The samples (approximately 0.05g) were first 
treated as described above to remove any acetic acid. Blends and networks were 
incubated for approximately 48 hours in buffer solutions ranging from pH 2 to 13. It 
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was confirmed experimentally that after a 48-hour incubation period, the films 
reached their swelling equilibrium. The films were withdrawn from the buffer 
solutions and their wet weights were determined by first blotting with a filter paper to 
remove absorbed water on the surface, followed by immediate weighing on an 
electronic balance. The percentage of specific solution content, or weight uptake, of 
the films is expressed by the following equation. 
E,,, = [(Ws-Wd)/Wd] XIOO [3.3.8-11 
Wd and W, are the weights of the samples in the dry and swollen states, respectively. 
In order to study the drug release mechanism, the volume fraction of water, H, in the 
swollen membrane was used. H value measurements where obtained by the swelling 
experiments in water at 23'C. The volume fraction of water is expressed by the 
following equation. 
H= (Ws -Wd) / Ws [3.3.8-2] 
3.3.9 Contact angle measurements 
Information on the surface properties of a material can be readily obtained by a 
relatively fast and simple contact angle measurement. This method measures the 
extent to which a liquid interacts with a solid to promote wetting, characterized by the 
contact angle [216-218]. 
The surface energy of a solid can be estimated by the measurement of a contact angle 
fortned at a three-phase interface. There are a number of possible methods of 
measuring the contact angle on a solid surface, including: 
Sessile drop 
Pendant and receding drop 
Advancing and receding bubble 
Drop on a tiled plane 
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When a drop of a liquid is placed on a solid surface, the system will try to establish a 
state of minimum total surface free energy. Depending upon the relative values of the 
interfacial tensions involved, the contact angle, 0, between the liquid and the solid 
phase will vary from 0' And 180'. Young [216] first proposed treating the contact 
angle of a liquid as the result of the mechanical equilibrium of a drop resting on a 
plane solid surface under the action of three surface tensions (see Figure 3.3.9). 
%NN 
ýXýN S"ýX'N.. 
Figure 3.3.9 Schematic of a liquid drop on a surface and the forces acting at 
three-phase contact point. 
The correlation between y and 0 is given by Young's equation [216]. 
JVSV IVSL + YLV COS 
0 [3.3.9-11 
where ysv is the interfacial tension between solid and vapour, ysL is the interfacial 
tension between solid and liquid, TLV is interfacial tension between liquid and vapour 
and 0 is the contact angle. 
The contact angle used in Young's equation relates to the equilibrium angle of a 
liquid on a surface, because it is assumed that the surface is both smooth and 
chemically homogeneous. However, the simplicity of Young's equation is deceptive 
because there are conceptual and experimental difficulties. 
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The surface free energy is related to the following relationship 
rsy rs -, To [3.3.9-21 
where ys is the true surface free energy of solid (equal to G). ro is a quantity known 
as the equilibrium spreading pressure. The term 7r, 9 is a measure of energy released 
through adsorption of the vapour onto the surface of the solid, a process that lowers its 
surface free energy. 7re is usually negligible when the contact angle is larger than 10', 
but becomes significant when the contact angle is smaller than about 10'. When 7rg is 
negligible, ysy equals to ys. 
Fowks [217] proposed a separation of the surface energy of a material into the 
potential energies of interaction between the liquid and the solid. He suggested that 
the surface tension of a phase could be divided up into independent component parts, 
such as London dispersion contribution Y4 and polar contribution )P as represented 
below: 
rd+r [3.3.9-31 
Fowks [217] also make a fundamental hypothesis important to the study of interfaces 
and adhesion, namely that materials exhibiting only dispersion force interactions 
interact with other surfaces by only those interactions. It was also Fowks' contention 
that polar force and dipole-induced dipole forces were insignificant when one of the 
materials at an interface was non-polar. Mathematically, this can be stated as follows. 
dV, l Y/2 
YSL "'= Ys + YSL YL -2W, L [3.3.9-4] 
The success of the Fowks hypothesis prompted others to develop a theory of 
fractional polarity. One such equation was developed by Owens and Wendt [218] 
YSL -"ý YS + YL - 
2ýdyd)112 
-2ýPyP 
Y/2 
[3.3.9-5] SLSL 
By combining Equations. 3.3.9-1,3.3.9-3 and 3.3.9 -5, 
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(1 + cos 0)yL / 2ý 
d Y/2 
= 
ýpy12ýp /ydy/2 +ý, i)112 [3.3.9-6] LsLLs 
yL, yLd andyLP can all be found in the literature. ysP and ysd may also be denoted as G"p 
and GdS - 
For contact angle analysis, solutions for both crosslinked and un-crosslinked chitosan 
and their blends with HPEO (or LPEO) were prepared as outlined in Section 3.2. 
Contact angle measurements were carried out using a Data Physics OCA20 
instrument, which comes with an automatic image capture system. The advancing 
sessile drop method was employed where the needle remained immersed in the drop 
during measurements. This is to avoid unnecessary vibration or distortion of the drop. 
The volume of the drop was increased by I ýil at a dosing rate of 0.5ýtl/s. The liquids 
used were pure water, mixtures of 70% pure water and 30% ethanol and 50% pure 
water and 50% ethanol. Due to the rapid evaporation of ethanol and the need to 
maintain consistency of results, dynamic tracking was set up to capture the contact 
angle of the drop at every second for up to I minute. Plots of contact angle (0) versus 
drop age (seconds) were generated for each sample with different liquid systems. 
3.3.10 Permeability and drug release studies for Vitamin B12 
In order to estimate the usefulness of hydrogel membranes for a given application, 
knowledge of their transport properties is required. The diffusion rate of selected 
solute through the membrane can be measured. When no chemical interactions 
between the solute and the membrane take place, solute diffusion through a hydrogel 
membrane is described by Fick's first law [219]. 
P dC 
= 
PAc [3.3.10-1] 
1 dt I 
where J, is the solute flux, P is the solute diffusion permeability coefficient in the 
membrane, I is the membrane thickness, and Ac is the solute concentration difference 
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across the membrane. The permeability coefficient is a product of the solute 
solubility coefficient in the membrane. 
The solute diffusion in the gel membrane, Dgel) was evaluated using the following 
equation: 
Dg, l =PlKd 
where Kd is a partition coefficient. 
[3.3.10-2] 
This partition coefficient is driven by interactions between the solute and the polymer 
chains. Here, the tendency of the magnitude of the partition coefficient may 
sometimes be contrary to that of the diffusivity. That is the polymer in which solute 
has a higher partition coefficient may sometimes show lower diffusivity. 
The diffusion apparatus consisted of two cylindrical half-chambers 23 OCM3 in volume. 
The chitosan membrane was placed between the compartments. The effective 
membrane area was 2.83CM2 . Each compartment was stirred continuously 
by an 
externally mounted constant-speed motor. The diffusion apparatus was placed in a 
water bath maintained at 37'C. Membranes were swollen to equilibrium in deionized 
water at 37'C before they were placed between the two chambers. 
The donor compartment was filled with 2mg/mI vitamin B12 solution and deionized 
water was added to receptor side. Samples of the donor and receptor chambers were 
taken at various time points. The vitamin B12 concentration of the samples was 
determined using a UV spectrometer. 
For diffusion cell experiment Equation 3.3.10-1 can be derived as following [2201 
In(1 - 
2c ')=- 2AP t [3.3.10-3] 
Co k7 
ct is the vitamin B, 2 concentration in the receptor cell at time t, co is the initial vitamin 
B 12 concentration in the donor compartment, A is the membrane surface area, V is the 
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volume of each cell, I is the membrane thickness and P is the permeability coefficient 
[221]. The permeability coefficient, P, was calculated from the UV absorbance data 
by Equation 3.3.10-3 
The partition coefficient can be defined in two ways [222]. One is the ratio of solute 
concentration in the membrane to that in the surrounding solution. This can be 
determined by solute uptake experiments. The membrane, previously equilibrated in 
deionized water, was incubated in a vitamin B12 solution (Img/ml, 20ml) at 37C. 
After 48 hours, the membrane were taken out from the solution, blotted with a tissue 
to remove the excess aqueous solution on the membrane surface and immersed in 
20ml deionized water at 37'C for 48 hours. The concentration of vitamin B12 released 
in the solution (C2) was determined by UV spectrometry as described above. From the 
known concentration of solute after equilibration with the membrane (CI), it was 
possible to estimate the amount of solute sorbed into the swollen membrane. The 
partition coefficient, Kd, was calculated according to Equation 3.3.10.4. 
Kd = 
C2V 
[3.3.10-4] Vp (Cl - C2) 
where V and Vp refer to the volume of the buffer and swollen membrane, respectively. 
The other is the ratio of the solute concentration in the membrane standardised by the 
water volume in the membrane to that in the bulk solution. If we express the former 
as Kd and latter as K, the two partition coefficients are related as follows. 
Kd =HK I [3.3.10-5] 
The diffusion coefficient (D) of vitamin B12 in the various the films was evaluated by 
Equation 3.3.10-2. 
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3.3.11 ES release from a drug carrier 
Figure 3.3.10 shows the UV spectra of ES at different concentrations. It can be seen 
that the absorption peak at 200nm increased markedly with increases in the solution 
concentration. The value of absorption at 200nm vs. ES concentration is shown in 
Figure 3.3.11, where the value of absorption at 400nm was considered as the base line 
because it was independent of the concentration of ES. A linear relationship between 
the value of absorption at 200nm and ES concentration was obtained. In the ES 
release study, this figure was used as the standard curve for determining the fractional 
ES release. 
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Figure 3.3.10 UV spectra of ES with different concentration 
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Figure 3.3.11 A standard concentration curve of ES 
Samples of loaded drug were prepared (see Section 3.2.7). For the drug release study, 
two methods of drug release were employed: from fully hydrated samples (fixed 
boundary condition) and from dry samples (moving boundary condition). 
For fully hydrated or dried samples, each film was immersed in a beaker containing 
250ml of distilled water at 37'C and was well stirred with a magnetic stirring bar to 
minimise boundary layer formation around the film. Samples of solution were 
removed from the beaker at various time intervals. ES concentrations of the collected 
samples were measured at 200nm with a UVNIS spectrophotometer as described 
above. 
MI, the amount of ES sorbate released at time t was calculated. M., the amount of ES 
released after infinite time was taken to be the value at which the equilibrium was 
attained. M/M., the fractional ES sorbate release value was plotted as a function of 
time. The calculation method has been outlined in the section on sample preparation. 
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3.3.12 Separation of protein from ES 
In order to study absorption capacity, the films were cut into small pieces and 
immersed in PBS solution at pH 7.4 for 2h prior to adsorption. Protein and ES 
solutions were freshly prepared by dissolving egg white or ES powder in PBS at pH 
7.4 to give a final concentration of 1mg/ml. Film substrates were incubated in glass 
bottles, containing 3ml protein solution, and the glass bottles were gently shaken 
overnight at 23T. 48 hours after equilibrium, the protein concentration in ES was 
measured using a UV-vis spectrometer via at the absorbance at 280nm. By comparing 
the initial and final concentrations, the adsorption capacities could be calculated from 
mass balances and plotted against the final concentration in solution. 
To study protein separation from ES solution, the same diffusion apparatus was used. 
The details of the method are described in Section 3.3.10.2. 
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CHAPTER 4 
Morphology of Chitosan/PEO Blends and Networks 
4.1 Introduction 
One of the important factors affecting the physical properties of a material, including 
its mechanical, optical and thermal properties, is its morphology. The morphology of 
a material depends on the components present, the fabrication methods used in sample 
preparation and thermal history. 
Polymer blending is a quite simple method by which a mixture of two or more 
polymeric components, which are not chemically bonded to each other, is produced. 
Generally, there are two main reasons for blending polymer together. The first is 
property modification of a given polymer to extend its range of applications or to 
tailor its properties to fit a special requirement. Indeed, depending upon the level of 
mixing of the components in a binary mixture, the blend can have properties that 
make it suitable to areas of application beyond consideration of either individual 
constituent. 
The mixing of polymeric materials is not always predictable. The vast majority of 
polymer pairs when blended are not miscible, but form separate phases or domains 
within the mixture. Such blends are termed immiscible. Miscibility, therefore, 
implies a level of homogeneity within the mixture or is defined in terms of the 
behaviour of macroscopic properties. Miscibility determines phase structure of blend 
systems. Chitosan has many functional properties [30]. When chitosan is blended 
with PEO, the miscibility between their molecules is a very significant factor 
especially for determining the mechanical properties of the blends. It is, therefore, 
essential to study the miscibility in order to understand the morphology of 
chitosan/PEO blends. 
In this chapter, the morphologies of chitosan/PEO blends and networks will be 
investigated by means of FT-IR spectroscopy, DSC and SAXS measurements. 
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4.2 Chitosan/HPEO Blends 
4.2.1 Molecular interactions of chitosan/HPEO blends 
An important consideration in the choice of components for a blend is the 
intermolecular interactions, which are considered to play a key role in polymer 
miscibility [91,223,224]. IFT-IR spectroscopy has been proven to be a powerful tool 
for the study of specific interactions [91,223,224] between two components in blends 
through observing any shifts in the position of peaks corresponding to the functional 
groups involved in the interactions. The purpose of this section is to provide direct 
information on the molecular interactions between the two components in the 
chitosan/PEO blends. 
The infrared spectra of pure PEO and chitosan have been reported [91,223]. The 
main characteristic bands are the following. 
3480cm-1 C6 - OH stretching band of chitosan 
3447cm-1 C3 - OH stretching band of chitosan 
3264cm7l N-H hydrogen bonding of amide 
1652cm-1 amide I band of chitosan. 
1558cm-1 amide 11 band of chitosan, overlaping with NH3' band (I 500cm") 
PEO: the C-0-C stretching band at 1280cm-land 840cm" 
The identification of these peaks allows us to investigate the influence of chain-chain 
interactions in the blend on the basis of band positions and relative intensities. The 
chain-chain interactions can be deduced from the shifts of the vibration frequencies of 
the group involved in the hydrogen bonding. 
Figure 4.2.1, parts (A) and (B), shows the FT-IR spectra for pure chitosan and the 
blends in the composition studies. The hydroxyl (OH) stretching band for chitosan, 
and for chitosan/HPEO blends, is shown in Figure 4.2.1 (A). 
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It can be clearly seen that when compared with the respective chitosan, the OH 
vibration is shifted to a higher frequency. The greatest frequency shift from about 
3424cm" to about 3438cm-1 was observed for the blend with 30% HPEO content. 
The OH vibration also broadened with increasing HPEO content. Analysis of the 
spectra of these blends indicates that hydrogen bonding interactions were involved in 
all the blends, probably between the chitosan hydroxyl and the PEO ether groups 
[224] and the greatest interaction occurred in the CS/HPE030 blend. 
The frequency of the free amine band of chitosan/HPEO blends is shown in Figure 
4.2.1 (B). It highlights that when HPEO content increased to 30% the amide I band 
shifts toward lower frequency from its original position at 1645cm" to about 1632cm' 
1. The a amide II band it is not easily amenable to quantitative evaluation because of 
vibrational overlap and possible changes in absorption intensity. The figure clearly 
shows that the absorption intensity of amine 11 band (1563cm-1) decreased when the 
HPEO content increased from 0 to 30%, but increased when the HPEO content was 
further increased to 50%. These correspond to hydrogen bonding interactions 
between the -0- in the HPEO repeat units and -NH side group in the chitosan repeat 
unit. Analysis of the spectra of these blends indicates that interaction between 
chitosan and PEO in the blends occurs and when the HPEO content was 30% the 
interaction between chitosan and PEO was the strongest. These results prove that two 
polymers are miscible. 
4.2.2 Miscibility and the interaction parameter of chitosan/HPEO blends 
For a polymer blend, it is important to understand the miscibility of its components. 
DSC is a particularly useful tool in studying polymer-polymer miscibility and phase- 
separated blends [211]. The most commonly used method for establishing miscibility 
in polymer-polymer blends, or partial phase mixing in such blends, is through the 
determination of the glass transition of the blend versus those of the unblended 
constituents. A miscible polymer blend will exhibit a single glass transition between 
the glass transition temperatures, Tg, of the components with a sharpness of the 
transition similar to that of the components [211]. In cases of borderline miscibility, 
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broadening of the transition will occur [211]. At the other extreme, a blend exhibiting 
essentially the glass transition behaviour of unmixed components is defined as 
immiscible [211]. Miscibility, therefore, implies, by this definition, a level of 
homogeneity within the mixture. In other words, miscibility also suggests a level of 
mixing adequate to yield the macroscopic properties expected a single-phase material. 
In practice, many polymer blends are neither completely miscible nor completely 
immiscible, but exhibit a degree of partial miscibility. However, when studying the 
miscibility of a blend using the single glass transition criterion, problems will arise if 
the two polymers have transitions at similar temperatures or very weak transitions. In 
this situation, it is very difficult to examine whether one or two transitions are present 
[211]. In such a case, it is necessary to use another method. Studying melting point 
depression [225-227] in the blends is another method for establishing miscibility in 
polymer-polymer blends. This method is usually employed in characterizing the 
miscibility of semi-crystalline/amorphous polymer blends [225]. From the melting 
point depression, it is possible to determine the Flory-Huggins interaction parameter, 
(X12) [226,227], in polymer blends. 
In this study, a thermal characterization of the chitosan/HPEO or chitosan/LPEO 
blends was undertaken as a macroscopic evaluation of the miscibility between the 
components. 
In order to estimate the miscibility of chitosan/PEO blends the melting point 
depression was analysed. 
Figure 4.2.2 shows heat flow vs. temperature plots for the chitosan/HPEO blends. The 
melting temperatures, T,,,, and heats of fusion, AH, for various weight fractions of 
HPEO were compared and plotted against the volume fraction of chitosan in Figures 
4.2.3 and 4.2.4. As shown in the later figures, a downward shift of melting 
temperature (T ) and heat of fusion of HPEO (AH) were registered as the chitosan 
content was increased. This shift in the melting transition of the crystalline polymer 
in the blend can be taken as qualitative evidence of miscibility [225,226] of the 
chitosan/HPEO blends. 
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Figure 4.2.4 Heat of fusion (AH) of HPEO versus the composition (wt. %) of 
chitosan 
Chitosan has been reported to impede PEO crystallization in chitosan/PEO blends 
[225]. This effect has been attributed to the retardation of the rate of crystal growth 
arising from the effect of the stiff chitosan molecular chains on the overall mobility in 
the blend. This was clearly seen in the chitosan/HPEO blends investigated here. 
Progressively increasing the chitosan component within the blends resulted in 
increasingly lower T value and more significantly, lower AH values. The AH values 
were lower, reflecting a lesser % crystalline phase in the PEO component of the 
blends. 
It is known that miscibility of polymer blends is controlled by thermodynamic factors 
[226]. The Flory-Huggins thermodynamic interaction parameter, X12. characterises the 
interaction in free energy of mixing and is used as a measure of the excess enthalPy 
and entropy contributions to potentially favourable mixing. The more negative the 
parameter the stronger the interactions are. These are often called specirylic 
interactions, as they are not present in either component by itself, but only appear 
when both are present. Several techniques [227] have been used to deten-nine the 
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Flory-Huggins interaction parameter for miscible polymer blends. The melting point 
depression of a crystalline component means that the re-growth of the crystalline 
phase is interrupted by the interactions in the blend, and can, therefore, be used to 
estimate the interaction parameter in the blend. The data obtained in these studies are 
usually analysed in terms of the equation derived by Nishi and Wang [228]. 
lfrm(b)- Ifrm ý -(R 
V2u 1AH, VIJ X12 ýl 2 [4.2.2-11 
where 114,,, (b) and T. are the melting temperature of the crystalizable polymer in the 
blend and in the pure state, respectively; AH. is the enthalpy of fusion of the 100% 
pure crystalline material per mole of repeating units, which can be calculated by 
extrapolating the data of semi-crystalline samples; Vju and V2u are the molar volumes 
of the repeating units of the amorphous and the crystalline polymers; ýj is the volume 
fraction of un-crystallized component; R is the gas constant (8.314J/mol K); and X12 is 
the interaction parameter. 
In turn, Equation 4.2.2-1 is based on using the classic Flory-Huggins model 
[229,230]. 
AH = NR TXI2 
01 02 [4.2.2-2] 
where N is the number of moles of segments in the system and T is the absolute 
temperature, 01 and 02 are the volume fraction of amorphous and crystalline 
components, respectively. 
Obviously, X12 is the key parameter for modelling phase behaviour, and is used as a 
measure of the excess enthalpy and entropy contributions to potentially favourable 
mixing. 
Chitosan starts to degrade at above 80'C. It is very difficult to obtain the equilibrium 
melting point for HPEO in the chitosan/HPEO blends. From Equation 4.2.2-1, T,, (b) 
and T. were taken instead Of Vin(b) (the equilibrium melting temperature of pure 
PEO) and 7r,, (the equilibrium melting temperature of PEO in the blends with 
chitosan). In this analysis, the following values were employed: V1. = 132.5CM3/Mol 
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and V2,, = 39.3cm 3/Mol are unit molar volume of chitosan and PEO, respectively, 
calculated from the densities and molecular weights and AH. = 9782.2J/mol (enthalpy 
of fusion of completely crystalline PEO). A plot of (11T,, (b) -11T. ) versus ýj 2 was 
constructed and fitted with a straight line (Figure 4.2.5). From it, the interaction 
parameter, X12, betweenthe components ofthe blend was calculated as -0.16. 
1:: 1 
+2 
Figure 4.2.5 (IIT,, (b)- IIT ) (K) versus volume fraction of chitosan (ýj 
2) 
. The 
interaction parameter (X12) is obtained from the slope. 
This negative value indicates that a certain degree of miscibility in the amorphous 
phase of the blends and that specific interactions are occurring between the 
components over the whole range compositions. 
4.2.3 Crystallinity of chitosan/HPEO blends 
The degree of crystallinity of the PEO in the blends can be determined from the 
following equation: 
Xr = (llfw)( (AH 1(AHý) 
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where AH,, is the heat of fusion for 100% crystalline sample of HPEO, AH is the heat 
of fusion of the HPEO component in the blend andfiv is the weight fraction of HPEO 
in the corresponding blend. 
1.0- 
0.8- 
F0 
0.6- 
0.4- 
ýo ýo io 160 
Wt. % of Chitosan 
Figure 4.2.6 Effects of the composition in chitosan/HPEO blends on the 
degree of crystallinity 
The X, value obtained is illustrated in Figure 4.2.6. It can be seen in the figure that 
the crystallinity of the chitosan/HPEO blends decreased as wt. % of chitosan 
increased. 
4.3 Chitosan/LPEO Blends 
The molecular weight of PEO influences the morphology, and, therefore, the physical 
properties of chitosan/PEO blends. In this section, the molecular interaction and 
morphology of chitosan/LPEO (molecular weigh of PEO: 600) blends were studied using 
a number of techniques, including DSC, FT-IR spectroscopy and SAXS. 
Figure 4.3.1 shows the DSC curves for chitosan and for the chitosan/LPEO blends. From 
these curves, the melting points (T .. ) and heat of fusion (AH) of LPEO in the 
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corresponding blends were obtained. The melting temperatures and heats of fusion for 
various weight fractions of LPEO were collated and are illustrated in Figures 4.3.2 and 
4.3.3. 
It is notable that the melting point, closely related to the composition, initially 
increased with increasing chitosan content, peaked at 60% chitosan at 20'C and then 
decreased rapidly to I5'C by 80wt. % chitosan. The melting enthalpy, AH, of LPEO 
decreased as the chitosan content increased. A comparison between Figures 4.2.3 and 
4.3.2 shows that chitosan/HPEO and chitosan/LPEO blends behaved differently as the 
wt. % of chitosan was increased. In the chitosan/HPEO blends, the melting point of 
HPEO decreased with increasing chitosan content in the blends. The chitosan/HPEO 
blends were miscible, as has been discussed previously. In the case of 
chitosanALPEO, a similar effect was observed for blends where the wt. % of chitosan 
was greater than 60%. In the case of blends with wt. % of chitosan smaller than 60%, 
however, the melting points increased as wt. % of chitosan was increased. 
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Figure 4.3.1 Heat flow vs. temperature curves for chitosan/LPEO blends 
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Generally, increases in the melting temperature of crystalline polymers are caused by 
increases in the lamellar thickness [23 1 ]. The melting behaviour of a polymer crystal 
is, therefore, sensitive to the lamellar thickness. For example, the relationship 
between melting temperature, Tr,,, and lamellar thickness, L, for polyethylene can be 
expressed as [171]: 
T= 414.2(l - 0.627/L) [4.3-11 
Hence, the larger the lamellar thickness, the higher is the melting temperature. In a 
miscible polymer blend, molecular interactions have an influence on the crystalline 
structure, which leads to a decrease of lamellar thickness. The decrease of lamellar 
thickness results in a depression of the melting temperature. However, for immiscible 
polymer blends, the lamellar thickness remains unchanged, giving rise to an 
unchanged melting temperature [232]. 
From a thermodynamic point of view, for a miscible polymer blend, its miscibility 
increases if the molecular weight of a constituent decreases [232,233]. The 
chitosan/HPEO blends are miscible, as has been discussed previously. Consequently, 
the chitosan/LPEO blend is certainly also a miscible system. 
As Figures 4.2.3 and 4.3.2 show, when wt. % of chitosan contents was less than 60%, 
chitosan/HPEO and chitosan/LPEO blends behaved differently. Contrary to usual 
expectations, in the case of chitosan/LPEO blends, the melting points increased as 
wt. % of chitosan was increased. The rules of thermodynamics state that an increase 
in the melting point of a polymer blend is caused by the effects resulting from an 
increase in lamellar thickness. However, this explanation is in conflict with the above 
discussion - if a polymer blend, such as chitosan/LPEO, is miscible, its lamellar 
thickness should not increase. This is a finding which requests further investigation. 
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Figure 4.3.4 SAXS curves for the chitosan/LPEO blends showing the 
changes in long period 
Figure 4.3.4 shows SAXS results for 20,40,50 and 60 wt. % of chitosan of the blends. 
(The theory behind and the discussion on the results obtained for long period analysis 
will be treated in detail in Section 4.4.2. ) The long periods (peak position) did not 
increase, but decreased with increasing chitosan content, meaning that the lamellar 
thickness of LPEO in the chitosan/LPEO blends certainly did decrease. Given this, 
the issue remains what caused the increase in the melting points. 
Molecular interactions between chitosan and LPEO in the blends were examined by 
FT-IR analysis. It can be seen, from Figure 4.3.5, that with increases in wt. % of 
LPEO, one observed an increase in the frequency shift of the free amine band, with 
the maximum shift of 30 units from 1563 cm-1 to 1593 cm-1 taking place at 60% 
chitosan content. This shows that there are strong intermolecular interactions in the 
chitosan/1, PFO blends. 
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Figure 4.3.5 FT-IR spectra for chitosan and chitosan/LPEO blends 
The morphology of crystalline polymer and amorphous polymer blends, in which 
crystallinity is not equal to zero, can be considered as a two-phase structure: one is the 
crystalline phase and the other is the amorphous phase. Generally, molecular 
interactions occur only between molecules in the amorphous phase and not between 
molecules in the amorphous with those in the crystalline phase [232,2331. The low 
molecular weight of PEO (600) must give rise to a small crystal. Due to the strong 
molecular interactions in the chitosan/LPEO blends, it is possible that molecular 
interactions between chitosan molecules and the molecules in the crystalline phase 
occur. It can be assumed that during melting, the crystalline phase must have the 
energy required for de-folding and to overcome the effiect of the strong molecular 
t'orces. So, in the chitosan/LPEO blends, it is believed that the increase in the melting 
points could result from the strong molecular interactions. The FTIR and DSC 
results, as shown in Figures 4.3.2 and 4.3.6, are of particular use. When looked at 
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together at 60wt. % chitosan content, the molecular interaction was at its strongest and 
the melting point was at its highest. 
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Figure 4.3.6 Change in the frequency of free amine band in chitosan/LPEO 
blends with varying chitosan content 
Assume that the increase in melting point resulting from the strong molecular 
interactions between chitosan molecules and these molecules in the crystalline phase 
of LPEO is AT(I), and the depression of the melting point resulting from miscibility is 
AT(m). Vv%en AT(I) > AT(m), DSC shows an postulated increase of melting points. In 
the chitosan/HPEO blends, with increasing chitosan content, the melting points 
decreased (see Figure 4.2.3). In the chitosan/LPEO blends, in some range, with 
increasing chitosan content, the melting points increased (see Figure 4.3.2). 
According to above analysis, it is believed that there is a molecular weight of PEO 
such that AT(I) = AT(m) and the melting points are unchanged. 
It is clear that the melting points of the chitosanALPEO blends, at least, are sensitive to 
PEO molecular weight. 
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4.4 Chitosan/HPEO or LPEO Blends Crosslinked by Genipin 
4.4.1 Phase separation behaviour of chitosan/HPEO (or LPEO) blends 
crosslinked by genipin 
The miscibility and morphology of chitosan/HPEO and chitosanALPEO blends were 
studied in the previous sections. The conclusion was that chitosan/PEO blends are 
miscible in the whole composition range. The issue that follows is whether that 
crosslinking by genipin affects the morphology of chitosan/PEO blend; in particular, 
whether it causes phase separation. SAXS is a particularly useful method of 
examining whether phase separation occurs in polymer system [205,234,235]. 
For a two-phase system, the structure factor, F(q), is given by the Fourier transform of 
the electron density function il(r) [234,235]. 
v 
F(q) = 
fi7(r)exp(- ir - 
#r 
0 
where V is the volume irradiated by the x-rays; the variable q is a scattering vector 
defined as (27c/X)(s,, -s') where the unit vectors s,, and s' correspond to the propagation 
directions of the incident and scattered rays, respectively, and its magnitude is given 
by h= (4n/, %)sinO, where 20 is the scattering angle; and X is the wavelength of the x- 
rays. 
The scattered intensity, 1, can be expressed in terms of the structure factor [234]. 
I= IFF* = 1, (7l')V fy(r)exp(- ir - q)dr [4.4.1-2] 
I, is the Thomson scattering intensity from an electron [234]. The mean square 
electron density fluctuation, <il2>, is given for the ideal two-phase system by 
Equation 4.4.1-3. 
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[4.4.1-31 
where pi and ýj are the electron density and volume fraction, respectively, of the ith 
phase. The function y(r) is the correlation function of the density fluctuation, which 
is a function of r only for an isotropic system [205,235]. 
For an isotropic and ideal two-phase system, it follows from Equations 4.4.1-2 and 
4.4.1-3 that 
I (h) = Ie(p I- p2)2 ýI ý2V f y(r)exp(-ir. q)dr [4.4.1-4] 
From Equation 4.4.1-4, the difference in electron density between the crystalline and 
amorphous regions, thus, indicates the extent of the homogeneity of the system. 
In this study, the morphology of chitosan/PEO blends and networks were examined 
by SAXS. Figure 4.4.1, parts (A) and (B), shows plots of the scattered intensity (1) 
versus the scattering vector, q, of chitosan/HPEO blends and networks, respectively. 
The scattering vector was calculated by: 
q= 47c A sin 0 [4.4.1-5] 
where X=0.154nm. The scattering intensity of the networks was comparatively 
stronger than the blends. The same was seen with chitosan/LPEO blends and 
networks (Figure 4.4.2, parts (A) and (B)). 
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Figure 4.4.1 Scattered intensity versus scattering vector (q) for 
chitosan/HPFO blends (A) and for the blend networks (B) 
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SAXS measurements provide information regarding the electron density distribution 
of the material. Analysis of the angular distribution of the intensities reveals the 
periodicity and magnitude of that electron distribution. The principle of the technique 
is that in an ideal two-phase system, the scattered intensity is proportional to the mean 
square electron density fluctuation [234]. If there is non-phase separation in a system, 
in which the electron density is the same, the scattered intensity only represents for 
background scattering. For a phase-separated system, there is a difference in the 
electron densities, which results in higher scattering intensity. A comparison between 
Figure 4.4.1, parts A and B, and between Figure 4.4.2, parts A and B, shows that 
crosslinking by genipin increased the scattered intensity for the chitosan/HPEO and 
chitosan/LPEO systems. These can be regarded as evidence of differences in electron 
densities in each group of network. Such differences signify partial segregation in the 
blend. The stronger the intensity, the greater is the segregation. This result indicates 
that crosslinking resulted in phase separation. 
As can be seen in Figures 4.4. IB and 4.4.2B, the chitosan network with 30% of 
HPEO (or LPEO) exhibits the strongest intensities - the stronger intensity the greater 
is the phase separation. The larger phase separation in the crosslinked chitosan/PEO 
blend leads to reduced molecular interaction between the chitosan and PEO and the 
network with the higher HPEO or LPEO contents produces a less than desirable 
blend. 
4.4.2 Restrictions on crystallisation 
Bragg's law states that the relationship between the long period and the scattering 
angle is given by: 
D,,, = 2n/q,,, =, %/(2 sinO,, ) [4.4.2-1] 
where D. is the periodicity of the structure and 0,,, is the scattering angle at the 
maximum intensity of the scattered rays. 
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Figure 4.4.3 shows SAXS results for 20,40,50 and 60 wt. % chitosan blends 
crosslinked by genipin. The maximum scattering angle increased as the chitosan 
content was increased. According to Bragg's law, therefore, the long periods 
decreased with increasing chitosan content. This means that the LPEO lamellar 
thickness in these chitosan/LPEO blends decreased. 
8. OOE-Oi3 - 
7. OOE-013 - CS/LPE080 
6. OOE-013 - 
5. OOE-013 - CS/LPE040 
4. OOE-013 - 
3. OOE-013 - 
2. OOE-01 3- 
I. OOE-013 - 
O. OOE+000 
I 
0.0 0.2 0.4 0.6 0.8 1.0 
20 
Figure 4.4.3 SAXS curves for chitosan/LPEO networks showing the 
changes of long period 
A comparison of Figure 4.4.3 with Figure 4.3.4 shows that with increasing chitosan 
content there were decreases in the long periods of both the blends and the networks, 
but these decreases were more noticeable in the case of chitosan/LPEO networks (see 
Table 4.4.1). Crosslinking using genipin led to decreases in the crystallite size, 
meaning that the presence of networks restricts crystal lisation. 
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Table 4.4.1: Comparison of the long periods of crosslinked and un-crosslinked 
chitosanALPEO blends 
Crosslinked Un-crosslinked 
Maximum Maximum 
LPEO content Long period Long period 
scattering scattering 
(D. ), nm (D. ), run 
angle (0, ), 0 angle (0), ' 
40 0.215 20.5 0.0875 50.4 
50 0.191 23.1 0.0775 56.9 
60 0.213 20.7 0.080 55.1 
80 0.0876 50.4 0.061 72.3 
The results of DSC analysis are shown in Figure 4.4.4. After crosslinking, the 
melting point of the chitosanALPEO blends decreased. Thermodynamically speaking, 
decreases in the lamellar thickness are responsible for the decreases in the melting 
points [171,232]. Consequently, DSC analysis also shows that crosslinking restricts 
crystallisation and leads to smaller crystals. 
Figure 4.4.5 shows SAXS results for the 50 wt. % LPEO blend crosslinked by 
different amounts of genipin. The scattering angles (20) of the long periods for 
blends with genipin contents of 0.5% and 0.8% are 0.382' and 0.415*, respectively. 
The angles for the blend with genipin content of 0.0 1% and 0.1 %, however, were not 
obtainable from the figure because their peaks occurred at very small angles. 
103 
Chapter 4: Morphology of ChilosanlPEO Blends and Networks 
19.5- 
-W- without genipin 
.I-, with genipin 
19.0- 
18.5- 
18.0- 
17.5- 
17.0- 
20 30 40 50 60 
wt. % of chitosan 
Figure 4.4.4 Comparison of Tn for chitosan/1-PEO biends and networks 
1.20E-01 2- 
1.00E-01 2-0.5% 
8. OOE-013 - 
6. OOE-01 3- 
S 4. OOE-013- -ý ft... 
2. OOE-01 3- 
O. OOE+000 - 
-2. OOE-013 
I-I 
-r--l 
0.0 0.2 0.4 0 .60.8 1.0 1.2 
20 
Figure 4.4.5 SAXS curves for chitosan/LPI'-050% networks showing the 
changes of long periods with genipin content: 0.0 1,0.1,0.5 and 0.8wt. %. 
104 
Chapter 4: Morphology of ChitosanIPEO Blends and Networks 
The results clearly indicate that with increasing genipin content, the long period of 
LPEO in a chitosanALPEO blend decreases. One can see from Bragg's law, stated 
above, that there is an inverse relationship between the size of the scattering angle and 
the magnitude of the long period. It has already been stated that crosslinking restricts 
crystallisation. This discussion shows that increases in the genipin content lead to 
greater restrictions on crystallisation, and, hence, to smaller crystals. 
The above discussion on the morphology of chitosan/HPEO or LPEO blends and 
networks has shown that blending and crosslinking, especially the latter, leads to 
substantial morphological changes, including phase separation and reduction in the 
crystallite size. The effects of such changes in morphology on the mechanical and 
other physical properties of the polymer will be discussed in the following chapters. 
4.5 Conclusions 
The molecular interaction and miscibility of chitosan/PEO blends were examined. 
For chitosan/BPEO system, FT-IR spectra reveal hydrogen bonding interactions 
between the -0- group in the HPEO repeat units and -NH side group in the chitosan 
repeat unit of the blends. The results show that chitosan/HPEO blends are miscible 
over the whole composition range and the interaction parameter, X12, between both of 
components of the blend was -0.16. An interesting phenomenon was observed for 
chitosanALPEO blends. When the composition of chitosan was less than 60% by 
weight, the melting points increased as the composition of chitosan was increased. It 
is believed that there are strong molecular interactions between chitosan molecules 
and the molecules in the crystalline phase of LPEO in these chitosan/LPEO blends. 
The morphology of chitosan/PEO blend networks was investigated. SAXS results 
showed that a heterogeneous structure exists in the chitosan/HPEO (or /LPEO) blend 
networks. Crosslinking by genipin restricts crystallisation and leads to smaller 
crystals. 
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This information on the morphology of chitosan and chitosan/PEO blends and 
networks will be helpful in the understanding of the properties of their films. 
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CHAPTER5 
Mechanical Properties of Chitosan/PEO 
Blend Films and Networks 
5.1. Introduction 
As reviewed in the Chapter 2, chitosan, as a member of the family of P (1-+4) linked 
polysaccharides, is a collective term applied to deacetylated chitin in various stages of 
deacetylation and depolymerisation. In contrast to most other polysaccharides, 
chitosan displays basic properties that impart it with unique physicalchemical 
characteristics [30,43]. Owing to the presence of reactive amino groups, chitosan can 
be modified [30,43]. Like many other polysaccharides, it manifests very good film- 
forming properties, which significantly extend its range of applications. The films are 
usually obtained from a solution of the polymer in the salt form. The mechanical 
characteristics of chitosan films depend on various parameters. Numerous studies 
have demonstrated that the salt-form [236], molecular weight [236] and degree of 
deacetylation [237] as well as the external conditions of film formation [236-238] 
influence the properties of this polymer. As some literature reports, the nature of the 
interactions, the concentration of chitosan and the nature of the acid used could 
influence the conformation of the polymer chains during the formation of the film 
and, as a consequence, the density of entanglement of the chains in the solid state. It 
is, therefore, these factors that must be considered carefully during film formation. 
For biomedical applications, one of the most important physical properties of chitosan 
films is their mechanical properties in the hydrous state, because the films have to be 
in contact with the living body for long periods of time. For a un-crosslinked chitosan 
film in anhydrous conditions, the stress at break can be relatively high and close to 
8OMPa and the Young modulus near 3.6GPa [238]. However, after immersion in 
deionized water for a few hours, a tremendous loss of mechanical properties takes 
place: 99% for the Young modulus and 88% for the stress at break [239]. Clearly, the 
mechanical properties of a un-crosslinked chitosan film cannot meet the requirements 
for biomedical applications. 
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One of the main tasks in our research is to develop a novel chitosan/PEO blend film 
crosslinked by genipin with the optimisation of mechanical properties for biomedical 
applications. The aim of this chapter is to study the mechanical properties of the 
novel chitosan/PEO blend films in both the dry and wet states. 
5.2 Effects of PEO Content, Molecular Weight of PEO and Crosslinking on 
Mechanical Properties of Chitosan/PEO Blend Films 
The strength and elasticity of a polymer film can be reflected by its tensile strength 
and elongation at break, which are measured by tensile testing. Films suitable for 
biomedical applications should be strong, but flexible. Films prepared from pure 
chitosan are rather brittle [43]. Therefore, it is very important to improve their 
ductility. There are several ways to obtain films with better elastic and strength 
properties, for example, preparing them from blends[90-93] and or by crosslinking 
[4,7,8j. In this study, PEO was introduced into chitosan and crosslinking with 
genipin was used to improve the flexibility and strength of chitosan. 
The tensile strength and the elongation at break plotted against wt. % LPEO for dried 
films of both crosslinked and un-crosslinked chitosan and chitosan/LPEO blends are 
shown in Figures 5.2.1 and 5.2.2, respectively. It can be seen that the pure chitosan 
film is brittle: the tensile strength was 39MPa and the elongation at break 8%. The 
highest tensile strength was found in the blend with 20wt. % of LPEO (55MPa) and 
the greatest enhancement of elongation at break (38%) occurred at 65% LPEO 
content, the highpoint of a general trend of elongation increasing as LPEO content 
increased. Crosslinking with genipin gave rise to improvements in both mechanical 
properties. It was also observed experimentally that films containing more than 65% 
LPEO were opaque, while films with lower LPEO content were transparent and pale 
yellow to brown in colour. From this observation, it can be concluded that films with 
a low LPEO content are likely less heterogeneous than films with high LPEO content. 
This fact has already been confirmed by the study of miscibility in Chapter 4. 
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Table 5.2.1. Tensile strength and elongation at break of the chitosan /HPEO 
blend systems (Genipin content: 0.5wt. %) 
PEO (%) 
Elongation at break 
(%) 
Stress at break 
(MPa) 
Un-crosslinked CS/HPEO System 
10 19 ± 2.0 60 ± 1.2 
20 25 ± 1.5 63 ± 1.7 
30 14 ± 1.2 50 ± 1.9 
Crosslinked CS/HPEO System 
10 15± 1.5 55 ± 2.0 
20 17 ± 1.2 70 ± 1.2 
30 15 ± 1.9 58: L 1.8 
Table 5.2.1 shows the results of tensile strength and percentage elongation at break 
for chitosan/HPEO systems. The chitosan/HPEO blend films could not be prepared 
when the HPEO content was higher than 30%. It can be clearly seen, from the results 
shown in the table, that crosslinking with genipin did not give rise to improvement in 
either tensile strength or elongation at break for the chitosan/HPEO systems. This 
may be due to the low miscibility of chitosan with HPEO as indicated previously in 
Chapter 4. 
5.3 Effects of Crosslinking Density and Water Content on Mechanical Properties 
of Chitosan/LPEO Blend Films 
It is clear from Section 5.2 that for all films containing LPEO crosslinking gave rise to 
increases in the tensile strength and elongation at break of the films. From the results 
shown in Figures 5.2.1 and 5.2.2, it can be seen that there is an optimal content of 
LPEO, 50150 by weight, for elongation and tensile strength in the chitosan/LPEO 
blend films. In discussing the effects of crosslinking density and water content on the 
mechanical properties of the chitosan/LPEO blend films, the focus is, therefore, on 
the results of chitosanALPEO (50150 by weight). 
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Figures 5.3.1 and 5.3.2 give the stress-strain curves for un-crosslinked and crosslinked 
CS/LPE050 blend films (genipin content: 0.5%) with different water contents. 
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It can be seen in both cases that with increasing water content in the films, elongation 
at break increased whereas tensile strength decreased. However, crosslinking gave 
rise to greater increases in both tensile strength and elongation at break than the 
equivalent dried samples. At 15% water content, the increase in tensile strength of the 
crosslinked film was more than twice that of the un-crosslinked one. At 25% water 
content, for the crosslinked film, the elongation at break reached 80% and the tensile 
strength was at about I 5MPa, and for the uncrosslinked film, the elongation at break 
was 35% and the tensile strength was at about 6MPa. 
Table 5.3.1 Comparison of the modulus and elongation at break of un- 
crosslinked and crosslinked CS/LPE050 films with different water contents 
(genipin content: 0.5%) 
Sample Water content Modulus 
(MPa) 
Elongation 
at break 
0 2114 105 25.4 ± 1.2 
5 1586 80 29.0± 1.6 
CS/LPE050 10 1117 40 32.9 ± 1.8 
25 547 ± 30 34.5 ± 1.8 
0 2341 ± 102 28.0 ± 1.4 
5 1942 98 45.1 ± 2.4 
CSR/LPE050 10 1567 78 58.5 ± 3.0 
25 627 35 80.1 ± j. 2 
Table 5.3.1 gives a comparison of the modulus and elongation at break of un- 
crosslinked and crosslinked CS/LPE050 blend films with different water contents. 
With increasing water content, the modulus of the CS/LPE050 films decreased and 
the elongation at break increased. However, crosslinking with genipin produced 
significant increases in the modulus when the water content was less than 25%. As 
the water content increased from 0 to 10%, the modulus for the un-crosslinked film 
reduced by 47%, but the modulus for the crosslinked film reduced only by 33%. As 
the water content increased from 0 to 25%, the increase in elongation at break for the 
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crosslinked film was more than 6 times that of the un-crosslinked film. These 
enhanced properties were more noticeable in films with higher water contents. The 
importance of preventing the carrier in a drug delivery system from disintegrating 
when the water content of its surrounding environment increases means that these W 
improvements in the mechanical properties are of real significance. 
The stress-strain plots of the crosslinked CSR/LPE050 blend film with different 
genipin contents are shown in Figures 5.3.3 (where the water content of the film is 
5%) and 5.3.4 (where the water content of the film is 13%). Both indicate that the 
increment in elongation at break was tremendous when the genipin content was 0.1%: 
the increase in elongation was 200% at 5% water content and 450% at 13%. When 
the genipin content was increased further to 0.5% and then 0.8%, the improvement in 
elongation at break were not as significant as that for 0.1% genipin. The reasons for 
this are not yet clear. It may have resulted from the effect of crosslink density. 
Table 5.3.2 shows a comparison of the modulus (as well as elongation at break) of 
crosslinked CSR/LPE050 blend films with different genipin contents, when they 
contain 5 and 13% water. Crosslinking reduced the loss in modulus of the films as 
the water content increased, in particular where the genipin content was high. 
As expected, films crosslinked by genipin became more elastic and maintained their 
strength when they were in wet state. 
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Table 5.3.2 Modulus for crosslinked CSR/LPEOSO blend films 
Genipin 5% water 13% water 
Sample content 
(%) 
Modulus 
(MPa) 
Elongation 
(%) 
Modulus 
(MPa) 
Elongation 
at break 
0 1586± 80 29.0 ± 1.6 870 ± 80 20.1 ± 1.8 
0.01 2096 ± 102 29. I: L 1.7 978 ± 50 35.6 ± 1.8 
CSR/LPE050 0.1 2143 ± 60 90.1 ± 3.1 1120 ± 56 111.2 ± 3.3 
0.5 1942 ± 98 45.1± 2.4 1720 ± 90 58.4 ± 2.9 
0.8 2025 ± 55 78.6 ± 3.5 1447 ± 70 78.4 ± 3.5 
Chitosan has been described in terms of the degree of deacetylation and average 
molecular weight in conjunction with its film-forming properties [175]. It has been 
observed that the film formation of un-crosslinked blends is closely related to their 
composition. Above 50wt. % of HPEO or 65wt. % of LPEO content, no useful films 
could be formed. Similar results have been reported by Zhao [225]. However, 
crosslinked blends at 80wt. % of LPEO or above overcame this problem. These 
indicate that using genipin as a crosslinker can improve the mechanical properties of 
chitosan/PEO blend films. 
Such improvements are in agreement with the previous discussions about changes in 
morphology. Crosslinking reduced crystal size and the degree of crystallinity and it 
gave rise to improvements of the mechanical properties. 
5.4 Effect of Solution pH on the Mechanical Properties of Chitosan Films 
Chitosan exists in the solid state in various forms such as films, yarns, flakes, powder 
etc [43]. Most of them arose by regeneration from a solution or gel. The mechanical 
properties of chitosan in the solid state obviously depend on the conditions of 
preparation, i. e. the solution or gel properties of this polymer. 
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Chitosan is an acidic soluble polymer. pH has an influence on the solution properties 
[30,43]. Solution behaviour of chitosan reflects the role of the superamolecular 
organizations and also allows us to understand various interactions in which this 
polymer can be involved. The gelation of chitosan solutions depends on the 
molecular mobility of the polymer chains in the media and the extent of acetylation. 
The first important point is the initial media [43]. Indeed, gel formation can only be 
achieved if chitosan is initially in the form a salt obtained with a weak acid [30,43]. 
The behaviour must be related to the fact that the reaction of acetylation is performed 
on free amine functions, and, therefore, favoured in presence of a weak acid. As a 
consequence, solution pH plays an important role in relation to the occurrence of 
gelation [30,43]. 
It is clear from the above that film formation conditions, such as solvent pH and the 
type of solvent used can certainly affect the mechanical properties of chitosan films. 
Thus, in this section, the mechanical properties of chitosan films, which were formed 
with different pH values, are discussed. 
Un-crosslinked and crosslinked chitosan films were prepared when solution pHs were 
2.5,3.0,4.0 and 5.0, respectively. The tensile strength and elongation at break plotted 
against pH value of solution for both films are shown in Figures 5.4.1 and 5.4.2, 
respectively. The results for the un-crosslinked chitosan films clearly indicate that 
solution pH has a significant influence on both tensile strength and elongation at 
break. The more acidic the solution, the greater the tensile strength and the larger the 
elongation at break. When the solution pH was 2.5, the values of both properties were 
double that when the solution pH was 5.0. For the crosslinked chitosan films, the 
results indicated that when the solution pH was 3.0 the elongation at break was the 
greatest, but that the solution pH did not have a substantial effect on the tensile 
strength. 
From the above results, it can be seen that the tensile stress and elongation of 
crosslinked and uncrosslinked chitosan films at break are influenced by the solution 
pH. From tensile tests alone, it is difficult to understand why solution pH has a 
significant influence on stress and elongation of chitosan films at break. 
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In order to understand this effect, it is necessary to investigate the aggregation 
behaviour of chitosan macromolecules during film formation. In Chapter 8, the 
results of this investigation are discussed and the issue of why solution pH has a 
significant influence on tensile strength and elongation at break of chitosan films is 
addressed. 
5.5 Effect of Film-forming Temperature on the Mechanical Properties of 
Crosslinked Chitosan Films 
Temperature is an important factor of affecting the solution properties of chitosan, 
which determine the mechanical properties of the chitosan films. It is because during 
film formation the molecular mobility of the polymer chains in the media is 
influenced by the solution properties [30,43]. In this section, the effect of film- 
forming temperature on the mechanical properties of crosslinked chitosan films was 
studied. The film-formation temperatures used are 25'C, 400C and 60'C, respectively. 
The tensile strength and elongation at break plotted against the film-forming 
temperature are shown in Figure 5.5.1, parts (A) and (B), respectively. When the 
temperature used was 25'C during the formation of the film, the elongation at break 
of the crosslinked chitosan films was the greatest, and double that at 40'C. However, 
the better tensile strengths of the films were obtained when the temperature was 40'C 
and 60'C. 
It is known that intrinsic viscosity of chitosan is influenced by the solution 
temperature [29] and the intrinsic viscosity could also affect molecular motion during 
the crosslinking or film-formation. This fact could cause different crosslinking 
processes, resulting in different morphologies of the network in chitosan films, giving 
rise to different mechanical properties. The temperature-dependence of the 
crosslinking reaction of chitosan and genipin (Chapter 7) will answer the question of 
why film-forming temperature affects the mechanical properties of crosslinked 
chitosan films. 
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5.6 Conclusions 
The mechanical propertics of chitosan/PEO blend films were examined. Itwasfound 
that, compared to the transparent yellow, un-crosslinked chitosan films, the blue, 
crosslinked films were more elastic and had better mechanical properties. Due to the 
miscibility of chitosan and LPEO, chitosan/LPEO blend films and networks show 
better mechanical properties than those of chitosan/HPEO blend films and networks. 
Improvement in the modulus and elongation at break at higher water contents in the 
films was achieved. This will prevent them from disintegrating during biomedical 
applications. 
Uncrosslinked and crosslinked chitosan films were prepared under different extemal 
conditions, such as solution pH and film-forming temperature. The solution pH 
affected the mechanical properties of chitosan films. The more acidic solution, the 
greater were the tensile strength and elongation at break. Film-forming temperature 
also had an influence on the mechanical properties of chitosan films. The film 
obtained by the lower crosslinking temperature (film-formation) of 25"C was 
endowed with larger eloilgation at break and lower tensile strength. 
It is difficult to understand, from tensile tests alone, why solution p1l and film- 
forming temperature have a significant influence on the mechanical properties of 
chitosan films. The study of the temperature-dependence of crosslinking reaction of 
chitosan and genipin (sce Chapter 7) and the static light scattering studies on the 
aggregation and collapse of chitosan chains in aqueous solutions (see Chapter 8) will 
answer this question. 
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CHAPTER 6 
Swelling Behaviour and Surface Properties 
6.1 Introduction 
It is known [239-241] that drug release from carriers depends on their physical and 
chemical properties in response to the surroundings. For drug delivery, materials 
have to be mechanically satisfactory and stimuli-responsive, because they are 
expected to reside in the body for a long period of time and modulate drug release by 
responding to local environmental stimuli [239]. 
Some polymers undergo strong conformational changes when only small changes 
occur in the environment, such as temperature, pH and ionic strength [240-244]. 
They can provide the tools for creating functional materials with a wide variety of 
uses because environmental changes induce structural changes. These polymers are 
called stimulus-responsive polymers. In particular, hydrogels exhibit dramatic 
changes in their swelling behaviour in response to surrounding environmental 
conditions, such as temperature [240,241], pH [242]], ionic strength [243], electric 
field [244] etc, both internal and external to the body [245]. These can result in the 
release of an entrapped drug in a controlled manner. Various stimuli that have been 
explored for modulating drug delivery are represented in Figure 6.1 [246]. 
Changes in pH are the most useful signal in the human body because they occur 
naturally in some areas of the body. For example, as the pH of the gastric condition is 
much lower than that of the enteric condition, a pH-sensitive hydrogel is a candidate 
as an intelligent device to deliver drugs to the small intestine while avoiding release in 
the stomach. In the pH system, the ionic group within polymer gels control polymer 
chain interactions. Recently, hydrogels based on chitosan have been developed for 
controlled drug delivery systems. The chitosan-based hydrogels, which swell and 
contract in response to external pH have potential uses in site-specific drug delivery 
systems [247,248]. Changes in temperature are another important signal in the human 
body. In the temperature system, the thermosensitive hydrogels swell and collapse in 
122 
Chapicr 0. Sivcffitig Beluivioul. wId sur/acc Propcrlic. s 
response to temperature variations. Okano and Kini el ul. 1249,2501 have syntlicsiscd 
cross-linked copolymer hydrogels, which achieved on-oIT regulation of drup release 
in response to step-wise temperature changes. As the hydrogel Nvas s\\oIlcn at high 
temperature, the drug COLIld be release from it. Recently, tcnipcraturc-rcsponsive 
crosslinked chitosan microspheres coated mth lipid for intelligent drug delivery 
systernshavebeen reported [251]. ThcdrLIo release rate\\ascontrolled bythcphase 
transition temperature of the lipid. The arnount ot'drug released increased \\Iicil the 
temperature was raised to 42"C and decreased when the temperature was lowered to 
37'C: the phase transition temperature was 41AT. 
Liqht 
pH 
radiation 
, 
Ultrasonic radiation 
Magnetic field 
lonic strr-ng9i 
T c, mp c- rnt u rc, '-k A' -Electricfield 0 
LI rea 
nsv) I)II011 I nf lam matiun - Sw oIIC, n rogo I 
i Metal hVdfogel GI uruse' 
Morphine Antibody 
StilIlLili lCtiOll 
fl, wj Ou%-t ý- ý- 
Figure 6.1 Stimuli responsive swelling ofliýdrogels for (fillo dcli\/ei, N 
As seen from the above overview, temperature and pil are the most widely litilised 
triggerim, signals for intelligent drug delivery systerns. III OUr research, it is proposed t) ýn 
to StUdy the novel chitosan/PFO film crosslinked by genipin as I material I'Or potential 
g systerns. 
bionledical Lises such as in dru- delivery The mechanical properties ol'the 
I-ilms have been improved by blending and crosslinking methods and these have been I 
discussed in the preceding chapters. Now, it is very Important to examine the nature z: 1 
of' the svsterns in their environnicntal conditions. III this Chapter, tile StabIlO, 
behaviour and SM swc1lino 1ace properties, \011ch respond to chalq, cs III 
environnicrItal conditions, are investigated. 
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6.2 Stability ot'Crosslinked Filins in Water 
From the point of view of medical applications, because materials have to rcsildc in 
the body for lon,, 41 periods of time, their mechanical properties ill the Nvct state arc 
more important than those in the dry state. It is known that chitosan iS illSOILlbIC '111 
water (1-)11 7), whereas both HPEO and LPFO are water-solLiblc. Ill order to develop 
Optil"111.1111 11OVel films I-or medical pUrposes, in this section, tllc stability of' both 
crosslinked and un-crosslinked blend 111111S ill lIeLltral water were investigated. 
FigUres 6.2.1 and 6.2.2 shmN the degrees of stability ol'the films plotted against wt. % 
ofl IPFO (I-PFO). A comparison shows that the un-crosslinkcd chitosanATFO filins 
are more stable than the un-crosslinkcd chitosan/HITO 1-11111s. with the la(ter heing 
vcrN unstable clue to the higher miscibilit) 01,1AILO with chitosan Compared to that ol, 
I IPFO (reported earlier in this thesis). 
100 
80 
60 
m 
40 
Figure 6.2.1 Comparison ofthe stability ol'cross-linkcd and un-cross-linked 
chitosand 11114) hicnd 1-ilms (0.51ý/o genipin) in \ýatcr at pl 17 
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Figure 6.2.2 Compai-ison of tllc stability ol' aoss-linked and ull-cl-oss-Illiked 
chitosan/I. Pl'. 0 Mend films (0.5'ý/() ocilipm) in walcr at pl 17. 1 
As seen from the figures, crosslinking, however, produced noticeable increases in the Z:, 
stability of both blends, in particular those of the chitosan/l, PFO blends. Hiis clTect 
of crosslinking, is of' much importance to the medical applications of such materials. 
since it is linked to then- stability dUrino Fabrication and storage and while in service. I 
6.3. Swelling Behaviour of Chitosan and Chitosan/1, PE. 0 Blend Net-svorks 
To examine the possibility of use in medical applications, the chitosan and 
chitosan/I. PFO new orks Nvere s\Nollcri in different pI I aqueous solutions to simulate 
the conditions of' GI (oastrointestinal) tract dclivcr\. It is knomi that \\hcn the 
macromolccular chains of a polynicr are f`ixcd by clicnilcal crosslinking, the s\\,, clliii,, 
ability ofthe polymeric network is reduced. 
Chitosan is soluble at I)l I<6.5. CrosslinkCd CllitOSall net\\orks have the advantage of' 
beim, insoluble in acidic and alkaline SOILltiOlIS and has the ability to s\\cll in thesc Lý 
aqueous media. Figure 6.3.1 shows that the swellability 01' purc Cllitosall 1-11111s was 
Un-crosslinked 
Crosslinked (0.5%) 
12S 
('Iitq)l(, i- 6: Swelliiig Bchaviour widSurfiwe Propcoics 
affiected by the crosslink density. From the fl, "Ure, it can be seen that filins \\ ith a low 
crosslink density (0.26%) dissolved at pil 4, \\Iiercas films vith higher crosslink 
densities (4.65% and 9.22%) \vere insoll. 1111C in acidic solutions. FL11111CIAllOrC, 1`01' 
illSOIL1111C films, all increase in the crosslink density meant a decrease in the extent ol, 
swelling. The degrees of swelling of a series of filins in dill'crent pi Is at 2TV and 
38')C' are shown in Fioures 6.3.2 and 6.3.3, respectively. It call lie Seel] that the 
swellino behaviour of tile filins was stronoIN' dependent oil the I)II value of' file 
When inedium and the wt. % of ITFO 'In the him and temperature. 
temperature was increased from 23T to 38"C', swelling in 1)11--7 hLIHer Solutions 
increased by 50-100%. In alkaline buffer solutions, hoý\ever, there ý\ere no notable 
increases in swelling, althOUgh the greatest swelling l10\V Occurred Under the less in zD 
alkaline condition of pFi 10 rather than the previous pf 1 12. It call he concluded that 
the genipin-crossfinked chitosan network resulted in sionificantly different s\ý, ellillo 
characteristics in various pl-I hUffer sOILItions. The increased swellim, of' the 
crosslinked filins at plis lower than 7 may he ascribed to the hydrolysis ol'the amide 
linkaoc of the crosslinked chitosan network bv acid and the regeneration of' anline 
groups in the networks [252]. 
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Figure 6.3.1 Swelling behavIOUr of chitosan hilms, at 23"C mth diffIci-cilt 
crosslink density. 
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Figure 6.3.2 Swelling behaviOUr of'cross-linked chitosan/ITFO bIcnd I-ilms at 
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Because of the fact that the amino groups reformed in the network could be 
protonated in acid, the equilibrium ratio of swelling of the chitosan film in acid was 
larger than that in the neutral solution. It would be a desirable characteristic for the 
swelling ability of a control led-release system to be both pH and temperature- 
sensitive. These films are, therefore, of general interest for medical applications such 
as artificial muscles or switches, medical separation systems and controlled drug 
release systems [5,176]. 
6.4 Surface Properties 
The surface properties of biornaterials are very important for applications ranging 
from solute separation to controlled drug delivery because of the surface interactions 
between the materials and the solutes [253,254]. The surface behaviour can minimise 
interfacial problems with host tissues and fluids. Generally, when PEO is introduced 
into polymer blends it contributes to their high water content and special surface 
properties because of their hydrophilic and biocompatible properties [62,63]. 
The wetting, or non-wetting, of solid surfaces by a liquid can be described in terms of 
thermodynamic parameters, such as surface and interfacial free energies. Wetting 
may be thought of as the process of achieving molecular contact. The extent of 
wetting may be defined as the number of molecular contacts between two phases 
comprising the system relative to that exhibited when wetting is complete. Since a 
liquid makes contact with the outmost molecular layer of a surface, the contact angle 
is more sensitive to chemical and structural changes that occur on surface. 
Contact angle measurements can be also used to calculate the surface free energy of 
solid, as outlined by Fowkes [217] with the assumption of smooth and homogeneous 
surfaces and under conditions where a state of equilibrium with the environment has 
been reached. The equilibrium contact angle is a function of the surface free energies 
of the solid substrate and liquid in contact with it and of the free energy of the 
interface between the two phases [216,217]. In this section, therefore, further 
characterisation of the surface properties of the chitosan films and the blends for both 
crosslinked and un-crosslinked samples were carried out by contact angle analysis. 
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6.4.1 Water contact angles on the surface of the films 
f 
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2 
Figure 6.4.1 Contact angles for crosslinked and un-crosslinked chitosan and 
blend films for water: (A) CS and CS/HPEO, (B) CS and CS/LPEO 
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Figure 6.4.1, parts (A) and (B), shows the contact angle for water media when a drop 
was placed on the surface of the chitosan and the chitosan/PEO blends and their 
networks. The contact angles for chitosan and the network films were found to be 80' 
and 62', respectively. Crosslinking resulted in an improvement in the wettability of 
the chitosan films. As seen from the figure, the angle decreased gradually when 10, 
20 and 30wt. % of HPEO (or LPEO) were introduced into the films, and in most cases 
the contact angle for crosslinked blends were much higher than for the un-crosslinked 
ones. In order to understand the wettability of the films, the surface free energy was 
investigated. 
Table 6.4.1 Surface free energies for diiodomethane (DIM), water and 
water/ethanol mixtures at 20'C [255] 
YL ypL 7L 
Liquid (Mj/m 2) (Mj/m 2) (Mj/m 2) 
DIM 50.8 0 50.8 
water/ethanol (100: 0) 72.8 51.0 21.8 
water/ethanol (70: 30) 35.5 17.0 18.5 
water/ethanol (50: 50) 29.7 12.1 17.6 
Table 6.4.2 DIM contact angles for chitosan, CS/PEO blends and networks at 
25'C 
Sample Contact angle (0') Sample Contact angle (0') 
CS 40.2 ± 2.2 CSR 40.6 ± 2.5 
CS/HPEOlO 44.0 ± 1.5 CSR/HPEOlO 29.1 ± 6.4 
CS/HPE020 32.2 ± 2.6 CSR/HPE020 36.6 ± 1.5 
CS/HPE030 45.1 ± 2.2 CSR/HPE030 38.6+2.5 
CS/LPEOIO 40.6 ± 2.7 CSR/LPEOIO 44.8 ± 1.5 
CS/LPE020 34.0 ± 2.4 CSR/LPE020 36.8 ± 1.2 
CS/LPE030 38.4 ± 3.7 CSR/LPE030 35.8 ± 2.6 
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In this experiment, two types of liquid with known surface energy, namely triply 
distilled water and diiodomethane (DIM), which represent polar and non-polar liquid 
media, were used. DIM was chosen as a reference medium and its contact angles on 
the surface of uncrosslinked and crosslinked chitosan and chitosan/PEO films were 
measured as shown in Table 6.4.2. The surface energies of triply distilled water and 
DIM, at 20'C, are given in Table 6.4.1 [255]. The surface free energy of a film and 
its dispersion and polar components can be estimated from the contact angle of a 
liquid by means of Equation 3.3.9-6. The surface free energy (y) with its respective 
dispersion (YSd ) and polar (y, P) components of un-crosslinked and crosslinked chitosan 
and chitosan/PEO blendes are listed in Table 6.4.3. 
Table 6.4.3 Water contact angles and surface free energies of crosslinked and 
uncrosslinked chitosan and CS/LPEO (or CS/LPEO) blends and networks 
Sample 
Contact angle 
M 
Id S-2) 
(Mjm 
7P 3-2) 
mjM (M 
Ys 
-2 JM 
CS 80.2 39.3 3.5 42.8 
CS/HPEO 10 45.2 37.6 21.9 59.5 
CS/HPEO 20 40.1 43.4 22.9 66.3 
CS/HPEO 30 20.3 37.1 34.8 71.9 
CS/LPEO 10 42.1 39.2 22.9 62.1 
CS/LPEO 20 30.4 42.4 27.6 70.0 
CS/LPEO 30 28.1 40.3 29.6 69.9 
CSR 62.0 39.2 11.5 50.7 
CSR/HPEO 10 70.0 43.7 6.3 50.0 
CSR/HPEO 20 68.1 41.2 7.8 49.0 
CSR/HPEO 30 52.2 40.2 16.7 56.9 
CSR/LPEO 10 52.4 37.1 18.1 55.2 
CSR/LPEO 20 50.6 41.1 17.4 58.5 
CSR/LPEO 30 42.3 41.6 21.7 63.3 
*The average experimental errors: contact angle ± 1.5*, surface energy: ± 1.2 MjM-2 
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The effect of crosslinking by genipin on the contact angle and surface free energy of 
chitosan films can be clearly seen in a comparison between the data in Table 6.4.3. 
The decline of contact angle for chitosan film indicates that the hydrophilicity 
increased as a result of crossl inking. This finding was confirmed by the calculation of 
surface free energy. The surface free energy of a crosslinked chitosan film was 
50.7mJ/m2, which was significantly greater than that of an uncrosslinked chitosan 
film (42.8Mj/M2). This means that the surface of the crosslinked chitosan film has 
better wetting capability compared with the surface of the un-crosslinked chitosan 
film. The increases in surface energy were due to increases in the polar component 
(y, P) of the film, rather than its dispersion (y, d) component. 
Figure 6.4.2, parts (A) and (B), shows the surface free energies of un-crosslinked and 
crosslinked chitosan/HPEO blend films and chitosan4LPEO blend films. It can be 
seen from both figures that as the wt% of PEO increased, the surface free energy also 
increased. Also, crosslinking the blends by genipin resulted in decreases in the 
surface free energy. As Table 6.4.3 indicates, the changes in the dispersion energy 
were smaller when 10,20 and 30 wt% of HPEO were introduced into chitosan. In 
consideration of the margin of experimental error, it can be ignored such changes. 
However, for the CS/HPE020 blend film, the dispersion energy increased by only 
about 4 mjm-2. With increasing wt. % of HPEO, the polar energy had a significant 
increase from 3.5 (CS) to 34.8mJm-1 (CS/HPE030). It is, therefore, clear that 
increases in the surface energy must be principally attributed to increases in the polar 
energy. From experimental data, it was also observed that crosslinking with genipin 
mainly resulted in changes in the polar energy component. For uncrosslinked and 
crosslinked chitosan/LPEO blend films, similar results were obtained. However, 
there was a difference in that a much greater impact on the surface free energy of the 
films was induced by crosslinking when the PEO was of a higher molecular weight. 
The polarity of both the liquid as well as the solid substrate is a factor to be 
considered in contact angle analysis. If both the liquid and solid are polar, then 
interactions will be formed at the interface between them, which means that there is 
better adhesion at the interface. This will result in a smaller contact angle being 
measured, which is due to the better wettability, or spreading, of the polar liquid on 
the polar solid substrate. On the other hand, if one of the liquids or solids is polar and 
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the other is non-polar, then interactions will not exist at the interface between them, 
and, therefore, a larger contact angle will be measured. 
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Figure 6.4.2 Surface energy of un-crosslinked and crosslinked CS/PEO blend 
films: (A) for CS/HPEO; (B) for CSALPEO 
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PEO is a polar polymer and its chemical structure is shown in Section 2.3.1 (Chapter 
2). When water, a polar liquid, interacts with PEO, interactions will be formed 
between -H atoms in water and -0- groups in PEO. The interactions formed between 
the liquid and solid substrate are stronger bonds than van der Waals forces. There is, 
therefore, more attraction (or "adhesion") between water and PEO, which is 
manifested as surface free energy. 
The lower surface free energy of the uncrosslinked chitosan films can be understood 
from its chemical structure and soluble nature. When the glucosamine residues are in 
the free amine form, these structures are strongly involved in the formation of three- 
dimensional networks by hydrogen bonding, hydrophobic and van de Waals 
interactions [30]. Under acid conditions, the amino groups of chitosan are protonated, 
and solubility of chitosan which is dependent on the nature of the anion is involved. 
At neutral or basic pH, chitosan contains free amino groups (NH2), which are neutral 
and so it is insoluble in water. In this case, the surface of an uncrosslinked chitosan 
film is, thus, more hydrophobic. 
However, as evident from the chemical structure of genipin (Figure 2.5.2 shown in 
Chapter 2), genipin contains the -COH group, which may form hydrogen bonds with 
water molecules. This may make the surface of crosslinked chitosan films more 
hydrophilic than that of the un-crosslinked ones. These -COH groups in genipin have 
relatively high polarity, which may significantly increase the polar component (YLP) of 
the surface free energy of the crosslinked chitosan films. 
The morphology of materials is another factor to be considered in contact angle 
measurements [255]. The surface free energy of a semi-crystalline polymer should 
vary with its crystallinity. The crystalline density is usually higher than the 
amorphous density. Therefore, the crystalline surface tension is usually much higher 
than the amorphous tension [255]. The homogeneity of a material has a significant 
effect on its surface free energy when it is in contact with liquid. Blends of 
compatible and incompatible polymers show different surface interactions [256]. The 
surface interactions of incompatible blends are further complicated by their phase 
structure [256]. Surface interaction of blends of poly(ethylene oxide)/poly(propylene 
oxide) and of poly(propylene oxide) and polyepichlorohydrin were studied by Rastogi 
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[257]. The surface energy decreases with increasing molecular weight, apparently 
because of increased incompatibility, i. e. phase separation. 
As discussed in Chapter 4 on the morphology of crosslinked chitosan/PEO blend 
films, crosslinking with genipin leads to phase separation. Phase separation results in 
the film becoming less homogenous. Furthermore, the higher the PEO content the 
more significant the phase separation and the less homogenous the film. Hence, 
crosslinked and uncrosslinked films have different wetting properties. The decline, 
after crosslinking, in the surface free energy for the crosslinked chitosan/HPEO and 
chitosan/LPEO films, as shown in Figures 6.4.2, can, therefore, be explained here. 
Additionally, a greater change in the surface free energy will be observed where the 
molecular weight is greater [255]. 
On top of this, from the above discussion, it is clear that the addition of PEO and 
crosslinking by genipin led to the existence of polar forces between the film and 
water, and, therefore, increases in the polar energy contributed to increases in the 
surface energy. 
6.4.2 Contact angles of water/ethanol mixtures on the surface of the films 
In recent years, studies on anti-cancer drugs, anti-AIDS drugs [4,38], gene therapies 
and anti-sense drugs have made much progress. Generally speaking, most drugs 
dissolve in water or water/ethanol mixtures, which are high performance solvents in 
pharmacy applications. However, it has been reported that some of the anti-cancer 
drugs, such as Taxolo, are insoluble in water, but soluble in ethanol [4,40]. 
Controlled drug-release is particularly important to the success of such a drug, given 
its highly sensitive activities. In order to develop the novel chitosan/PEO films as 
anti-cancer drug carriers, the surface properties of the films with water/ethanol 
mixtures were studied. 
Figures 6.4.3 and 6.4.4, parts (A) and (B), show the contact angles for all of the 
chitosan and chitosan/HPEO (LPEO) blends and networks in two water/ethanol 
mixtures (700/o/30% and 500/o/50%). As seen, the contact angles of the crosslinked 
chitosan and blends exhibited higher values than that of the un-crosslinked films. 
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Similarly, the contact angle of the blend film deceased gradually when 10,20 and 30 
wt. % of HPEO (or LPEO) were incorporated. The lower contact angles corresponded 
well to the fact that HPEO (or LPEO) has high chain mobility and hydrophilicity. 
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Figure 6.4.3 Contact angles of the cross-linked and un-cross-linked chitosan 
and CS/PEO blend films with a mixture of 70% water/30% ethanol: (A) for 
CS/HPEO; (B) for CS/LPEO 
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Figure 6.4.4 Contact angles of the cross-linked and un-cross-linked chitosan 
and CS/PEO blend films with a mixture of 50% water/50% ethanol: (A) for 
CS/HPEO; (B) for CS/LPEO 
It can be observed from a comparison between Figures 6.4.1,6.4.3 and 6.4.4 that a 
slight, but gradual, decrease in contact angles took place when water was diluted with 
30 and 50% of ethanol. In aiding the understanding of the surface properties of the 
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blends and networks, the surface free energy with its respective dispersion and polar 
components were analysed. 
The values of the surface free energies for the water/ethanol mixtures (70: 30,50: 50) 
at 20'C are given in Table 6.4.1. From the contact angle measurements, the surface 
free energies of the films were calculated with DIM as a reference liquid, All results 
are listed in Tables 6.4.4 and 6.4.5. 
Table 6.4.4 Contact angles and surface free energies of the films with the 
70%water/30%ethanol mixture 
Sample 
Contact angle 
(00) 
7d S-2) 
(Mjm 
7P S-2) 
mjm (M 
Ys 
-2 JM 
Cs 50.2 39.3 0.3 39.6 
CS/HPEO 10 40.4 37.6 1.5 39.1 
CS/HPEO 20 22.6 43.4 2.0 45.4 
CS/HPEO 30 10.1 37.1 4.8 41.9 
CS/LPEO 10 45.0 39.2 0.7 39.9 
CS/LPEO 20 35.3 42.4 1.1 43.5 
CS/LPEO 30 25.2 40.3 2.5 42.8 
CSR 60.4 39.2 0.0 39.2 
CSR/HPEO 10 60.0 43.7 0.2 43.9 
CSR/HPEO 20 55.1 41.2 0.0 41.2 
CSR/HPEO 30 50.6 40.2 0.2 40.4 
CSR/LPEO 10 70.8 37.1 0.3 37.4 
CSR/LPEO 20 60.4 41.1 0.1 41.2 
CSR/LPEO 30 55.2 41.6 0.0 41.6 
*The average experimental errors: contact angle ± 1.5, surface energy: ± 1.2mJm'2 . 
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Table 6.4.5 Contact angles and surface free energies of the films with the 
50%water/50%ethanol mixture 
Sample 
Contact angle 
(00) 
7d 3-2) 
(MjM 
7P S-2) 
Mjm 
Ys 
-2 (MjM 
CS 50.5 39.3 0.2 39.5 
CS/HPEO 10 60.3 37.6 1.0 38.6 
CS/HPEO 20 30.2 43.4 0.0 43.4 
CS/HPEO 30 18.0 37.1 1.0 38.1 
CS/LPEO 10 35.4 39.2 0.1 39.3 
CS/LPEO 20 25.4 42.4 0.1 42.5 
CS/LPEO 30 10.2 40.3 0.7 41.0 
CSR 55.0 39.2 0.7 39.9 
CSR/HPEO 10 65.6 43.7 3.6 47.3 
CSRIHPEO 20 55.3 41.2 1.1 42.3 
CSR/HPEO 30 38.4 40.2 0.0 40.2 
CSR/LPEO 10 60.6 37.1 0.9 38.0 
CSR/LPEO 20 50.2 41.1 0.5 41.6 
CSR/LPEO 30 42.3 41.6 0.1 41.7 
*The average experimental errors: contact angle ± 1.5, surface energy: ± 1.2MjM-2 
The results show that the polar component of the surface energy has a greater 
influence when water/ethanol mixtures were used. As Table 6.4.5 indicates, the polar 
energy induced by 50%water/50%ethanol was much smaller. In consideration of the 
margin of experimental error, we can ignore such figures. It is, therefore, clear that 
the surface free energy can be principally attributed to the dispersion energy. This 
fact of surface behaviour of the films is very important in developing drug delivery 
systems. As a carrier of anti-cancer drug, the surface of the carrier has to have lower 
polarity, and moreover, to achieve controlled drug-release there must be no 
interactions between the drug and the carrier. These surface properties can meet the 
delivery requirements for anti-cancer drugs. The issue that has to be addressed now is 
the reasons why water/ethanol mixtures bring about a significant difference in the 
surface free energy when compared to using water. 
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Ethanol is a very common polar solvent, but its polarity is much less than water. The 
chemical structure of ethanol is C2H5OH. 
The effect of the ethanol content in the mixture on the surface free energy of the films 
may come from two sides. Firstly, ethanol influences the film surface properties by 
changing the properties of the solvent. The increase of ethanol content reduces the 
average interaction between molecules of the solvent, which leads to a decrease in the 
surface free energy of solvent mixture, as indicated in Table 6.4.1 (the surface 
energies at water/ethanol volume ratios of 100: 0,70: 30 and 50: 50 are 72.8,35.5 and 
29.7mjM-2) . This effect must induce a reduction of surface tension in the system. 
Hence, the surface free energy of the film tends to decrease as the ethanol content in 
mixture increases [257,258]. Secondly, where there are two or more surface active 
compounds in a solution, mixed absorption films are generated [257,258]. These 
parameters, which determine their surface behaviours are dependent both on the 
solvent (chemical structure, polarity etc. ) and on the solid. Ethanol as a kind of 
surface-active liquid absorbs at the air/solvent interface and competes with the solid 
for the position of surface layer. Moreover, with increases in the ethanol content, the 
hydrophilicity of the films is reduced, inducing the weaker absorption tendency of the 
films. Both of them make the absorption of the film in water/ethanol mixtures lower 
[259]. From the above discussions, it is clear that the lower surface energy of the 
films in water/ethanol mixtures is due to the lower polarity of ethanol in comparison 
to water. 
6.5 Conclusions 
With the use of crosslinking, there were noticeable increases in the stability of the 
chitosan/HPEO (or LPEO) blends. The swelling behaviour of the films exhibited p1l 
and temperature-dependent characteristics. However, the swelling extent can be 
regulated by the crosslink density. 
In terms of the wettability of chitosan, chitosan/PEO blends and networks, with the 
one exception of crosslinked chitosan in 100% water, the crosslinked chitosan/PEO 
blends of both molecular weights were more hydrophobic than the uncrosslinked 
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ones. Although crosslinking resulted in decreases in the wettability of the films 
surfaces in some cases, this unwanted effect was negated to some extent by the 
addition of PEO. The addition of PEO and crosslinking by genipin led to the 
existence of polar forces between the film and water, and therefore, the increases in 
the surface free energy were mainly contributed by increases in the polar component. 
However, the reduced surface free energy for the crosslinked chitosan/HPEO and 
chitosan/LPEO films resulted from the phase separation in the system. Also, a greater 
change in the surface free energy was observed where the molecular weight was 
greater. 
In water/ethanol mixtures, the surface free energy of the films is lower than that in 
water due to the lower hydrophilicity of ethanol. 
These novel films are sensitive to the environment and the surface properties of 
chitosan/PEO blends and networks in water/ethanol mixtures have provided some 
particularly important information regarding their potential success as drug carriers. 
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CHAPTER 7 
Temperature-Dependence of Crosslinking Reaction 
7.1 Introduction 
The crosslinking mechanism of chitosan with genipin has been investigated by Sung 
and co-workers [252]. From a series of spectra analysis, it was confirmed that genipin 
could go through a ring-opening reaction to form an intermediate aldehyde group due 
to nucleophilic attack by the amino group in chitosan. A heterocyclic compound of 
gen i pin-cross I inked chitosan was formed by a nucleophilic attack by the amino group 
on the olefinic carbon atom at C-3 of deoxyloganin aglycone, followed by the opening 
of the dihydropyran ring and attack by the secondary amine group on the intermediate 
aldehyde group. Additionally, secondary amide linkages could be established in the 
genipin-crossl inked chitosan network by the reaction of the ester group of genipin 
with the amino groups of chitosan. These bifunctional linkages of genipin with the 
amino group of chitosan lead to the formation of crosslinked networks. Genipin 
reacted with a nucleophilic reagent such as chitosan could further go through 
polymerisation to form an oligomer-bridge in the crosslinked networks. The 
suggested schematic [252] of the reaction mechanism for the synthesis of chitosan 
network using genipin as a crossl inker is given in Figure 7.1.1. 
Although this figure gives a clear picture of the reaction mechanism, the details of the 
crosslinking process in relation to the passage of time and changes in temperature are 
still unknown. Differences in the crosslinking temperature may affect crosslinking 
characteristics and result in different mechanical properties of the networks. From the 
studies of the mechanical properties of crosslinked chitosan films (see Chapter 5), it 
was found that the mechanical properties, such as tensile strength and elongation at 
break, were influenced by the crosslinking temperature. In particular, when the 
temperature is at about 25'C, the films have larger elongation at break and lower 
tensile strength compared with those at crosslinking temperatures of 40'C and 60'C. 
This chapter facilitates the understanding of the effect of crosslinking temperature on 
the mechanical properties of the films by investigating the reaction process of 
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crosslinking networks at different temperatures by means of FT-IR and UV 
spectroscopies. 
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Figure 7.1.1 Schematic of the reaction mechanism for the synthesis of 
genipin crosslinked chitosan [252] 
7.2 Fr-IR Study 
Figure 7.2.1 displays the FT-IR spectra of crosslinked chitosan with progress of time. 
The reaction temperature was 25'C. From Figure 7.2.1(A), it can be seen that the 
broad band of the hydroxyl group at 3400cm-1, one of the characteristics of chitosan, 
became narrower with time. This indicates that the crosslinking reaction occurred 
after the addition of genipin, where the initial broadness is attributable to the 
abundance of hydroxyl interaction sites. As crosslinking proceeded, there was a more 
uptake of these interaction sites and the width of the absorbance band was thus 
reduced. 
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For the amide region shown in Figure 7.2.1 (B), it was found that the intensities of the 
carbonyl stretching peak at 1645cm-1 (amidc 1) and 1560cm-1 (amide 11), representing 
the N-acetyl functional group of chitosan, decreased with time. This suggests an 
increase in the crosslinking activity of the amide group in chitosan. As the reaction 
time exceeded 48 hours, the amide band disappeared relative to the absorbance band 
at 1560cm-1, and the absorbance band at 1645cm" appeared as a shoulder. This again 
suggests that most of the free amino groups in chitosan had reacted. 
Figure 7.2.2, parts (A) and (B), displays the FT-IR spectra of crosslinked chitosan 
with genipin at a reaction temperature of 40'C. Similar FT-IR spectra were observed 
for the hydroxyl band at 3400cm-1 and in particular the broad band became narrower 
with time. However, for the amide region the absorbance bands at 1645cm-1 and 
1560cm" decreased gradually over 10 hours. Then they appeared again and the 
absorbance band at 1560cm-1 acquired a strong shoulder after 48 hours reaction. 
Figure 7.2.3, parts (A) and (B), shows the FT-IR spectra of chitosan crosslinking by 
genipin at a reaction temperature of 60'C. There is very little difference between 
these results and those shown in Figures 7.2.1 and 7.2.2. Figure 7.2.4, parts (A) and 
(B), shows the spectra of chitosan when crosslinking time was 10 and 48 hours at 
different crosslinking temperatures. These results indicate the reaction characteristics 
were quite different due to the effect of temperature. The relationship between the 
mechanical properties of crosslinked chitosan films and different temperatures for 
crosslinking cannot, at the moment, be determined on the basis of the FT-IR study. 
We, therefore, have to tum to UV spectroscopy study. 
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Figure 7.2.1 FT-IR spectra showing the hydroxyl region (A) and the amide 
region (B) of chitosan crosslinked with genipin at 25'C as a function of time 
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Figure 7.2.2 F'F-IR spectra showing the hydroxyl region (A) and the amide 
region (B) of chitosan crosslinked with genipin at 45'C as function of time. 
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Figure 7.2.3 FT-IR spectra showing the hydroxyl region (A) and the amide 
region (B) of chitosan, crosslinked with genipin at 60'C as function of time. 
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Figure 7.2.4 FT-IR spectra for comparing the temperature effect on the 
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7.3. Crosslinking Study by UV Spectra Analysis 
7.3.1 Characteristics of UV spectrum of chitosan and genipin 
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Figure 7.3.1 UV spectrum of genipin 
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Figure 7.3.2 UV spectrum of chitosan 
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One of the most useful applications of UV-visible spectroscopy to polymers is for the 
characterisation of conjugated or aromatic materials [213]. Polymers with aromatic 
structures have delocalized electrons and exhibit strong characteristic UV absorption 
at very short wavelengths. 
Figures 7.3.1 and 7.3.2 show UV spectra of genipin and chitosan. It was found that 
genipin dissolved in water and displayed a single ultra-violet absorption peak at 
240nm. The chemical structures of genipin and chitosan are shown in Figures 2.2.1 
and 2.5.1. Genipin is a heterocyclic compound with a conjugation bond. The UV 
spectrum of genipin was very compatible with the chemical structure of genipin. 
Figure 7.3.3 shows UV spectra for a series of concentrations of genipin. The spectra 
illustrate that the intensity of the absorption peak at 240nm increased with increasing 
concentration of genipin. The relationship between the area of the absorption peak 
and the concentration of genipin was found to be linear, and the dependence of the 
former on the latter is shown in Figure 7.3.4. 
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Figure 7.3.3 UV spectra of genipin at different concentrations 
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Figure 7.3.4 Area of absorption peak at 240 nm vs. concentration of genipin 
The concentration of genipin, which represents the ester group content, is related to 
the area of absorption at 240nm. Based on this result, a new method of analysing the 
crosslinking process as time progresses can be introduced. This method will be used 
later in the study of the crosslinking of chitosan by genipin. 
7.3.2. UV spectra study on temperature-dependence of crosslinking reaction 
Various amounts of genipin were added to the chitosan solutions to monitor the 
crosslinking reaction process with time. 
It has been confirmed that genipin reacts with chitosan via covalent bonding to form 
chemically crosslinked networks [200,252]. In this study, the extent of chemical 
crosslinking can be examined by UV spectra analysis. Figure 7.3.5, parts (A), (B) and 
(C), shows the variation of UV spectra of chitosan reacted with genipin (genipin 
content: 0.1%, 0.5% and 1%) at a reaction temperature of 25'C with time. They 
display the characteristic absorption peak at 240nm for the ester group of genipin and 
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at 280nm for reaction of genipin and the amino group of chitosan [252]. This 
suggests that genipin reacted chemically with chitosan. As can be seen from the 
figures, the two peak positions shifted during crosslinking. and, therefore, it is very 
difficult to use the intensity of the absorption peak to analyse the results. However, 
the area of characteristic absorption peak at 240nm decreased and the area of 
absorption peak at 280nm increased with increasing reaction time. This suggests the 
ring-opening of genipin via crosslinking, which is in agreement with Sung's studies 
[252]. With increasing genipin content, the changes in both areas of absorption peak 
at 240nm and 280nm became greater. This means that the crosslinking reaction 
became more extensive. 
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Figure 7.3.5 UV spectra showing the time-dependence of the crosslinking 
reaction at 25'C (A) 0.1 % genipin, (B) 0.5% genipin, (C) I% genipin 
Figures 7.3.6 and 7.3.7 show the UV spectra of chitosan crosslinked by genipin at the 
reaction temperature of 400C and 600C, respectively. The concentration of genipin, 
which represents the ester group content, is related to the area of absorption at 240nm, 
as discussed above. We can now use this new method to analyse the reaction process. 
Table 7.3.1 lists the value of two areas of absorption peak at 240nm and 280nm as 
reaction time proceeded. A comparison of these data shows that the total value of the 
two areas was constant. This suggests the conversion of the ester groups of genipin to 
amide linkages. The increased area of absorption peak at 280nm is attributed to the 
fon-nation of a heterocyclic amino compound. The smaller area of the absorption at 
240nm the greater the conversion of the ester group to the amide linkage was. The 
extent of the crosslinking reaction at different times can be examined using these 
convcrsion characteristics. 
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Figure 7.3.6 UV spectra showing the time-dependence on crosslinking 
reaction at 40'C: (A) 0.1% genipin, (B) 0.5% genipin, (C) 1% genipin 
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Table 7.3.1 The two areas of absorption peaks 
Genipin content Temperature Reaction time A A' A+A' 
(wt. %) (OC) (hr) (at 240 nm) (at 280 nm) 
1 13.12 2.94 16.06 
5 7.36 9.28 16.65 
1 60 22 4.07 12.30 16.37 
48 2.56 14.62 17.18 
72 1.47 13.87 15.29 
1 14.95 2.46 17.41 
5 11.75 5.70 17.45 
1 45 22 5.28 11.61 16.89 
48 3.13 14.08 17.21 
1 15.00 1.36 16.36 
5 13.07 2.68 15.75 
1 25 22 10.80 6.21 17.01 
48 7.95 8.62 16.57 
1 7.27 3.76 11.03 
5 6.89 5.07 11.96 
0.5 25 22 5.50 6.25 12.05 
48 3.63 8.14 11.77 
1 8.61 3.34 11.95 
5 4.42 7.22 11.66 
0.5 45 22 2.75 9.04 11.79 
48 2.24 9.69 11.99 
1 8.79 3.18 11.97 
5 6.13 5.89 12.07 
0.5 60 22 3.45 8.32 11.78 
48 2.76 9.89 12.65 
72 2.02 10.07 12.09 
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Figure 7.3.8 plots the percentage area of absorption peak at 240nm (calculated from 
the combined area of the absorption peaks at 240nm and 280nm), which represents 
the extent of the crosslinking reaction, against reaction time (genipin content 1%). 
The percentage area of the characteristic absorption peak at 240nm decreased with 
increasing reaction time due to the ring-opening of genipin via the crosslinking 
reaction. Furthermore, within the first 5 hours, the extent of crosslinking reaction 
increased slowly at the lowest temperature of 25'C, but far more quickly at 400C. 
This proves that the conversion of the ester group of genipin into amide linkage was 
quickest at 40'C. It can be seen from the figure that a linear relationship between the 
extent of the crosslinking reaction and time was obtained at 25'C. This means that at 
this temperature the reaction rate was constant. At 40'C, the reaction rate was fastest 
in the initial stages, but then changed sharply to a much slower rate. In the later 
stages, the reaction rate was nearly constant, which can be observed from the straight 
line indicated in the figure. At 60'C, the rate of reaction was fast within the initial 5 
hours, and then became slower. In the whole crosslinking process, the reaction was 
heterogeneous, which was confirmed by the non-linear relationship between the 
deceased area of absorption peak at 240nm and the reaction time (as shown in Figure 
7.3.8). From the experimental data, the area value can be extrapolated to zero, as 
shown in the figure, to estimate the end time of the crosslinking reaction at different 
temperatures. 
From Figure 7.3.8 the time of crosslinking reaction at different temperatures can be 
estimated. Although this method could not give an accurate estimate of the time 
needed for the crosslinking reaction, the details of the reaction process were obtained. 
This information may be very important in helping us to understand the effect of 
crosslinking reaction temperature on the mechanical properties of crosslinked 
chitosan films. 
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Figure 7.3.8 Concentration of genipin as a function of time during 
crosslinking reaction of chitosan 
7.4 Effect of Crosslinking Reaction Temperature on the Mechanical Properties 
of Crosslinked Chitosan Films 
The mechanical properties of crosslinked chitosan films were investigated at the 
different temperatures of 25'C, 400C and 600C, which were used for film-formation 
(or crosslinking). As concluded in Chapter 5, the crosslinking temperature has an 
influence on the mechanical properties of chitosan films. When the temperature used 
for film formation was 25'C, the elongation at break of the crosslinked chitosan films 
was the largest, and double that at 40'C. However, better tensile stresses for the films 
were obtained when the temperature was 400C and 60'C. 
From the above FT-IR and UV spectra studies, it is clear that using different 
crosslinking temperatures for the formation of chitosan films leads to significant 
differences in the crosslinking process, particularly in terms of the reaction rate, 
reaction homogeneity and the necessary reaction time. These factors may have an 
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effect on the morphologies of chitosan films, which is seen through different 
mechanical properties. 
The above analysis suggests that in order to understand the mechanical properties of 
chitosan films that are formed by a process in which chitosan solution turns to gels 
and then films, we have to understand the effect of the temperature on the solution 
properties of chitosan, the effect of these properties on the crosslinking process and 
the morphology of the chitosan films obtained. 
The intrinsic viscosity of chitosan solutions is influenced by temperature. With 
increasing temperature, the intrinsic viscosity of chitosan decreases linearly [30,43]. 
The intrinsic viscosity can affect on the molecular mobility in solution. During the 
formation of crosslinked chitosan film at lower temperatures, the molecular mobility 
of genipin may be restricted due to the higher intrinsic viscosity of the chitosan 
solution. The crosslinking reaction is, therefore, slower, which has been confirmed by 
previous studies when the temperature used was 25'C. 
During film-formation of crosslinked chitosan, the temperature causes changes in the 
solvent quality as well as affecting the intrinsic viscosity of the solution. Hydrogen 
bonding plays an important role in the gelation process of chitosan and a significant 
influence on the mechanical properties of chitosan [260]. If the solution temperature 
is high, it can decrease chitosan solubility by the disruption of hydrogen bonding with 
water and reduce junction points on the chains in the solution [30,260]. At such 
temperatures, the molecular motion of genipin is, therefore, easier, causing a faster 
crosslinking reaction. The UV spectra results studied above are in agreement with 
this analysis. 
As crosslinking proceeded with time, the solutions gradually formed chitosan gels, a 
process obviously dependent on the molecular mobility of the polymer chains in the 
media and in which there is an increasing density of physical crosslinking reticulation. 
In the initial stages, the density of crosslinking reticulation increased quickly due to 
the faster crosslinking reaction. However, the reticulation could also cause reductions 
in the contact opportunities between chitosan and genipin molecules and restriction of 
molecular mobility (or penetration) of genipin. As a result, the reaction rate 
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7.5 Conclusions 
The temperature dependence of the crosslinking reactions was studied by means of 
FT-IR and UV spectra analysis. The results of FT-IR spectra analysis indicated that 
the crosslinking reaction occurred after the addition of genipin, which is confirmed by 
the amino group of chitosan reacting with the ester group of genipin. The decrease in 
the number of amino group resulted in the change of intra-hydrogen bounding 
interactions. Information about the temperature dependence of the crosslinking 
reaction of chitosan was obtained by the UV study. The results show that at the 
lowest temperature of 25'C a homogeneous crosslinking reaction occurred and this 
resulted in better elongation at break of the chitosan films. At higher temperatures, 
heterogeneous crosslink density in the films formed due to the effect of the intrinsic 
viscosity of chitosan solution and crosslinking reticulation during film-formation on 
the molecular mobility of genipin. The localised high crosslinked density region can 
be treated as fillers in the film and from this result it is, therefore, possible to 
understand the mechanical properties: greater tensile strength and lower elongation at 
break when the crosslinking temperature used was higher than 25'C. 
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CHARPTER 8 
Aggregation and Collapse of Chitosan Chains 
in Aqueous Solutions 
8.1 Introduction 
Chitosan belongs to a family of linear cationic polymers and it is also an acidic 
soluble polymer. pH has a significant effect on the solution properties of chitosan. 
These properties are also influenced by the degree of deacetylation and average 
molecular weight. Factors that affect the solution properties also affect its film- 
forming properties [236,237]. Film-making conditions, including solution p1l, ionic 
strength, type of solvent (acid) used and annealing treatment, are parameters often 
manipulated to alter the physical and mechanical properties of chitosan films, which 
are particularly important to their medical applications. The results of Chapter 5, 
where the mechanical properties of chitosan films were discussed, indicate that tensile 
strength and elongation at break were affected by the pH of the solution used for film- 
making. In particular, when the solution was of pH 2.5 the mechanical properties of 
the film formed were at their optimal. Ionic strength, or pH, can be used to adjust the 
inter- and intra-molecular electrostatic repulsions between chitosan chains, thus 
allowing the chains to approach each other and enhancing the inter- and intra- 
molecular hydrogen bonding, and, therefore, resulting in changes in the molecular 
conformation [261]. Although several publications on the rheological and 
fluorescence properties of chitosan solution have been produced [261,262], the effect 
of the interactions on microscopic behaviour is still not yet fully understood. Hence, 
in order to understand the effect of solution pH on film formation of chitosan solution, 
which has an influence on the mechanical properties of chitosan films, there is a need 
to use an appropriate technique to investigate the molecular-level behaviour of 
chitosan solution. 
Laser light scattering has been proven to be a particularly useful rnethod of studying 
molecular conformation, especially in very dilute solutions [30,263,264]. In this 
chapter, the effects of pH on chitosan macromolecular conformation in solution were 
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studied by means of static laser light scattering and an understanding of the impact of 
chitosan solution pH on the mechanical properties of the film was developed. The 
dilute solution properties of chitosan with various acetic acid concentrations were 
investigated. Based on the experimental data, the dependence of the conformation of 
the chitosan macromolecules on acetic acid concentration will also be discussed. 
8.2 Background to the Theory of Static Laser Light Scattering 
Figure 8.2.1 shows relative position of the observer Q(x,, ) and the scattering volume 
v(xg, ). The scattered intensity is the square of the scattered electric field [207]. The 
incident light field, EINc, is polarized in the z-direction and is propagated in the ki- 
direction. The vector R is defined from the origin of the scattering volume to the 
idealized point detector. 9 is the scattering angle. 
Figure 8.2.1 Relative position of the observer Q(x,, ) and the scattering volume 
v(x'. ). ( Index of refraction = n) [207] 
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For a single small particle with polarisability a, the scattered electric field E. is 
proportional to the polarisability, which is related to the volume of the particle (Vp). 
Thus, the intensity of scattered light from a single particle (i, ), is proportional to E, 2 
and also to cc 2. For an incident beam IINc, the scattered intensity of a single small 
particle i, is 
i, 
-k4 
a' 
INC d2 
where k =27AO and d is the distance between the particle and the observer. For N 
identical particles in a solvent of refractive index n,, and polarisability a., the 
background scattering of the solvent has to be subtracted. Namely, cc in Equation 8.2- 
1 has to be replaced by (Xex = cc - cc,, as follows. 
2_2 
n no = 4; W, ý 
[8.2-2] 
n. (n-n,, ) M [8.2-3] 
2; r C NA 
where N= CNA/M with C being the weight concentration. M is the mass of a particle. 
The excess scattered intensity, 1,,,, for a dilute solution with N identical small particles 
in volume V without both intra-particle interference and inter-particle interactions is 
I- 
=, 
k'a,, N 
[8.2-4] 
II, C d' 
Correspondingly, the excess Rayleigh ratio ARvv(K) d2 /I[Nc ) of the solute 
particle for vertically polarised incident and scattering light has the form 
ARvv (K) = 
On. ' (an 2 
MC = HCAf [8.2-5] ý; 7NA ýaC)T.. 
p 
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In the presence of intra-particle interference and inter-particle interaction, the 
scattered intensity of a single particle i,, where there is uniform polarizability, a, due 
to a phase shift, is 
il 
=ka fVpp(r)exp(iK - r)dv =ka P(K) [8.2-6] IINC d2 VP d2 
which can also be written as 
ARvv (K) = HMCP(K) [8.2-71 
where exp(iK * r) is the phase factor, with r (=ri - rj) being the vector distance 
between the two scattering elements inside the particle volume Vp; and p(r) is the 
radial distribution function for the scattering elements inside the particle, which may 
be defined by the statement that p(r)dvNp is the probability of finding the th 
scattering element within the volume element dv at a distance r from thejth scattering 
element. A normalized intra-particle scattering factor of a single particle of uniform 
density and finite size is 
P(K) 1, p(r)exp(iK - r)dv [8.2-8] p 
In general, for a randomly oriented particle with an arbitrary shape, the probability 
that K and r have an angle between (p and (p + d(p is 27c sin(p d(p, and, thus, the average 
value of the phase factor is 
ff fcos(Kreoso)sinodo 
sin(K - r) (exp(K - r)) 2 jr --- -- =ý 
[8.2-9] 
fsin (pd(p 
Kr 
0 
164 
Chapter 8: Aggregation and Collapse of Chitosan Chains in Aqueous Solution 
Therefore, for a single particle with a radial distribution function p(r) and finite size, 
the normalized intra-particle scattering factor can generally be defined as 
p(r) 
sin(Kr dv 
Kr P(K) p 
p(r)dv 
[8.2-10] 
For a uniform sphere, p(r ) =land fvpp(r ) dv =Vp. so that, 
I 2; r R2 sin(Kr)dr 
= 
41r R 
r2 sin(Kr)dr 
ýT 
f [8.2-11] P(K) fd(p fsin (pd(p fr --jý- - 
p v00r-0 
Kr 
where R is the particle radius. At small values of Kr, and with the mass density 
dependent on r, we then have for the normalized particle scattering factor 
f p(r)r2dv K2R2 
P(K) = 
(p(K) 
-I_ K2 vp =I- 
(P(O) 3f p(r)dv 3 
Vp 
where Rg is the radius of gyration, which for a particle can be defined as 
f p(r)r2dv 
R2)= vp 
9f p(r)dv 
VP 
For a uniform solid sphere, fp(rýr 
v 
[8.2-12] 
[8.2-13] 
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8.3 Effect of the Solution pH on the Conformation of Chitosan Macromolecules 
8.3.1 Multi-chain aggregation phenomenon for chitosan in aqueous solution 
Static laser light scattering was carried out at 25'C with a scattering angle, 0, of 30' 
for chitosan/acetic acid/water solutions with a chitosan concentration of 10-. 4g/mL and 
at various pH values. 
It is known [263] that the association behaviour of semi-dilute systems of chitosan 
can be affected by pH. As a linear polyelectrolyte, chitosan has both reactive amino 
groups and hydroxyl groups that can interact with the surroundings. Thus, it is 
expected that the physical and solution properties of chitosan will change with the 
surrounding environment. In acid solution, the presence of acetic acid causes the 
NH2 groups of chitosan to change to positively charged -NH3+ groups and the strong 
positive charges attract negatively charged molecules and ionically bind them. It is 
obvious that the acetic acid concentration affects the charge density of the dissolved 
chitosan molecules, and thus, the chitosan chain conformation in aqueous solution. It 
follows that under acid conditions chitosan molecules would be expected to exhibit 
the behaviour of a typical polyelectrolyte, i. e. the pH affects macromolecular 
conformation [30]. 
Figure 8.3.1 part (A) shows the auto-correlation function, I(t), measured as the time- 
average intensity, for a chitosan solution of pH 2.04. By Fourier transformation, a 
particle size distribution can be obtained as shown in Figure 8.3.1 part (B). In the 
distribution function, r(r), a peak represents the greater probability of the radius of a 
particle being of the corresponding value. In Figure 8.3 (B), the peak represents the 
much larger number of bigger-sized particles in the distribution. 
In low pH chitosan solutions, the chitosan molecules have higher -N113+ charge 
densities and are expected to exist as random coils having a relatively extended 
conformation [30,263). This is due to the high intra- and inter-molecular electrostatic 
repulsions. 
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Figure 8.3.1 (A) The time-average intensity auto-correlation function 
and (B) particle size distribution in a solution of p1l 2.04 
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Figure 8.3.2, parts (a), (b), (c), (d) and (e), shows particle size distribution functions 
of chitosan in solutions with pH values ranging from 2.53 to 5.49. Once the pH value 
of the chitosan solution reached 2.53, the main peak in the distribution function split 
into two peaks. This result indicates that multi-chain aggregation of chitosan in 
aqueous solution took place, which can be explained by the increase in the pH value 
of chitosan solution causing a decrease in the inter-chain electrostatic repulsion by the 
-NH3+ group, and also shows that the weak phase separation occurred in the solution. 
A comparison of the distribution functions for chitosan solutions of pH 2.53 and 3.10 
shows that the larger peak moved to the right, indicating an increase in multi-chain 
aggregation. As the pH increased to 4.45, there was a noticeable decrease in the 
height of the second peak. This indicates that the majority of chitosan molecules have 
aggregated. As the pH increased to 5.49, there was a further decrease in the height of 
the second peak, so much so that it has almost merged with the larger, first peak. The 
larger peak, on the other hand, moved further to the right and became wider. The 
relationship between the pH of the solution and the strength of the inter-chain 
electrostatic repulsion has already been explained. Here, it is important to emphasise 
that there comes a point where the inter-chain electrostatic repulsion is so weak that 
they become insignificant compared to the van der Waals and dispersion forces. The 
effect of these latter forces is greater inter-chain attraction and the greater aggregation 
of the chitosan molecules. Overall, having regard to Figure 8.1 part (b) as well, one 
can see that as the pH increased from 2.04 to 4.45, the particle size increased steadily. 
As the pH increased to 5.49, the second peak continued to decrease in height. 
Furthermore, the experimental results showed that as the pH increased, the solubility 
of chitosan became poorer and the solution turned milkier. 
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Figure 8.3.2 The effect of pH on chitosan macromolecular conformation in 
solution 
The average radius of the particle can be calculated using Equations 8.2-13 and 8.2- 
14. The average particle size for chitosan macromolecules in the each solution with 
various pH values are summarised in Table 8.3.1. 
Table 8.3.1 Summary of the results of particle size (R. ) for chitosan 
macromolecules in different pH solutions. 
Sample No. pH value R. (nm) WS (nm)* 
1 2.04 65.5 39.0 
2 2.53 123.7 89.8 
3 3.10 113.7 69.5 
4 3.57 189.2 145.7 
5 3.89 212.5 173.2 
6 4.45 280.2 204.4 
7 5.49 356.5 242.2 
Half width of particle size distribution function. 
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It can be seen that the particle size of the chitosan macromolecules, R,, increases as 
the pH value increases (see Figure 8.3.3). However, it can be seen that in lower pH 
values, the increase in particle size is smaller. Higher pH resulted in a stronger 
aggregation of the chitosan macromolecules. 
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Figure 8.3.3 pH-dependence of the radius of chitosan particles in 
aqueous solution. 
Based on polyelectrolyte solution theories [265], the intramolecular interactions along 
the chains are directly affected by the electrostatic repulsion arising from charges on 
the polymer chains. These interactions contribute to the local stiffness of the chain 
(i. e. the persistence length in the worm-like model of a chain molecule), affect the 
excluded volume in a good solvent and also impact upon the intermolecular 
interactions. The strength of the electrostatic interactions may be moderated by 
increasing the concentration of the -NH3+ groups, which screens the electrostatic 
repulsion on the polymer chains. However, excessive amounts of -NH3+ may 
significantly alter the solvent quality, which eventually leads to the weak phase 
separation of the polymer from the solution. 
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These results lead to the conclusion that the chitosan-solvent interactions must play an 
important role in the conformation of chitosan chains in acid solutions. The polymer 
chains in solution exhibit different conformations, which are mainly dependent on the 
chitosan-solvent interaction. In a good solvent, chitosan chains exist as a more 
extended coil, while in a poor solvent, inter-macromolecular aggregation occurs 
easily. 
8.3.2 Single chain coil-to-globule transition (chain collapse) 
A flexible polymer chain can change from an expanded coil to a collapsed globule, as 
first predicted by Stockmayer [266]. Since then, this prediction has been extensively 
studied both theoretically and experimentally [267,268]. It was concluded that there 
is a two-stage kinetics for the collapse of a single chain; a fast crumpling of the un- 
knotted chain followed by a slow knotting of the collapsed polymer chain. The 
transition between the coil and globule conformations of a polymer chain depends on 
the properties of both solvent (molecular structure) and polymer (molecular weight 
and structure) [268]. For a given polymer solution, the solvent can change from a 
good to a E) solvent and finally to a poor solvent. When the solvent quality is poor, a 
flexible polymer chain collapses [269,270]. Grosberg et al. [269] stated that there is 
a two-stage process of collapse. At the first stage, the chain density in its occupied 
volume quickly increases as the chain collapses, while at the second stage the chain 
density increases much more slowly during the rearrangement of the collapsed chain 
into the globule. 
On the basis of the above concepts, to detect the globule state of isolated chains it is 
necessary to work at low concentration, so that the formation of multiple chain 
aggregates, which mask the coil-to globule transition, can be avoided, and where it is 
easier for individual chitosan chains to reach a collapsed state. For these reasons, a 
solution concentration of 10-6 g/ml was used instead of 10-4 g/ml. The scattering angle 
of 45' was used in this experiment due to the long distance between macromolecules 
in the dilute solutions. 
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It is well known for a polydisperse sample that the species with the higher molecular 
weight will undergo phase transition first, which makes the whole solution into a 
thermodynamically unstable region [268-270]. It is also known that for a 
polyelectrolyte polymer the coil-to-globule transition is easier because of a relatively 
strong electrostatic interaction [268-270]. 
Figure 8.3.4, parts (A) and (B), shows, respectively, the correlation and particle-size 
distribution functions of chitosan macromolecules in a dilute solution of pH 1.03. It is 
clear that there is basically one peak in the distribution function. Figure 8.3.5 parts 
(a), (b), (c) and (d), shows the particle-size distribution function of chitosan 
macromolecules in various pH solutions. 
0.16-- 
.a 
0.12- 
0.08 - 
0.04- 
0.0040-1 
7 n\ pH=2.03 
0.1 10 100 
Radius (nm) 
lvvv 
0.16- 
0.14- 
0.12- 
0.10- 
0.08 - 
0.06- 
0.04 
0.02 
0.00 
pH-2.74 
man 
Nam no IF "%-a MEMO 
0.1 1 10 100 1000 
Radius (nm) 176 
Chapter 8: Aggregation and Collapse of Chitosan Chains in Aqueous Solution 
0.16 
0.14 
0.12 
0.10 
0.08 
0.06 
0.04 
0.02 
0.00 
0.16 
0.14 
0.12 
0.10 
0.08 
0.06 
0.04 
0.02 
0.00 
C 
pH=3.64 
-ý I no oo-IF-'%-mmm on It 
0.1 10 
Radius (nm) 
100 1000 
d 
pH=4.17 
O-Em OEM ME 
sommummomm, M, 
M-M 
-r- II TI-T 
0.1 1 10 100 1000 
Radius (nm) 
Figure 8.3.5 Effect of pH on chitosan macromolecular conformation in very 
dilute solutions. 
177 
Chapter 8: Aggregation and Collapse of Chitosan Chains in Aqueous Solution 
A comparison of the data sets in Figure 8.3.5 clearly shows a lcftward movement of 
the peak. This indicates a decrease in the radius of the chitosan macromolecules. The 
phenomenon of the single chain collapse of chitosan molecules has occurred 
[271,272]. 
The dilute nature of the chitosan solution leads to the existence of long distances 
between molecules and the only a small possibility of molecular aggregation taking 
place. For a particular chitosan macromolecule, the increase in the pH of the solution 
resulted in a decrease in the concentration of the -NI13+ groups, which caused a 
decrease in the solubility of chitosan in acetic acid solution. The decrease in -NI]3+ 
concentration also led to a decrease in intra-molecular electrostatic charge repulsion, 
which gave rise to the single chain collapse. The end result of this was the reduction 
in the radius of chitosan macromolecules. 
It is obvious from Figure 8.3.5 that when the pH of the chitosan solution increased 
from 2.03 to 2.74, there was a further leftward movement of the peak. This indicates 
an increase in the severity of the single chain collapse phenomenon. A further 
increase in the pH of the solution led to a further decrease in the concentration of the 
-NH3+ ions, and, therefore, one in the intra-chain electrostatic charge repulsion. As 
the pH of chitosan solution increased to 3.45 and then to 4.17, the leftward movement 
of the peak continued and there was an increase in the width of the peak, indicating 
further reduction in the size of the individual chains. This reflects the inter-chain coil- 
to-globule transition. 
From the above experimental data, the particle sizes of chitosan macromolecules were 
calculated and are summarised in Table 8.3.2. Figure 8.3.6 shows the dependence of 
the radius of chitosan macromolecules on pH. The particle size of the chitosan 
macromolecules decreased with increasing pH value. When pl-I value increased from 
2.74 to 3.54 and then to 4.17, the radius decreased sharply to 98.76nm and 50.73nm, 
respectively. In low-pH dilute solutions, the chitosan chains adopt an extended 
random coil conformation, because of electrostatic repulsion by the N113+ groups, 
which result in the larger radius of chitosan chains. The solution is transparent. In 
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high pH solutions, the chains adopt compact coils because of the poor solvent quality. 
The solution is milky. These results suggest that in dilute solution the main driving 
force of the chitosan phase transition is the intra-chain forces, which can be much 
stronger than the inter-chain forces. Thus, in dilute solution, it should be easier for 
the individual chitosan chains to reach a collapsed state. The inter-chain association 
is relatively less likely than inter-chain collapse. 
Table 8.3.2 The summary of the results for single chain collapse 
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Figure 8.3.6 pH-dependence of the radius of chitosan particles in dilute 
solution. 
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There was a transition in the single chain conformation of chitosan molecules from 
coil to globule. It was found that the coil-to-globule transition depends on the p1l of 
the dilute chitosan solution. 
Figure 8.3.7 is a schematic diagram of the intra-chain collapse of chitosan chains in 
solution when the pH is changed. It can be seen that the greater the pH the smaller 
the size of the chitosan molecules and the greater the chain density. 
Changes in the rheological properties of chitosan solutions with pH, ionic strength, 
and type of anion have been studied [262]. Between pH 2.0 and 5.0, the apparent 
viscosity increased with the decrease of pH in chitosan-organic acid solutions. 
Recently, Pa [263] studied the intrinsic viscosity of chitosan in dilute acetic acid 
solutions. These results show that the intrinsic viscosity increased with decreasing 
pH. This suggests the chain expansion of the chitosan molecules with increasing 
acetic acid concentration in water solution, which is in agreement with our results. 
Cý, 
Good solvent Poor solvent 
low pH high pH 
Figure 8.3.7 Schematic diagram of the single chain collapse of chitosan 
macromolecules in solution when the p1l value is changed [263] 
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From the above discussion, it can be concluded that at a low p1l, chitosan chains are 
homogenous in solution without liquid-liquid phase separation, and that when the plI 
increased, the chitosan chains became heterogeneous in the solution: the transition 
being the result of the collapse of the chains to globules. Phase separation also 
occurred. 
8.4 Effect of Aggregation Behaviour on Mechanical Properties of Chitosan 
Films 
The effect of the pH of the chitosan solution used in the preparation of the chitosan 
films on the films' mechanical properties were investigated in Chapter 5. The plis of 
the solutions were 2.5,3.0,4.0 and 5.0. The results clearly indicate that there is a 
direct relationship between the two: the more acidic the solution, the greater the 
tensile stress and the larger the percentage elongation at break. When the solution 
was of pH 2.5, the values of both properties were double those when the solution was 
of pH 5.0. 
One of the important factors affecting the physical properties of a material, including 
its mechanical properties, is its super-macromolecular structure or morphology. The 
morphology of a material depends on the components present, the fabrication methods 
used in sample preparation and so on. To get a better insight into the mechanical 
behaviour of the chitosan films in terms of tensile strength and elongation at break, a 
more detailed knowledge of morphology of the chitosan solution at different pl-I is 
required. 
Figure 8.3.1 (B), part of the above discussion on the light scattering results, clearly 
shows that only one peak exists at p1l 2.04 in the distribution function. As the p1l 
increased from 2.04 to 2.53, the peak split into two peaks (as seen in Figure 8.3.2). 
This points to the chitosan backbones folding up to form compact coils and the 
chitosan chains becoming more favourable to intermolecular aggregation, which is 
caused by the poor solubility in solutions of high p1l values. This also means that 
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phase separation in the solution existed. The higher plI the stronger was the dcgrce of 
phase separation in solution. When the pH 2.04 solution was used to prepare a 
chitosan film, a homogenous solution structure may be obtained, and the chitosan 
chains became more expanded as a result of the mutual repulsions by the -NII+3 ions 
along the chitosan backbone. This expansion leads to easier interpenetration, or 
entanglement, of chitosan chains. The effect of this is to increase the opportunity for 
intermolecular association, resulting in the end in a homogenous gel network. When 
the solution pH was higher it means that a comparatively heterogeneous networks 
have formed. Applying a force to these films may lead to crack propagation along the 
phase boundaries (formed because of phase separation), which could explain the poor 
tensile strength and the low elongation at break of these chitosan films. However, for 
crosslinked chitosan films, the interfacial boundaries may be smeared by crosslinking. 
The fracture behaviour could be the same for the crosslinked films formed at lower 
and higher pHs. The pH will have little influence on stress at break (See Figure 5.4.2 
(A) in Chapter 5). Although crosslinking can smear the interfacial boundaries, the 
morphology of networks formed at lower pHs are different from that formed at higher 
pHs. The structure of networks formed at lower pHs was homogeneous, but 
heterogeneous structures formed at higher pHs were revealed by the results of static 
light scattering. The homogeneous networks led to higher elongation at break (See 
Figure 5.4.2 (B) in Chapter 5). 
The preceding discussion indicates that the p1l of a chitosan solution can control the 
degree of the chain aggregation or phase separation. Therefore, by changing the 
solution pff, it is possible to control the mechanical properties of chitosan films in a 
way which is now clear. 
8.5 Conclusions 
The aggregation behaviour of chitosan macromolecules and the coil-to-globule 
transition of a single chain of chitosan in solution at different plis were examined by 
the static light scattering technique. The results show that the conformation of 
chitosan macromolecules in solution was influenced by pli values. In chitosan 
solutions of a low pH, the chitosan chains exhibit a more extended conformation and 
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in high pH solutions, they have a tendency to aggregate. In the dilute chitosan 
solutions, the coil to globule transition of single chains exists when solubility of 
chitosan in the solvent became poorer. The aggregation behaviour of chitosan 
macromolecules in solution has a clear influence on mechanical properties of chitosan 
films. In low pH solutions, a homogenous gel network was formed due to 
intermolecular chain association during gelation, resulting in better mechanical 
properties (tensile strength and elongation at break) of these chitosan films. 
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CHAPTER 9 
Evaluation of Chitosan/PEO Blend Films Crosslinked by Genipin 
for Controlled Drug Release and Protein Separation 
9.1 Introduction 
Controlled drug release technology first emerged in the 1980s as a commercially 
sound methodology of extending existing ways of -administering pharmaceutical 
therapies [4]. Conventional dosage forms often lead to wide swings in serum drug 
concentrations [133-136]. The safety and therapeutic efficacy of current treatments 
may be improved if their delivery rate, biodegradation, and site-specific targeting can 
be predicted, monitored and controlled. 
In recent years, considerable research efforts have been directed towards the 
development of safe and efficient drug delivery systems with the use of polymers as 
agents for the controlled release of drugs from various types of formulated products, 
such as tablets, implants, and adhesive strips. Evidence of the high degree of interest 
in the design of such dosage forms is provided by the number of reviews [273,274] 
and books [275,276] that have been concerned with the subject. The release of drugs, 
absorbed or encapsulated by polymers, involves their slow and controlled diffusion 
from, or through, polymeric materials. Drugs covalently attached to biodegradable 
polymers or dispersed in a polymeric matrix of such macromolecules may be released 
by erosion or degradation of the polymer [273-276]. Therapeutic molecules, 
complexed by polymers, may also be released from gels by diffusion [273-276]. 
Chitosan is a naturally occurring polysaccharide with excellent biodegradable and 
biocompatiblc characteristics. Because of its unique polymeric cationic character, gel 
and film-forming properties, chitosan can be a suitable matrix, available in different 
forms, for sustained release of various drug formulations 
Hydrogels based on chitosan have been widely used in control led-rc lease systerns 
[277,278]. Hydrogels are highly swollen, hydrophilic polymer networks that can 
absorb large amounts of water and drastically increase in volurne, while maintaining 
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their three-dimensional structure [277,278]. The three dimensional structure is often 
described as a mesh, with spaces between the polymer chains filled with water. The 
crosslinks can be formed by covalent or ionic bonds, van der Waals forces, hydrogen 
bonds, or physical entanglements [279]. It is well known that the physicochernical 
properties of hydrogels depend not only on the molecular structure, the gel structure, 
and degree of crosslinking, but also on the content and state of water in the hydrogel. 
Based on chitosan, pH-sensitive hydrogels have been developed. They have potential 
use in site-specific delivery of drugs to specific regions of the gastrointestinal tract 
[5,40,137. ]. These polymers are expected to reside in the body for a longer period and 
respond to local environmental stimuli to modulate drug release [239]. 
As indicated in the previous literature review, conscious of the limiting effects of the 
poor mechanical properties of chitosan upon its application, drug delivery 
formulations based on chitosan (such as films, beads, microspheres etc. ) have been 
prepared by chemical crosslinking with glutaraldehyde etc [4]. However, the 
chemical crosslinking agents may induce toxicity and other undesirable effects, for 
example, chemically synthesized glutaraldehyde can cause irritation to mucosal 
membranes due to its toxicity [ 15,182,183,280]. 
In the preceding chapters, we have discussed chitosan/PEO blend films crosslinked by 
genipin that are pH-sensitive and have desirable mechanical properties. These 
characteristics and the film's non-poisonous nature [15], make it ideal for 
development as a controlled drug release delivery system. In this chapter, the 
potential for such development is investigated. 
9.2 Vitamin B12 Release Through Chitosan and Chitosan/PEO Blend Membranes 
In this section, investigations of the permeability and diffusion rate of chitosan and 
chitosan/PEO blends, crosslinked by genipin, were carried out using diffusion cclis. 
vitamin B12 was used as the model drug. 
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9.2.1 Free volume theory of diffusion 
In general, solute transport through a polymer membrane is described in terms of two 
mechanisms: the pore mechanism [281,282] and the partition mechanism [281,282). 
In the pore mechanism, the solute diffuses through the water-filled pores or 
microchannels. The permeability is determined by the average pore size in relation to 
the molecular volume of the solute and the water solubility of the solute [281,282]. In 
the partition mechanism, the solute transport is presumed to occur by a process 
involving the dissolution of the solute within the polymer followed by diffusion 
through the membrane. Solubility parameters for the system determine the 
permeability for the most part in such a model based on solution diffusion [281,282]. 
Molecular transport regulated by free volume was first introduced by Cohen and 
Turenbull [283]. According to this theory, the solute diffuses by jumping into voids 
formed in the solvent space by the redistribution of the free volume within the liquid. 
It is assumed that the free volume can be redistributed without any energy change. 
The voids are pictured as being formed by a general withdrawal of the surrounding 
liquid molecules due to random thermal motion. These holes are then filled in by the 
reverse processes [283]. 
Solute self-diffusion is dependent on the jumping distance, the thermal velocity of the 
solute and the probability that there is a hole free volume adjacent to the molecule 
[283]. At a given temperature, where the rate of diffusion is determined by the 
probability of a void being formed of sufficient volume to accommodate the solute in 
the liquid at infinite dilution, the self-diffusion coefficient, Do, is expressed as 
Do oc VA exp 
yv* 
) (- 
Vf 
in which V is the average thermal velocity, X is the jumping length roughly cquivalent 
to the solute diameter, v* is the critical local hole free volume required for a solute 
molecule to jump into a new void, y is a numerical factor used to correct for overlap 
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of free volume available to more than one molecule (0.5 :5y :5 1), and vf is the 
average hole free volume per molecule in the liquid. 
Yasuda et al. [284,285] were the first to apply this theory to solute diffusion in gels. 
Within the gel, in addition to the requirement of finding a sufficient free volume 
within the liquid, the solute molecule also needs to find an opening between the solute 
chains large enough to allow its passage. Thus, the diffusivity of a solute in the gel is 
given by the product of the probabilities of finding a proper free Volume and a proper 
opening within the chains. According to this concept, Equation 9.2-1 yields the 
following expression for diffusion in a gel [284,285]. 
Dge, 
= po exp(- 
Ba* ( "1 [9.2-2] 
Do Vf, w I-V)) 
In Equation 9.2-2, po is the probability of finding an opening between the polymer 
chains, a* is the effective cross-section area of the solute molecule, B is an undefined 
constant of proportionality, 9 is the volume fraction of polymer in the gel and vf., is 
the free volume per molecule of the water. 
Based on the free volume theory, a theory for solute diffusion through hydrated 
polymer membranes was developed by Yasuda el aL, which they indicated explained 
the experimental results of the dependencies of solute diffusion cocfficicnt on the 
solute size and degree of swelling. Peppas and Reinhart presented a similar physical 
model for solute diffusion [286]. According to this theory, the normalized solute 
diffusion coefficient, that is the ratio of the solute diffusion coefficient in the swollen 
gel membrane, Dgel) to that in pure water, Dwater) is expressed as follows. 
D 
'I =B(Vd)ex - D. 
ater 
V, (Q. - 
0) [9.2-3] 
or 
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nr, 'I(l /H- 1) B(Vd)exp 
V, 
[9.24] 
D. 
wer I 
Here, r., is the Stokes hydrodynamic radius, I is the characteristic length, VI is the 
average free volume of water, Q is the volume degree of swelling of the network and 
H is the volume fraction of water in the gel membrane. The term B(vd) denotes the 
probability of a diffusion species of volume Vd finding a mesh of a volume of at least 
Vd. formed by the crosslinked chains of the polymeric network. By assuming that the 
normalized diffusion coefficient is linearly related to the mesh size, Peppas and 
Reinhart derived the expression for B(Vd) and presented the following equation [2861. 
= k, 
(ME 
- M: 
) 
exp(_ 
k2 r. 
2 
[9.2-5] 
Dwaler TM-7: ý-Mýý Q. -1 
Here M, is the average molecular weight between crosslinks, Aj*' is the threshold 
value of M, below which no diffusion of solute can occur, A, is the average 
molecular weight of the polymer before crosslinking, and the constants k, and k2 are 
structure parameters. 
They demonstrated that the experimental data showed reasonable linear dependencies 
between log(Dg,, ID ...... ) and r, 
' and between log(Dg,, ID,,,,,,,. ) and II(Q,, -I), as 
expected by Equation 9.2-5. 
Reinhart and Peppas [286] have investigated the influence of crosslinking on diffusive 
properties. They showed that the normalized diffusion coefficient depends on the 
value of M, However, it was concluded that the linear dependence of tile diffusion 
coefficient on the mesh size, which is expressed by Equation 9.2-5, was not correct. 
Thus, the appropriate expression for the probability B(Vd) has not been presented. 
Based on the free volume consideration, the normalized diffusion coefficient in a gel 
membrane is expressed as Equation 9.2-3. In order to make this theory more 
quantitative, the term B(Vd) must be determined. The term B(Vd) is a proportionality 
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factor dependent upon the size and shape of the mesh formed by the crosslinkcd 
chains [285]. The characteristics of B(Vd) are as follows. For chains far apart from 
each other so that there are no entanglements, the solute diffusion is not obstructed by 
the chains. In such a case, B(Vd) must be unity unless there is no interaction between 
polymer chain and solute. On the other hand, when the polymer chains are well 
crosslinked and no solute diffusion occurs, B(Vd) must be zero. 
The gel membrane usually has high water content, that is, a large pore portion in the 
total volume. In such gel membranes, the partition coefficient occasionally may be 
determined simply by the space volume (mesh size) rather than the interaction 
between the solute and polymer chains. Furthermore, it is well known that the 
network of the get fluctuates in time and space. However, the cooperative diffusion 
coefficient of the gel is much smaller than that of the small solute [287] and therefore, 
the gel polymer network behaves as a fixed obstacle for diffusion of small molecules 
in the gel [288]. It follows that the gel membrane can be treated as a rigid porous 
material. When the interaction between the solute and the polymer is negligible and 
the water content in the gel membrane is high, the diffusion coefficient of the solute is 
determined only by the mesh size of the polymer network and the size of solute [287]. 
In this case, the probability of a diffusion species of volume Vd finding a mesh formed 
by the crosslinked chains of the polymer network, B(VA depends on the size and 
shape of the mesh formed by the crosslinked chains. Recently, a new equation based 
on the free volume theory for crosslinked poly(vinyl alcohol) was presented by 
Mastuyama [289] as follows. 
Dgel 
= K'exp 
nr2l(IIH-1 [9.2-6] 
Do V, 
In this equation, the partition coefficient was introduced as the probability of a 
diffusing species finding a mcsh. A linear relationship between ln(Dg, I/D,,,. terK and 
1/(H-1) was obtained for the crosslinked poly(vinyl alcohol). 
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9.2.2 Vitamin B12 release 
Vitamin B12 was dissolved in phosphate saline (PBS) (pH = 7) solution to prepare 
solutions with a series of concentrations. Figure 9.2.1 shows UV spectra for the 
vitamin B12 solutions. A strong absorption peak was observed at 361nm, which is 
indicative of the concentration of vitamin B12 solutions. Figure 9.2.2 is the plot of a 
calibration curve of absorbance (at 361nm) against concentration. In the vitamin 1312 
release study, this standard curve was used to determine an unknown concentration of 
vitamin 1312 solution. 
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Figure 9.2.1 UV spectra of vitamin B 12 at different concentrations 
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Figure 9.2.2 A standard concentration curve for vitamin B12 
From the diffusion cell experiments, the permeability, P, of the membranes for 
vitamin B12 were determined using Equation 3.3.10-3. The vitamin 1312 diffusion 
coefficient, D, was calculated from the results of the permeability and partition 
coefficient, Kd, using Equation 3.3.10-2. The effects of crosslink density, PEO weight 
content in crosslinked chitosan/PEO blends and pH of vitamin B12 solution on the 
release behaviour were investigated. 
9.2.2.1 Effect of crosslinking density on vitamin B12 release through 
chitosan/PEO blend membranes 
The permeation of vitamin B12 through the crosslinked chitosan membranes with 
different crossl ink densities was studied in phosphate buffer (0.1 M) of pf I 7.4at37'C. 
Table 9.2.1 lists the calculated values of permeability, diffusion and partition 
coefficients of the membranes with different crosslink densities. Tile raw data are 
shown in Appendix A. 
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Table 9.2.1 Permeability, diffusion and partition coefficients of vitamin B12 
through chitosan membranes at pH 7.4 and 37'C 
Crosslinking Density 
Sample N p 
(CM, /S) 
D 
(CM2/S) 
Kd 
0 7.04 x 10-' 3.44 x 10-" 2.045 
0.068 5.43 x 10-7 5.99 x 10-7 0.906 
0.264 3.12 x 10-7 2.83 x 10-7 0.908 
0.985 1.29 x 10-7 1.26 x 10-7 1.026 
CSR 2.227 1.09 X 10-7 9.90 x 10-8 1.101 
4.645 9.57 x 10-8 8.14 x 10 1.176 
9.220 6.75 x 10-8 4.63 x 10-8 1.458 
14.350 4.25 x 10-8 2.39 x 10-8 1.779 
8 
6 
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" to cc E 4) E 'ry 
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Figure 9.2.3 Effect of crosslink density on permeability of vitamin 1312 
through the chitosan membranes at pH 7.4 and 37'C 
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Figure 9.2.3 shows the effect of crosslink density on the permeability of vitamin 1312 
through chitosan membranes. The results shown in Table 9.2.1 and Figure 9.2.3 
indicate that the drug release rate was found to be dependent on the crosslink density. 
As expected, the permeability decreased with increasing crosslink density. It can also 
be clearly observed from Figure 9.2.3 that permeability was particularly sensitive at 
low degrees of crosslink density, which could provide useful information for 
controlled drug release. 
The permeability and release rate of hydrogels are influenced by the type of solute 
and the mesh size of the membrane [279]. The mesh size is the space between 
neighbouring chains in the polymer network, and can be considered as an indication 
for the available space in the membrane for solute diffusion [290]. Crosslinking a 
polymer generally leads to a reduction in permeability to solutes [290]. The 
permeability reduction may be due to a number of causes, such as interactions 
between the solute and the chains. In the case of hydrogels, the reduction in the mesh 
size by increasing crosslink density is likely to be a more important factor. 
According to the free-volume theory, Equations 9.2-3 and 9.2-4 express a general 
form of diffusion. When the crosslink points are sufficiently spaced, the jumping 
rates of the solvent molecules and the interaction between these molecules and their 
neighbours (which is represented by D,,,, t,, ) will not be influenced by the presence of 
crosslinks. Following this line of reasoning, one is led to conclude that crosslinking a 
polymer influences only the diffusion coefficient through the thermodynamics of the 
polymer-solvent interactions and the specific hole volume of the polymer. The 
addition of chemical crosslinks to a polymer will obviously inhibit the segmental 
motion of the chains that arise due to thermal fluctuations. Consequently, the free 
volume of a crosslinked polymer is expected to be less than that of a non-crosslinkcd 
polymer. This anticipated behaviour is substantiated by the fact that crosslinking 
increases polymer density. Furthermore, it can be assumed that loss of free volume 
associated with the formation of crosslinking reduces the hole free volume, which 
dictates solvent transport. 
According to the free volume theory, the permeability and release rate through 
membranes made from hydrogels are influenced by the crosslink density, which can 
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be directly explained by the degree of equilibrium swelling achieved by the network 
under experimental conditions. The effect of crosslink density on the equilibrium 
network swelling has been discussed in Chapter 6. A reduction in water up-take by 
the membrane accompanies increased crosslinked density. 
Figure 9.2.4 shows the plot of ln(Dg,, /D,,, t,, K against 1/(H-1) for the crosslinkcd 
chitosan membrane. A linear relationship was obtained. Therefore, equation 9.2-6 
used for a crosslinked poly(vinyl alcohol) membrane [289], in which the partition 
coefficient was introduced as the probability of a diffusing species finding a mesh, is 
suitable for treating our results. 
2.1 
2.1 
OJ 
0. ( 
-0.1 
-1.1 
-1.11 
1/(H-1) 
Figu re 9.2.4 ln(Dgel/Dwate, K vs. I /(Il- 1) 
9.2.2.2 Effect of PEO on vitamin B12 release through crosslinked chitosan/PEO 
blends 
In Chapter 5, the improvements in the mechanical properties of chitosan films after 
the addition of PEO were discussed, and it was also found that the degree of water 
wettability increased with increasing PEO content. In this section, the effect of the 
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PEO content in membranes on the permeation of vitamin 13,2 was examined. Table 
9.2.2 shows experimental results (the raw data are shown in Appendix A). 
Table 9.2.2 Effect of PEO content on the permeability of vitamin B12 
Sample Genipin content 
(%) 
p 
(CM2/S) 
D 
(cm 2/S) 
Kd 
cs 0 7.04 x 10-' 3.44 x 10-7 2.045 
CSR/LPEOIO 4.06 x 10«' 6.33 x 10«' 0.641 
CSR/LPE020 9.81 x 10--' 1.56 x 10-'5 0.651- 
CSR/LPE030 0.5 1.17 x 10-6 1.20 x 10-'5 0.981 
CSR/HPEOIO 1.96X1O-b 2.89X1O-" 0.678 
CSR/HPE020 3.68x10-" 5.07x10"' 0.761 
CSR/HPE030 8.56 x 10 1.06 x 10«" 0.80F 
80 
E 60 
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40 
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Figure 9.2.5 Effect of PEO content on the permeability of vitamin 1312 through 
crosslinked chitosan/PEO membranes 
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Figure 9.2.5 shows that the permeability of vitamin B12 through the membrane 
prepared by blending chitosan with PEO was much higher than through chitosan 
alone. The permeability of vitamin B12, for instance, increased with increasing weight 
ratio of PEO in the chitosan/PEO blend membranes. It can be observed from a 
comparison between chitosan/LPEO and chitosan/HPEO blend membranes that the 
rate of drug permeation of crosslinked chitosan/HPEO blend membranes was higher 
than that of chitosan/LPEO blend membranes. 
The permeability through a membrane is controlled by the morphological features of 
the material, which can alter the mesh size of networks [291]. In Chapter 4, the 
morphology of chitosan/PEO blends and networks was studied by small angle X-ray 
scattering. The results indicate that crosslinking resulted in phase separation. With 
increasing HPEO or LPEO content, the phase separation increased in the crosslinked 
chitosan/HPEO or LPEO system. Phase separation leads to a reduction of the 
molecular interaction between the chitosan and PEO in the chitosan/PEO system. 
This fact has been proven by the previous studies from the stability of crosslinked 
chitosan/PEO blend film in water. These results indicate that after immersing the film 
in water some of the PEO dissolved. The lower the HPEO or LPEO content the better 
was the stability. The stability of the crosslinked chitosan/LPEO film was better than 
that of the crosslinked chitosan/HPEO film due to the effect of different molecular 
weight of PEO. Figure 9.2.6 is a schematic diagram of the mesh sizes for crosslinkcd 
chitosan, chitosanALPEO and chitosan/HPEO membranes. The low stability gave rise 
to larger mesh size for the chitosan/HPEO membrane. From the above discussions, it 
can be concluded that the PEO content and the different molecular weight of PEO 
used in the chitosan/PEO blend network can alter the mesh size of tile membrane and 
control drug release rate. 
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Table 9.2.3 shows the effect of pH on the permeability and the diffusion coefficient of 
vitamin 1312 through the membrane (the raw data are shown in Appendix A). These 
clearly show an increase in the release rate of vitamin 1312 when the pH of buffer 
system becomes acidic. This result agrees with the previously discussed results of tile 
equilibrium swelling nature according to the pH condition. The membrane at low plis 
exhibited a high-swelling ratio due to the fact that the repulsive forces between the 
same charges on the molecules caused greater intermolecular distances and 
hydrophilicity. The swollen membrane was expected to have a large-sized mesh, and 
hence higher rates of drug permeation at lower pH could be attributed to the changes 
in the mesh size. 
Table 9.2.3 Permeability, diffusion and partition coefficients of vitamin B 12 in 
solutions with different pHs 
p D 
pH (Cn2/S) (cm 
2/S) Kd 
7.4 0.96 x 10-' 0.85 x 10-' 1.123 
5.5 1.26 x 10-7 0. gg X 10-7 1.284 
4.3 1.81 X 10-7 1.24 x 10-7 1.456 
3.8 2.91 x 10-7 2.04 x 10-7 1.425 
9.2.2.4 Effect of degree of deacetylation of chitosan on vitamin B12 release 
Films or membranes with different pore sizes and mechanical properties can be 
prepared from chitosans with different degrees of deacetylation or molecular weights 
[43]. The films or membranes thus prepared are important for purification, 
separation, controlled release etc. In this section, three kinds of crosslinked and 
uncrosslinked chitosan membranes are used to study the release of vitamin 1312. They 
were formed using three different degrees of deacetylation (72%, 85% and 95%) and 
some of them crosslinked by a 0.5% genipin content. The results are listed in the 
Table 9.2.4 (the raw data are shown in Appendix A). The permeability of the 
uncrosslinked chitosan membrane increased with increases in the degree of 
deacetylation. The degree of deacetylation affects the physical characteristics of the 
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membranes. Where the degree of deacctylation is high, chitosan has greater chain 
flexibility and the flexible molecules result in a larger mesh size in the membrane 
[292]. Consequently, more drug molecules are released. From the comparison of the 
data for crosslinked and un-crosslinked chitosan membranes, it can be seen that 
crosslinking, by causing decreases in the mesh size of the membranes, led to 
reductions in the permeability and diffusion coefficient. 
Table 9.2.4 Permeability, diffusion and partition coefficients of vitamin B12 
through chitosan membranes with different degrees of deacetylation 
Sample DD (%) P (CM2/s) D (CM2/s) Kd 
72 4.02 x 10-8 2.23 x 10 1.797 
cs 85 3.44 x 10-' 1.67x 10-' 2.045 
95 2.68 x 10-6 1.19 x1 o', ' 2.242 
72 1.62 x 10-" 0.81 x 10-8 2.011 
CSR 85 0.57 x 10-' 0.49 x 10-' 1.1 T6- 
95 7.26 x 10--' 6.67 x 10--' 1.087 
9.2.3 Conclusions 
The permeability of vitamin B12 was investigated through crosslinked and un- 
crosslinked chitosan and chitosan/PEO blend membranes. The drug release rate was 
controlled by the mesh size of the membrane, which can be adjusted by a number of 
factors, such as the crosslink density, the presence of PEO in the membrane, external 
pH, and the degree of deacetylation of the chitosan. Crosslinking resulted in a 
decrease of the drug release rate. Furthermore, as the crosslink density increased, the 
drug release rate decreased. The drug release rate was also very sensitive at low 
crosslink densities. The introduction of PEO into the membrane changed the mesh 
size of the membrane, resulting in changes in the drug release rate. These changes 
depended on the molecular weight and amount of PEO. Increasing tile degree of 
deacetylation led to increases in the drug release rate. The drug release rate was also 
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sensitive to solution pH, which is in agreement with the swelling nature of these 
membranes. 
These membranes are expected to be very useful in medical applications because 
solute permeation through them can be controlled. 
9.3 Release of Eleutherococcus Senticosus (ES) Drug from Chitosan Film 
Carriers 
In this section, controlled drug release from chitosan and chitosan networks was 
studied by sorption and desorption experiments under two carrier conditions of fixed 
and moving boundary. Eleutherococcus senticosus, discussed at greater length in 
section 9.4, was used as a model drug. 
9.3.1 Fixed boundary 
9.3.1.1 Fundamental theory of drug release with fixed boundary conditions 
The conservation of species in one dimension is given by the following equation 
[219] 
ac a 
at ax 
[9.3.1] 
where c is the concentration of the diffusing species, t is the time, andj, is the flux in 
the x direction, which is along the thickness of the membrane and is the only direction 
in which mass transfer is taking place. If A is the area of the face of the membrane, 
then A"2>>I, where I is the membrane thickness, which makes the dynamics one- 
dimensional. Equation 9.3-1 assumes that there is no convection. Considering a 
boundary effect in concentration c, requires that flux be related to the concentration 
field. According to Fick's law, we have 
=-D 
ac 
[9.3-2] 
ax 
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Combining Equations. 9.3-1 and 9.3-2 one has 
ac 
=a 
(D ac) [9.3-31 
at ax ax 
which is essentially the equation that has to be solved subject to appropriate initial and 
boundary conditions. 
In simple sorption and desorption experiments, the solute dissolves and diffuses into 
the membrane. The fractional mass uptakes are a function of time. For constant D, 
Equation 9.3-3 leads to 
81 4D(2m + 1)'7r't 2L, 
=I -, exp [9.34] 
112 
Mý ; r' (2m + 1)' 
where Mt and M. are the mass release at time t and at infinite time, respectively, I is 
the membrane thickness and m is an integer. 
For long times, Equation 9.3-4 may be approximated to the following equation [218] 
M, 8T4; r'Dt] 
m exp 
[9.3-5] 
At short times it approximates to 
M, 
;z4 -LI-) 
1/2 
[9.3-61 
M. 
(ZJ2 
A plot of Mt/M ,, versus tlý2 is linear and from the slop, D can be evaluated. 
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9.3.1.2 Diffusion behaviour of ES from a chitosan carrier with fixed boundary 
The release of ES over time was investigated at 37'C. The diffused mass can be 
calculated on the basis of the measurement of concentration. Figure 9.3.1 shows 
Mt/M. for released ES versus the time. M,, the amount of ES sorbate released at time 
t, was calculated. M., the amount of ES released after infinite time was taken to be 
the value at which the equilibrium was attained. 
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Figure 9.3.1 Mt/M. for released ES versus time 
From the linear part of the curves, the diffusion coefficient D was calculated using 
Equation 9.3-6. 
Figure 9.3.2 shows the change of diffusion coefficient with crosslink density. The 
results indicate that the diffusion coefficient strongly depends on the crosslink 
density. When the genipin crosslink density was 2.23 % or 4.65%, the diffusion rate 
was slower than that of the un-crosslinked ones. However, when the crosslinking 
density was increased to 9.22 % or 14.35 %, the diffusion rate became faster than that 
of 
ihe 
uncrosslinked ones. 
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Figure 9.3.2 Diffusion coefficient as a function of crosslink density 
It can also been observed from Figure 9.3.1 that the release amount of ES was very 
small. Even when the release time was 350minutes and the crosslinking density was 
14-35%, only about 15% of the loaded drug was released from the carrier. This 
suggests that for the carrier (chitosan/ES system), the drug release mechanism is not 
only regulated by the 'pore' mechanism, and that there exist molecular interactions 
between chitosan and ES. This means that the release rate may be controlled by both 
the mesh size of the membrane and the interactions between chitosan and ES. In 
order to understand the above diffusion behaviour, the molecular interactions between 
chitosan and ES was studied by FT-IR spectra analysis, the results of which are 
shown in Figure 9.3.3. The frequency of the free amine band of chitosan in 
chitosan/ES system shifted up from 1558 to 1567cm-1, confirming that ES interacts 
with chitosan at the position of amino groups. 
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Figure 9.3.3 Fl'-IR spectra of CS, ES and CS/ES (DD: 85%) 
For further understanding of the effect of crosslink density on the interactions 
between ES and the free amino groups of chitosan, chitosan samples with 72% and 
95% degree of deacetylation were employed. Figure 9.3.4, parts A and B, shows FT- 
IR spectra for chitosan/ES systems with 72% and 95% degree of dcacetylation, 
respectively. Table 9.3.1 gives a comparison of frequency shifts. The results indicate 
that the molecular interactions were stronger when chitosan with higher degrees of 
deacetylation was used, which is explained by the greater shifts of the frequency of 
the free arnine band. 
The free amino groups of chitosan reacted with genipin, which was confirmed by FT- 
IR and UV spectra analysis (see Chapter 7). The content of free amino groups of 
chitosan could be reduced due to crosslinking. According to this, the content of 
amino group will decrease with increasing crosslink density. 
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Figure 9.3.4 FT-IR spectra of CS and CS/ES. (A) DD: 72% (B) DD: 95%. 
Table 9.3.1 A comparison of frequency shifts using different degree of 
deacetylation of chitosan 
Wavenumber Shift Wavenumber Shift 
DD Sample (CM-1) (cm-) (cm"') (cm-1 ) 
CS 1563 1627 
72 CS/ES 1574 11 1626 1 
CS 1558 1647 
85 CS/ES 1567 9 1632 -15 
CS - 1599 
92 CS/ES - 1631 -32 
From the FT-IR results and the above analysis, it can be assumed that the interaction 
between chitosan and ES in chitosan/ES systems may be reduced when chitosan is 
crosslinked by genipin. For the crosslink densities of 2.23 % and 4.65%, the diffusion 
rate deceased because the mesh size decreased, although because of crosslinking the 
DD: fS% 
cs 
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interaction between chitosan and ES became weaker. In this case, the mesh size is 
more important than the interaction for controlling the release rate in the chitosan/ES 
system. However, for the crosslink densities of 9.22 % and 14.35 %, the drug release 
rate was more dependent on the interactions in the chitosan/ES system. 
9.3.1.3 Conclusions 
ES drug release behaviour from the chitosan carriers with fixed boundary was 
affected by the crosslink density of the chitosan films. The drug release rate for the 
chitosan/ES system was governed by both the mesh size of membrane and specific 
interactions between chitosan and ES. 
9.3.2 Moving boundary 
9.3.2.1 Introduction to the moving boundary concept 
In the above studies, we investigated the drug release behaviour for fully hydrated 
monolithic slabs of un-crosslinked and crosslinked chitosan gels. The amount of drug 
released at any one time could be determined by judicious selection from a number of 
variables, but invariably the rate of release diminished with time at a t' /2 
proportionality. Starting off with the drug dispersed in a dehydrated hydrogel offers 
several practical advantages over the hydrated system. When dried down, the drug 
substance is essentially immobile, trapped in the matrix, and contact with penetrating 
water is necessary to unlock the immobilised solute and trigger the release process 
[4,43,293,294]. 
For a drug such as prostaglandin E2 (PGE2), which degrades in water, a viscous 
aqueous gel for vaginal application [293] has to be dispensed in the hospital pharmacy 
prior to administration, whereas a dried hydrogel containing dispersed PGE2 provides 
a long-lasting stable formulation, which is immediately available when required. 
Other advantages in starting with a dried device are the swelling process necessary to 
activate the release that helps to linearize the decreasing rate normally associated with 
an initially hydrated device and the extension of the period of effective release. 
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An initially dried hydrogel containing a dispersed drug with the added safety that it 
cannot dump the entrapped medication when administered would, in general, be of 
more interest for pharmaceutical formulations than one swollen with, or containing a 
solution of the drug [294]. 
In the context of drug release systems, one important class of problems arises where 
moving boundary is encountered in the drying of polymer films [4,294]. The 
boundary can move as a function of time. In particular, the key feature is the jump 
boundary condition at the interface, where many quantities become discontinuous. A 
schematic representation of the overall physics of the situation is given as Figure 
9.3.5. 
In order to solve these problems, a well-defined initial state and the concentration 
profile to change along with the position of the interface are required. The issue of 
numerical stability of the algorithm at the moving interface is a complex one. Such 
swelling and diffusion do not generally follow a Fickian mechanism [219]. Until 
now, no single model can be used to describe such problems. This section aims at 
presenting a phenomenological analysis of release results and at contributing to the 
understanding of the mechanisms of drug release from dried uncrosslinked and 
crosslinked chitosan membranes. 
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Figure 9.3.5 Schematic diagram depicting the physical situation of drug 
release from dry polymer films (0, polymer concentration ----- ; C, Drug 
concentration -; --+, release of drug/polymer into bulk water) [294]. 
[Figure 9.3.5 (a) shows where water begins to diffuse into a polymer film at initial stage. Since the 
water continues to diffuse into the film, the drug diffuses out into bulk water as shown in Figure 9.3.5 
(b). Then the polymer concentration has achieved steady profile and moves right at constant velocity, 
drug continues to diffuse out at a rate based on C (x - 0) and dC/dt (x - 0) as shown in Figure 9.3.5 (c). 
This representation predicts that there will be a period of time (t =0 to t- tý, j where the drug release 
will be controlled by Fickian diffusion. The diffusion rate of drugs within the film, and the diffusion 
rate of water into the polymer are all important parameters. ) 
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9.3.2.2 Fundamental theory of drug release mechanism with moving boundary 
Release kinetics may employ one of the detailed mathematical models based on the 
diffusion equations [219]. To describe Fickian and non-Fickian release behaviour of 
swelling controlled release systems [295], the exponential relation equation shown 
below can frequently be used. 
kt" [9.3-71 
where, M, is the total mass of drug released through time t, M.. is the total mount of 
drug released, k is a constant that characterises the macromolecular network system 
and n is the diffusional exponent characteristic of the release mechanism. For this 
analysis, M,,,, was taken as the total initial amount of the drug. An analysis of 
cumulative release data (MIM. ) versus time for all formulations yields the 
dependence on time of the drug release, n, as well as the constant, k. This value, n, of 
the exponential dependence on time of the drug release indicates whether degradation, 
diffusion, anomalous transport or other mechanisms are the predominant factors in the 
mechanism of drug release. A value of n=0.5 shows that Fickian (Case 1) diffusion is 
observed and the release rate is dependent on to's. A value of n=1 indicates Case 11 
transport and the release rate is directly proportional to time. For values of 
0.5<n<1.0, anomalous (non-Fickian) transport is the predominating mechanism. For 
values of n<0.5, pseudo-Fickian diffusion occurs. Values of n>1 define Super Case 11 
transport [295] in which a pronounced acceleration in solute release by a film occurs 
toward the latter stages of release experiments, resulting in a more rapid relaxation- 
controlled transport [291,295]. Such diffusion behaviour can be summarised in Table 
9.3.2. 
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Table 9.3.2 The diffusional exponent characteristic of particular release 
mechanisms 
Diffusional exponent Diffusion mechanism 
n=0.5 Fickian (Case I) 
N<0.5 pseudo-Fickian 
n= I Case 11 transport 
0.5< n <1 Anomalous 
n>1 Super Case 11 
The general behaviour, known as anomalous transport, is bound by pure Fickian 
diffusion and Case II transport, which have been observed in several 
polymer/penetrant systems [292]. Figure 9.3.6 explains the two typical responses of 
the fractional mass release curves. Transport in all of these physical situations can 
generally be reduced to three types of driving forces: a penetrant concentration 
gradient, a polymer stress gradient and osmotic forces [2921. 
8 
t 
8 
t 
Fickian Cn. se Il 
Figure 9.3.6 The different types of release response curves 
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Swell ing-control led release systems are based on the above principles, where a 
polymeric carrier can counterbalance normal Fickian diffusion by hindering the 
release of an imbedded solute or drug, leading to an extended period of drug delivery 
under zero-order release conditions [296]. In addition, the presence of a polymer 
network surrounding a drug molecule has also been shown to act as a stabilizer [296], 
maintaining biological activity until the solute is released. 
9.3.2.3 Effect of dynamic swelling of dried membranes on drug release 
Swelling is a common phenomenon for various hydrophilic systems that are widely 
used as drug delivery devices. Water uptakes with time for un-crosslinked and 
crosslinked membranes have been plotted as shown in Figure 9.3.7. In order to 
determine the rate of swelling, the incremental weight difference between each 
recorded weight was used rather than the gradient of the curve. This method is more 
sensitive, accurate and less subjective in detecting subtle changes in the swelling 
pattern [294]. The rates of water uptake at each recorded time were also calculated 
and are shown in Figure 9.3.8. For a better comparison of the swelling rate of un- 
crosslinked and crosslinked chitosan membranes, two different scales were used in 
Figure 9.3.8. As seen there are two distinct peaks in the rate plot for an 
uncrosslinked chitosan membrane, at 5mins and 15mins and a levelling off period 
around 80mins. The membrane is still swelling, albeit slowly, after 180 minutes. 
Similarly, the rates of swelling for crosslinked chitosan membranes were fast in the 
first twenty minutes and then became slow after 150mins. Swelling was limited by 
the presence of crosslinking and the uptake rates decreased with increasing crosslink 
density. 
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Figure 9.3.7 Water uptake of un-crosslinked and crosslinked chitosan 
membranes 
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Figure 9.3.8 Rate of water uptake of un-crosslinkcd and crosslinked chitosan 
membranes 
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Swelling of dried thin membranes accompanied by expansion was investigated. CS 
and 0.3CSR samples were placed in distilled water at 370C, removed after different 
periods, measured and returned to the water to continue swelling. The surface area of 
the membranes was calculated and ratioed to the initial area. The rate of change of 
surface area for each interval of time was also calculated. The results for both 
chitosan and crosslinked chitosan membranes are illustrated in Figure 9.3.9. It shows 
that the peak rate between 5 and 15mins is due to the ease of water absorption at a 
surface in intimate contact with an aqueous environment. The layer of membrane 
close to the surface expands rapidly, but is constrained by the adjoining inner dry 
layer, which can only swell by absorbing water from the outer swollen layer. The 
rate, therefore, soon falls away as the advancing waterfronts from opposite faces 
approach to meet in the middle. From all the above dynamic swelling studies, it can 
be concluded that in early stages of dynamic swelling the rate of swelling was rapid, 
then became slow and finally reached equilibrium. 
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Figure 9.3.9 Surface expansion (red cures), and rate of change of surface area 
(black cures) for chitosan and crosslinked chitosan membranes 
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Fractional ES releases from uncrosslinked and crosslinked chitosan films were plotted 
as a function of time in Figure 9.3.10. The release profiles followed the expected 
trends, in that the release from the films was most rapid at the initial stages. The 
highest initial release rate for each film was observed as seen in Figure 9.3.11. For 
fully hydrated hydrogels containing the dissolved drug, the release into an infinite 
sink is nearly always Fickian [219,295]. However, starting with a loaded drug in a 
dried hydrogel, the xerogel has first to absorb water, which act as a solvent for the 
drug, followed by diffusion of the solute along the aqueous pathways to the surface to 
be released to the surrounding fluid. From Fick's law of diffusion, the flux is directly 
proportional to the surface area for fixed values of other dependent variables. 
Although the diffusion coefficient, D, depends on the water content and has a fixed 
value for fully hydrated systems, it will not be constant for systems which are 
swelling while they are releasing active additive. Until the hydrogel is fully swollen, 
there will be a decreasing gradient of diffusion from surface to the centre. Release 
across the surface will be partly controlled by the D value in the hydrogel close to the 
surface [297], which may quickly approach the characteristic D value for the fully 
hydrated composition. 
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Figure 9.3.10 Fractional ES release from various chitosan films 
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Figure 9.3.11 Rate of drug release as a function of tirne 
Provided the supply of the drug from the interior by diffusion, or dissolution of 
dispersant in the surface layer can maintain a constant level of concentration of 
dissolved drug, the flux would be expected to increase along with expansion of the 
surface in accordance with Fick's Law. Comparing to Figures 9.3.9 and 9.3.11, the 
mobility of the surface expansion peaks and of the peak rate for ES release is similar. 
This emphasises the importance of surface expansion with swelling release profiles. 
9.3.2.4 Drug release mechanism 
According to Equation 9.3-7, the diffusional exponents for ES release were calculated 
from the release data by plotting log (Mt/Moo) versus log (t) which yielded straight 
lines. The diffusional exponents were obtained from the slope of these lines, while 
the diffusional constant (k) was also obtained from the intercept (Table 9.3.3). It can 
be seen that the exponent n for ES release from all crosslinked chitosan membranes, 
with the exception of the 0.8CSR sample, were smaller than 0.5, Such that the release 
behaviour for ES dispersed in crosslinked chitosan membranes can be categorized as 
pseudo-Fickian. 
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Table 9.3.3 Exponential dependence of drug release on time 
Sample Exponent (n) Constant (k) 
cs 0.65 0.24 
0.3CSR 0.29 1.37 
0.5CSR 0.34 1.74 
0.8CSR 0.51 0.93 
ICSR 0.22 3.99 
However, the exponent for ES release from uncrosslinked chitosan membrane is 0.65, 
suggesting that the transport process had an anomalous (non-Fickian) character. For 
0.8CSR sample (genipin content: 0.8%), the release behaviour is in the nature of 
Fickian diffusion. From the experimental data, it can be concluded that crosslinking 
with genipin produced different drug release behaviours. 
The mechanism for release would not be expected to be Fickian, but rather more 
likely to be anomalous and possibly the often desirable zero-order release. The 
existence of a slow macromolecular relaxational process in the swollen region is 
believed to be responsible for the observed non-Fickian behaviour [2981. Many 
parameters may influence the release profile: (1) polymer composition, and hence 
water uptake; (2) the polymer/drug interactions and the drug load concentration in 
polymer; (3) association of drug with polymer structure; (4) kinetics of swelling 
behaviour; etc. 
A comparison of the drug release profiles of hydrated and dried crosslinked films, as 
shown in Figures 9.3.1 and 9.3.11, indicates the differences in drug release behaviour. 
For hydrated films, when the genipin content was 0.3% or 0.5 % the amount of drug 
release was smaller than un-crosslinked ones, but when genipin content was 0.8% or I 
% the diffusion rate became faster than uncrossed ones. However, for dried films the 
higher the genipin content the greater was the arnount of drug release. These results 
could be caused by interactions between ES and chitosan. As a result of intimate 
contact, there are stronger interactions between ES and the amino group in chitosan in 
the dried state than in the hydrated state. If crosslink density increased, it could 
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reduce the number of free amino groups, leading to weaker interactions in the drug 
release system, and a increase in the amount of ES released from the film. It can bc 
summarised that interactions between dissolution media, polymer and drug are the 
primary factors in release control. 
The controlling mechanisms are essentially quite different to the swelling-controlled 
systems described above. This can be explained by the fact that after a dry sample 
was swollen to equilibrium, some macromolecular chains could be disentangled to 
yield a different structure and different swelling kinetics upon subsequent swelling 
processes. The release profile derives from a combination of several contributing 
factors, which may change with time at different rates and various formulation 
variables influence drug release rate to a greater or lesser extent. 
9.3.2.5 Conclusions 
The mechanisms that control the release of loaded ES drug from initially dry films are 
complex. From the above studies, it can be concluded that the drug release behaviour 
from a dry membrane divides into two stages. In the first stage, the dynamic swelling 
changes the water content from zero to the equilibrium water uptake over a period. 
Transport of solute through the network depends on the degree of swelling, ranging 
from zero in the dry membrane to a maximum which determines the diffusion 
coefficient, D, for the fully equilibrated hydrogel. In the second stage, the diffusion 
coefficient is constant. The increase in the surface area with time and the presence of 
the-interaction between the ES drug and chitosan amino groups were shown to be 
important factors governing the profile and level of the release rate. The diffusional 
exponent, n, is an important indicator of the release mechanism. When tile film was 
crosslinked by genipin, the value of n decreased and the release behaviour gencraliscd 
from anomalous diffusion to pseudo-Fickian or near to Fickian diffusion. 
Furthermore, depending on the crosslink density in the films, a burst or lag effect can 
be observed at the very early stages of the drug release 
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9.4 Separation of Protein from Elcutherococcus Senticosus 
9.4.1 Introduction 
There has been a dramatic revival in recent years in the use of herbal preparations for 
the treatment of a wide range of ailments [299]. Some products are being 
recommended for use as 'specific' to treat particular illnesses or conditions much like 
conventional synthetic medicines are prescribed in North America, Western Europe 
and the rest of the economically developed world [300]. Eleutherococcus Senticosus 
(ES) is a typical oriental herb and a herbal medicine that has been widely used in a 
number of countries, including China, Japan, Korea, Russia and the USA, both as a 
health supplement and for medical purposes, including enhancing capacity for 
physical and mental work, increasing the protective functions of an organism against 
physical, chemical and biological stress, and treating heart disease, diabetes and blood 
circulatory problems [3001. As a result of its high protein content, ES can only be 
taken in tablet form and cannot be injected directly into the patient's body [17]. Its 
use is, therefore, limited. In recent years, research into its use, with a view to 
widening its application, has been undertaken by a number of countries across the 
world, including many universities in the USA [301]. There is not yet any report on 
solutions to this problem. 
Proteins are very diverse. They differ by size, shape, charge, hydrophobicity and 
affinity for other molecules. All these properties can be exploited to separate them 
from one another. It is well known that this herbal medicine is a very complex 
compound. Therefore separating protein from ES is also more difficult. Chitosan is 
capable of absorbing protein due to chitosan molecules containing a larger number of 
hydroxyl (-OH) and amino groups [30]. In this research, in order to develop novel 
chitosan films crosslinked by genipin as potential membranes for protein separation 
from ES, the feasibility study of protein separation will be carried out. 
9.4.2 Introduction to Elcutherococcus Senticosus 
ES belongs to the family of ginsengs, which is a well-known herbal medicine. It is 
also named Acanthopanax senticosus, Araliceae or Siberian ginseng. It is a woody 
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shrub that is usually 1.5-2m tall. Its shoots are 4-6cm in diameter with a very spiny, 
light grey or brownish bark. The leaves are long-petioled, compound palmate. The 
flowers are 5-merous, long-pedicelled. Its fruit are black drupes about 0.7cm long. 
ES is widely distributed in the northern regions of Russia (Siberia) and Northeast 
Asia, such as China, Korea, Japan al. [302], where they have been valued for 
thousands years. Figure 9.4.1 shows a diagrammatic representation of ES. 
ES is a useful medicine plant. The cortical tissues of its roots and shoots contain 
higher concentrations of biologically-active substances and are used as a tonic in 
Chinese traditional medicine [303,304]. It became a popular herb plant especially in 
the last three decades because of the therapeutic properties of its roots. They are 
considered to have a similar pharmacological action to Chinese ginseng. Tile 
biological ly-active constituents, showing adaptogenic activity, are heterogeneous 
compounds known as eleuterosides [303,304]. 
The chemical composition of ES is very complex [300,3021. In order to verify and 
confirm the medical use, since the late 1970s a variety of chemical investigation have 
been undertaken, leading to the isolation of triterpenes, lignans, phenylpropane 
derivatives and cournarins [300]. ES has been found to contain niacin, amino acids 
(protein), carbohydrates and other vitamins and minerals [300]. It has been used to 
promote an overall sense of well-being. Herbalists call this herb an "adaptogen", 
which means that it helps the body adapt to any situation, which normally would alter 
its function. The eleutherosides have been shown to be responsible for the 
adaptogenic properties of the plant. Eleuthosides are a range of glycosides with 
aromatic alcohol aglycones. The glycosides appear to act on the adrenal glands, 
helping to prevent adrenal hypertrophy and excess corticosteroid production in 
response to stress. The eleutherosides additionally help to reduce tile exhaustion 
phase of the stress response, and return the adrenals to normal function at a faster rate 
than otherwise. As a result, ES has beneficial effects on the heart and blood 
circulation. It has been shown to increase energy and stamina, and to help the body 
resist viral infections, environmental toxins, radiation, and other chemotherapy. In 
Chinese medicine, the roots of ES are used to treat rheumatic diseases and heart 
ailments. ES is also popular herbal remedy for debility and depression [17,300-304]. 
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Figure 9.4.1 Diagrammatic representation of eleutherococcus senticosus. (A) 
portion of root; (B) leaf whorl; (C) inflorescence (D) fruit and seeds [304] 
9.4.3 Characterisation of protein content in ES 
The methods most commonly used for measuring protein concentration are based on 
UV absorption of protein solution or visible region spectrophotometry [213]. Most 
proteins exhibit an absorption maximum at 280nm, which is attributable to the amino 
acid. The absorbance of the sample can be measured at both 280nm and 260nm with 
a correction formula applied [305] as follows: 
Protein (mg ml-1) = 1.55 A280 - 0.76 A260 
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In this study, hen egg white was used as a standard protein and its UV spectra for 
various concentrations of the solutions are shown in Figure 9.4.2. It is clear that the 
absorption peak at 280 nm increased with increasing the protein content in hen egg 
white solution. The protein contents in the solutions were calculated by Equation 9.4- 
1 and shown in the figure. This method was only used for pure protein solution 
because if a mixture contains protein such as ES, its base line of UV spectrum usually 
changes. In order to characterise protein content in ES it is necessary to find a new 
method. 
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Figure 9.4.2 UV spectra of hen egg white for various solution concentrations 
From Figure 9.4.2, the area of each absorption peak at 280nm was calculated and it 
was found that the linear relationship between the protein concentration and area of 
absorption peak at 280nm as shown in Figure 9.4.3, is a characteristic that can be 
introduced as a novel method of quantifying protein content in ES, thus overcoming 
the problem mentioned above. Figure 9.4.3 introduces a standard curve of protein 
content and this will be used in the later study. 
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Figure 9.4.3 Relationship between protein concentration and area of 
absorption peak at 280nm. 
Figure 9.4.4 shows a series of UV spectra for various concentrations of ES solution. 
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Figure 9.4.4 A series of UV spectra for various concentrations of ES solutions 
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The area of the absorption peak at 280nm was calculated and using the standard curve 
as shown in Figure 9.4.3 the protein content in each concentration of ES solutions was 
estimated. All the data obtained are listed in Table 9.4.1. It was found that the 
average percentage of protein content in ES solution was about 15%. 
Table 9.4.1 Estimate of the protein content in ES solutions 
ES concentration Protein content Protein /ES 
(mg1ml) (mg/ml) (%) 
0.2 0.0308 15 
0.4 0.0559 14 
0.6 0.0829 14 
0.8 0.1204 15 
1.2 0.1709 14 
1.6 0.2220 14 
2.0 0.2790 15 
*Average percentage protein content: 15%, Standard deviation: ± 2% 
9.4.4 Absorption method for separation of protein from ES 
Chitosan has the ability of absorbing protein from aqueous solutions, which was 
firstly demonstrated by Hachman [306]. Since chitosan contains chemically reactive 
groups (-OH and -NH2 groups), its surface can be easily coupled with various affinity 
ligands. Flachman's results indicated that maximum absorption occurs at the 
isoelectric point of the protein and that, at a given pH, the extent of absorption 
decreases with increases in the ionic strength of the solution. Recently, many 
researchers have developed novel macroporous chitosan mernbranes, which possess 
controlled pore sizes, good mechanical strength and chemical stability, as well as 
hydrophilicity and biocompatibility [307]. They have been successfully employed for 
affinity separation or purification of lysozyme and serum albumins [308,309]. 
Efficient separation was achieved, and high purity (>99%) lysozyme obtained [308]. 
In this section, we will examine whether chitosan membranes crosslinked by genipin 
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are suitable to use for protein separation from ES. The absorption method will be 
employed. 
The equilibrium absorption of protein on uncrosslinked and crosslinked chitosan films 
was carried out in bath experiments at room temperature. The samples were cut into 
small pieces (3 OCM2) . The sample membranes were first swollen in phosphate buffer 
saline (PBS, pH 7.4) solution to reach equilibrium, and then they were introduced into 
test tubes containing 20ml ES solutions of known initial concentration. These 
suspensions were gently shaken (at 200rpm) at 25'C during the experiment. it is 
known that chitosan is insoluble in neutral or alkaline solution, but in this study it was 
observed that when uncrosslinked chitosan film immersed in the ES solution after two 
hours, the chitosan film completely dissolved. This suggests that the changes in the 
solubility of chitosan were brought about by ES due to the interactions between 
chitosan and ES molecules, which have been studied in Section 9.3.2 (as shown 
Figures 9.3.3 and 9.3.4). Figure 9.4.5 shows UV spectra for ES solution measured at 
time of 0,48 and 72 hours after the sample of crosslinked chitosan film (0.5CSR) had 
been immersed in the bath. It was clearly observed that the absorption peak at 280nm 
for the ES solution decreased and the absorption equilibrium was reached within 48 
hours. 
2.5- Absorption protein from ES 
Sample: (0.5CSR) 
2.0- 
ES solution (t-0) 
t-48h 
1.5- t-72h 
N 
1.0- 
0.54 
0.0 
240 260 280 300 320 340 360 
Wavelength (nm) 
Figure 9.4.5 UV spectra of ES solution before and after absorption of protein 
by crosslinked chitosan film (0.5CSR) 
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Figure 9.4.6 shows UV spectra for ES solutions before and 48 hours after sarnples of 
OACSR or 0.3CSR were introduced into the solutions. The results again indicate a 
decrease of the absorption peak of protein at 280nm and these results conf irm that the 
crosslinked chitosan films have the ability to absorb protein from ES solution. 
However, the results also show that the extent of protein absorption depends on the 
crosslink density of the chitosan film - the higher the crosslink density the lower the 
film's ability to absorb protein. In this study, the capacity of protein absorption is 
defined as the percentage of absorbed protein from the solution onto a unit volume of 
a film. From the UV spectra results, as indicated in Figures 9.4.5 and 9.4.6, the total 
protein absorbed on each sample was determined and the capacity for protein 
absorption for each film was calculated. Each experiment was done 5 times and the 
average values were taken as shown in Table 9.4.2. 
2.5 
2.0 
1.5 
tu 
0 1.0 
0.5 
0.0 
Absorption protein from ES solution 
by using Crosslinked chitosan films 
--- ES solutin 
-- 0.3% genipin 
-o- 0.1 % genipin 
240 260 280 300 320 340 360 
Wavelength (nm) 
Figure 9.4.6 UV spectra of ES solution before and after protein absorption by 
crosslinked chitosan films (0.1 CSR and 0.3CSR) 
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Table 9.4.2 Capacity of protein absorption by chitosan films from 
ES solutions 
Sample Crosslink density 
M) 
ES concentration 
(mg/ml) 
Capacity 
M) 
CS 0 0.45 (Dissolved) 
O. lCSR 0.26 0.45 67 
0.3CSR 2.23 0.45 60 
0.5CSR 4.65 0.45 50 
*Standard deviation: 
The results indicate that over 50% of the protein in ES was removed by the 
crosslinked chitosan films. The crosslinked chitosan membranes are very stable and 
maintain their strength in the solution, and the film with lower crosslink density had 
higher protein absorption capacity than the ones with higher crosslink density. This is 
because chitosan molecules contain a large number of free amino groups (NI-12), and 
crosslinking, which reduced the number of free amino groups, probably reduced the 
number of H' bonds in amino groups, causing a decrease in the number of cations and 
thereby lessening the absorption of proteins which carried negative charge at neutral 
pH [30]. 
From the above study, it can be concluded that protein can be separated from ES by 
means of crosslinked chitosan membranes, although the efficiency is not high. In the 
practical medicine industry, separation or purification of a mixture by the absorption 
method is not commonly used due to the appearance of bioactive substances. So, in 
the following section, protein separation from ES by a membrane separation method 
was investigated. 
9.4.5 Membrane separation of protein from ES 
Membrane separation involves separating two phases using a barrier and restricting 
the transport of various chemicals in a selective manner. A membrane can be 
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homogenous or heterogeneous and symmetric or asymmetric in structure [310]. 
Transport through a membrane can be affected by convection or by diffusion of the 
individual molecules, induced by an electric field or gradients of concentration, 
pressure or temperature [3 10]. The membrane thickness may vary from as small as 
100 microns to just several nanometres. Membrane separation techniques allow the 
separation and concentration of solution components without the denaturation of 
proteins or bioactive substances and without causing any changes. Furthermore, these 
techniques are energy efficient. As a result, they are considered as particularly useful 
in the development of raw materials and medicines [310]. ES is a herbal medicine 
and a functional substance. Membrane separation may be extremely well-suited to ES 
processing. 
Membrane separation of protein from ES solution was investigated using diffusion 
cells. The details of the method were outlined in Chapter 2. Before carrying out the 
experiment, the samples of membranes were first swollen in phosphate buffer saline 
(PBS, pH 7.4) solution to reach equilibrium. From Figure 9.4.7, which shows UV 
spectra for ES solution before and after passing through chitosan (CS) membrane, two 
areas of absorption peak at 280nm were calculated. 
Separation protein from ES by CS film 
A2 
0 
0 
j2 
S solution 
-After separation solution 
220 240 260 280 300 320 340 360 
Wavelength (nm) 
Figure 9.4.7 UV spectra for ES solution before and after separation of 
protein by the CS membrane 
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The fact that two values was the same means that there was no change in the protein 
content after the solution had passed through the membrane. This indicates that the 
chitosan membrane was unable to separate protein from ES solution. 
Figure 9.4.8 shows UV spectra for ES solutions before and after passing through 
crosslinked chitosan membranes (samples: OACSR, 0.3CSR and 0.5CSR). The area 
of the absorption peak decreased for the solutions that had passed through a 
membrane. The decrease was more pronounced where highly crosslinked membrane 
had been used. For characterisation purposes, in this study, the capacity of protein 
separation is defined as the decreased area of the absorption peak at 280nm as a 
percentage of the total area. The capacity of separation protein from ES solution for 
each membrane was calculated. Each experiment was done a total of 5 times and the 
average values of the protein separation capacity for each membrane were taken and 
are summarised in Table 9.4.3. 
0.6-- 
0.4- 
c 0. 
0.2-1 
0.0+- 
220 
Wavelength (nm) 
Figure 9.4.8 A comparison of UV spectra for ES solution after protein 
separation by crosslinked chitosan films 
228 
240 260 280 300 320 340 360 
Chapter 9: Evaluationfor Controlled Drug Release and Protein Separation 
Table 9.4.3 Capacity of protein separation from ES solution 
Sample Crosslink density ES concentration Capacity 
(%) (MgIMI) (%) 
cs 0 0.11 0 
O. ICSR 0.26 0.11 14. 
0.3CSR 2.23 0.11 81 
O-5CSR 4.65 0.11 88 
*Standard deviation ± 5% 
The results of this study suggest that chitosan membrane crosslinked by genipin can 
be used for the separation of protein from ES. The capacity of protein separation 
increased with increasing crosslink density. When the film with crosslink density was 
2.23%, the capacity reached 81%. However, further increases in the crosslinking 
density did not give rise to significant improvements in the capacity of the film. 
Crosslinked chitosan membranes as opposed to uncrosslinked ones are suitable for 
protein separation from ES, and this method is most optimal when the crosslink 
density was 2.23%. 
The significant differences in the capacity behaviour of a film produced by the two 
methods of protein separation can be understood by looking to the speciFics of the 
separation mechanisms. There are two main controlling factors of protein separation 
in the membrane separation method: the molecular interactions between ES and 
chitosan and the mesh size of a membrane. The effects of crosslink density on the 
molecular interaction between ES and chitosan and on the mesh size of crosslinkcd 
chitosan films were studied in a previous section (9.2 Controlled drug release). The 
conclusion was that crosslinking of chitosan resulted in decreases in both the mesh 
size of the film and the interaction between ES and chitosan. For low crosslink 
densities, the capacity of protein separation is low due to the effect of interactions 
between ES and chitosan. For high crosslink densities, because of the large size of 
protein molecules, the capacity is determined mainly by the mesh size of the film. 
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9.4.6 Conclusions 
ES is a useful medical plant and is a well-known herbal medicine. As a result of its 
high protein content, ES can only be taken in tablet form and cannot be injected 
directly into the patient's body. It is necessary to separate the protein frorn ES before 
injection. From the study in this section, it can be concluded from the protein 
separation studies that chitosan films crosslinked by genipin offer a potential 
membrane material for separation of protein from ES. 
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CHAPTER10 
Conclusions and Future work 
10.1 Introduction 
Novel crosslinked chitosan and chitosan/PEO blend films were prepared using the 
solution casting technique. A naturally occurring and non-toxic crosslinking reagent, 
genipin, was used to form chitosan and chitosan/PEO blend networks. Two types of 
PEO were used, one with a molecular weight of 20,000g/mol (HPEO) and the other of 
600g/mol (LPEO). Genipin is used in traditional Chinese medicine and extracted 
from the Gardenia fruit. Importantly, it overcomes the problem of physiological 
toxicity inherent in the use of some common synthetic chemicals as crosslinking 
agents. The morphology and the physical properties of the films were characterised 
by a number of techniques, such as differential scanning calorimetry (DSC), infrared 
spectroscopy (FT-IR), static laser light scattering (SLLS), small angle x-ray scattering 
(SAXS) etc. The study of the membranes for potential medical application such as 
drug delivery carriers and for protein separation from eleutherococcus senticosus (ES) 
was also conducted. Based on the results obtained from this study, the following 
conclusions can be drawn. 
10.2 Conclusions 
Morphology and crosslinking 
The miscibility of chitosan/HPEO and LPEO blends was investigated by DSC and 
FT-IR spectroscopy. The spectra of the blends indicated that there are specific 
intermolecular interactions between the two components. The interaction parameter, 
X12, in the chitosan/HPEO blends was found to be -0.16. From a thermodynamic point 
of view, the more negative the X12 value, the stronger the interactions are in a blend. 
The degree of crystallinity of HPEO in the samples, which was estimated from DSC 
data, decreased with increasing chitosan content. A phenomenon was observed for 
chitosan/LPEO blends: when wt. % of chitosan was smaller than 60%, the mciting 
points increased as wt. % of chitosan increased. From the studies of FT-IR spcctra, 
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DSC and SAXS, it is believed that there were molecular interactions between chitosan 
molecules and the molecules in crystalline phase in the chitosan/LPEO blends. 
The effects of crosslinking on morphology of the films were also investigatcd. The 
high scattered intensities from chitosan/HPEO and chitosan/LPEO networks suggest 
that heterogeneous structures exist in the blends. This indicates that crosslinking the 
blends, particularly at high HPEO or LPEO contents, leads to phase separation. 
SAXS and DSC results also demonstrated that using natural ly-occurring genipin as a 
crosslinking agent led to decreases in the crystalline size, meaning that the presence of 
networks restricts crystallisation. 
The temperature-dependence of the crosslinking reaction was studied by means of 
FT-IR and UV spectra analysis. The results of FT-IR spectra analysis indicated that 
the crosslinking reaction, where the amino group in chitosan reacted with the ether 
group in genipin, occurred after the addition of genipin. From the UV spectra study, 
the results show that the crosslinking reaction rate and the homogeneity of the 
crosslinking process were influenced by temperature. At 25'C, a homogeneous 
crosslinking reaction occurred. At higher temperatures, the heterogeneous 
crosslinking reaction took place due to the restriction of molecular mobility of genipin 
by the intrinsic viscosity of the chitosan solution and crosslinking reticulation during 
film-formation. 
Conformation of chitosan macromolecules in aqueous solution 
For a more comprehensive understanding of the mechanical properties of chitosan 
films, the examination of the effects of pH on the conformation of chitosan 
macromolecules in solution were performed by SLLS. The results show that the 
conformation of chitosan macromolecules in solution was influenced by the p1l. The 
radius of gyration of chitosan macromolecules in solution increased with increasing 
pH, indicating that chitosan has an extended chain conformation in low pil solutions 
and a tendency to aggregate in high pH solutions. In the dilute chitosan solutions, a 
coil to globule transition, the single chain collapse occurred. 
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Mechanical properties 
The mechanical properties of the chitosan/PEO blend films were investigated under 
various film-forming conditions. 
An improvement in the mechanical properties was achieved when chitosan/LPEO was 
crosslinked with genipin. Tensile tests revealed that the greatest strength (50MPa) 
occurred at 20wt. % LPEO in the chitosan blend and the greatest extension (30%) at 
65wt. % LPEO. The increases in the elongation at break, tensile strength and modulus 
of the crosslinked films, especially in those with high water content, would prevent 
them from disintegrating in medical applications. However, for chitosan/IIPEO 
systems, the results clearly show that crosslinking with genipin did not, because of the 
lower miscibility of chitosan with HPEO, give to rise to improvements in the 
mechanical properties. 
The effects of the solution pH used for film-formation on the mechanical properties of 
the chitosan films were understood by studying the aggregation behaviour of chitosan 
macromolecules in aqueous solutions. In low pH solutions, the homogenous gel 
network was obtained due to intermolecular chain association during gclation, 
resulting in better mechanical properties (tensile strength and elongation at break) of 
the chitosan films. 
The effects of the crosslinking temperature on the mechanical properties of the 
chitosan films were also investigated. The results show that crosslinked chitosan 
films have larger elongation at break when the temperature of 250C was used, This 
can be explained by a homogeneous crosslinking reaction. When the crosslinking 
temperatures were of 400C and 60'C, the films have greater tensile strength and lower 
elongation at break. The localised high crosslinked density region, caused by a 
heterogeneous crosslinking reaction, can be treated as fillers in the film. 
Swelling, stability and surface properties 
With the use of crosslinking, there were noticeable increases in the stability of 
chitosan/HPEO or LPEO blends. Genipin crosslinking produced chitosan networks 
that were insoluble in acidic and alkaline solutions, but were able to swell in these 
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aqueous media. The swelling behaviour of the films exhibited pff- and temperature- 
dependent characteristics. The swelling ability can be controlled by the crosslink 
density. 
The surface properties of the films were also examined by contact angle 
measurements using water and mixtures of water/ethanol. Crosslinked chitosan films 
increase the wetting properties of the film as shown by contact angle measurement. 
The results showed that in water the crosslinked chitosan/HPEO and chitosan/LPEO 
blends were more hydrophobic than the uncrosslinked ones. The addition of PEO and 
crosslinking by genipin led to the existence of polar forces between the chitosan and 
water, and therefore, increases in the surface free energy. However, as a result of 
phase separation in the system, the surface free energy for the crosslinked 
chitosan/HPEO and chitosan/LPEO films declined. When water/ethanol mixtures 
(70/30,50150) were used as media, the surface free energy of the films was lower than 
that in water due to lower hydrophilicity of ethanol. 
Controlled drug-release 
The permeability of vitamin B12 through crosslinked and uncrosslinked, chitosan and 
chitosan/PEO blend membranes was investigated. The effect of crosslink density on 
the drug-release behaviour was also assessed. The drug-release rate decreased with 
increasing crosslink density and was particularly sensitive at low crosslink densities. 
PEO was introduced into the membrane to adjust its mesh size and control the drug- 
release rate through the molecular weight of PEO and the amount used. The effect of 
external pH on the drug-release behaviour was also examined. The drug-release rate 
was sensitive to pH and this was in agreement with the swelling nature. Additionally, 
the results of the study of the effect of the different degrees of deacetylation of 
chitosan on the controlled drug-release show that high degrees of deacetylation meant 
fast rates of drug release. 
ES drug-release from chitosan carriers was conducted in two ways: fixed boundary 
(fully hydrated state) and moving boundary (dry state). For fixed boundary, it was 
clear that the ES release rate from the carrier was governed by both tile mesh size of 
membrane and the molecular interactions between chitosan and ES. This drug-release 
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mechanism obeys Fick's diffusion law. For the moving boundary case, the release 
mechanisms were complex. In the early stages, ES release rate through the carrier 
depends on the degree of swelling ranging from zero in the dry membrane to a 
maximum, which determines the diffusion coefficient (D), for the fully equilibrated 
hydrogel. At the second stage, the diffusion coefficient is constant. When the film 
was crosslinkcd by gcnipin, the value of the diffusional exponent (n), an important 
indicator of the release mechanism, decreased, and the release behaviour was 
generalised from anomalous diffusion to pseudo-Fickian diffusion. 
Protein separation from ES 
The feasibility study of the separation of protein from ES solution by crosslinked 
chitosan membranes was also carried out. Its results suggest that chitosan membrane 
crosslinked by genipin can be used to separate protein from ES when the genipin 
content is higher than 0.3%. 
Overall, it is believed that the present study has provided useful information for 
developing the chitosan/PEO blend films for future medical applications. 
10.3 Recommendations for future work 
In view of the findings of and the developments in the research, recommendations are 
proposed for future work leading to the development of chitosan/PEO blend films 
crosslinked by genipin as potential functional membranes. 
Controlled drug-release 
It is clearly that crosslinking with genipin produced chitosan networks, which are 
sensitive to environmental pH and temperature. They showed remarkable 
characteristics as a drug carrier for control release systems. In this research, drug- 
release through or from the membranes was conducted using vitamin B12 and ES as 
the only drug models. In order to obtain more useful information for medical 
applications, other drugs, such as sensitive drugs (anti-cancer drugs), lower molecular 
weight drugs etc. need to be investigated. 
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Protein separation from ES 
The present feasibility study of protein separation from ES using crosslinked chitosan 
membranes shall be built upon by collaboration with the medical industry to develop 
the protein-removed ES for the purpose of direct injection, thereby widening the use 
of ES. 
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Appendix A: Raw data for study of vitamin B12 release 
Part 1: 
Sample: CS Film thickness: 0.42mm Temp: 37'C, p1l: 7 
Sample: 0.05 CSR (crossl inking density: 0.06 8%) Film thickness: O. Olmm 
Temp: 37'C pH: 7 
t (h) I1 12 13.5 516.5 81 10 1 18 133 
C (mg/L) 1 1.07 1 3.482 16.785 11.505 1 17.251 20.723 1 22.701 1 25.122 1 28.9737d 
Sample: 0.2CSR (crossl inking density: 0.26%) Film thickness: 0.17mm 
Temp: 37'C pH: 7 
Sample: 0.3CSR (crosslinking density: 2.23%) Film thickness: 0.03mrn 
Temp: 37'C pH: 7 
Sample: 0.5CSR (crosslinking density: 4.65%) Film thickness: 0.0085 rnm 
Temp: 370C pH: 7 
Sample: 0.8CSR (crosslinking density: 9.22%) Film thickness: 0.04 rnm 
Temp: 370C p1l: 7 
Sample: ICSR (crosslinking density: 14.35%) Film thickness: 0.036 
Temp: 37'C p1l: 7 
Part 2: 
Sample: 0.5CSR (crosslinking density: 4.65%) Film thickness: 0.0085 rnm 
Temp: 37'C pH: 7 
Sample : CSR/LPEOIO (crosslinking density: 9.22%) Film thickness: 0.025 mm 
Temp: 37'C pH: 7 
Sample : CSR/LPE020 (crosslinking density: 9.22%) Film thickness: 0.04 rnm 
Temp: 370C pH: 7 
Sample : CSRALPEO 30 (crosslinking density: 9.22%) Film thickness: 0.42 mrn 
Temp: 37'C PH: 7 
Sample 4: CSR/HPEOIO (crosslinking density: 9.22%) Film thickness: 0.32 
rnm Temp: 370C PH: 7 
Sample: CSR/HPE020 (crosslinking density: 9.22%) Film thickness: 0.55 
rnm Temp: 37'C pH: 7 
Sample : CSR/HPE030 (crosslinking density: 9.22%) Film thickness: 0.48 rnm 
Temp: 37'C p1l: 7 
Part 3 
Sample: 0.5CSR (crosslinking density: 4.65%) Film thickness: 0.0085 rnm 
Temp: 37'C PH: 7 
Sample: CSR (crosslinking density: 9.22%) pH: 5.5 
Film thickness: 0.15 mm 
It (h) 11 12 13 15 17 18 1 10 124 
1C (mgAL) 10.42 10.71 
_11.02 
1 1.64 12.02 13.51 15.12 1 15. 
ý12 
Sample: CSR (crosslinking density: 9.22%) pfl: 4.3 
Film thickness: 0.21 mm 
t (h) I1 12 ýý4 15 16 18 10 
C (mg/L) 10.22 10.49 1 1.55 11.93 12.56 14.91 
Sample: CSR (crosslinking density: 9.22%) pH: 3.8 
Film thickness: 0.35 mrn 
It (h) 11 12 14 15 16 18 1 10 124 
LC (mg/L) 10.20 10.39 10.78 1 1.19 1 1.46 13.91 1-1 15. 
Part 4: 
Sample 1: CS (DD: 75%) pH: 7.0 
Film thickness: 0.19 mm 
t (h) 2 13 14.5 6 18 110 
90 1 1.24 12.06 2.70 13.71 14.98 
Sample: CS Film thickness: 0.42mm Temp: 37'C, p1l: 7 
Sample 2: CS (95%) pH: 7 
Film thickness: 0.45 mm 
It (h) 11 12 13.5 14.5 16 1= 24 
1C (mg/L) 10.21 10.34 10.75 1 1.24 1 1.46 1 1.61 12.78 1-ý 
Sample 1: CSR (DD: 75%) pH: 7.0 
Film thickness: 0.32 mm 
It (h) 11 12 13 14.5 16 18 1 10 --f -24 
1C (mgAL) 10.44 1080 1 1.14 1 1.86_., l 2.65 13.51 14.78 1- 
Sample: 0.5CSR (crosslinking density: 4.65%) Film thickness: 0.0085 rnm 
Temp: 37'C pH: 7 
Sample 3: CSR (95%) pH: 7.0 
Film thickness: 0.41 mm 
It (h) 11 12 13.5 15 16 18 1 10 1 
IC (mg/L) 10.012 10.34 10.75 11.24 12.46 13.51 14.78 
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Novel cross-linked chitosan-based films were prepared using the solution casting 
technique. A naturally occurring and nontoxic cross-linking agent, genipin, was used to 
form the chitosan and chitosan/poly(ethylene oxide) (PEO) blend networks, where two 
types of PEO were used, one with a molecular weight of 20 000 g/mol (IIPEO) and the 
other of 600 g/mol (LPEO). Genipin is used in traditional Chinese medicine and extracted 
from gardenia fruit. Importantly, it overcomes the problem of physiological toxicity 
inherent in the use of some common synthetic chemicals as cross-linking agents. The 
mechanical properties and the stability in water of cross-linked and un-crosslinked 
chitosan and chitosan/PEO blend films were investigated. It was shown that, compared 
to the transparent yellow, un-cross-linked chitosan/PEO blend films, the genipin cross- 
linked chitosan-based film, blue in color, was more elastic, was more stable, and had 
better mechanical properties. Genipin-cross-linking produced chitosan networks that 
were insoluble in acidic and alkaline solutions but were able to swell in these aqueous 
media. The swelling characteristics of the films exhibit sensitivity to the environmental 
pH and temperature. The surface properties of the films were also examined by contact 
angle measurements using water and mixtures of water/ethanol. The results showed that, 
with the one exception of cross-linked pure chitosan in 100% water, the cross-linked 
chitosan and chitosan/PEO blends were more hydrophobic than un-crosslinked ones. 
